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Abstract 
 
Skeletal health is a critical determinant of animal health and welfare. Kyphosis is one such 
idiopathic skeletal disease that compromises the welfare of commercial pigs. Vitamin A 
regulates the expression of genes that define bone growth and development, and has been 
suggested to associate with kyphosis. This thesis aimed to establish the molecular basis of 
kyphosis, clarify vitamin A’s role on the expression of genes that regulate skeletal 
development, and to ascertain vitamin A’s role on gene expression in kyphotic pigs.  
The TGF-β signalling pathway was associated with kyphotic bone and cartilage tissues. This 
was due to bone and cartilage tissues showing associations with small-leucine rich 
proteoglycans, ASPN and DCN respectively, which regulate TGF- β signalling. Potential 
effects as a result of differential gene expression include reduced endochondral bone 
growth and deterioration of articular cartilage.  
The dose of vitamin A was observed to be a critical factor in the regulation of expression of 
skeletal genes within bone tissue. Genes related to the family of Rho-GTPases, which control 
cytoskeletal dynamics, were observed to be differentially regulated within the trabecular 
bone in response to vitamin A. In addition, vitamin A dose was observed to initially 
antagonise serum 25(OH) D, and upon full saturation of the liver with vitamin A, serum 
25(OH) D was restored through, as of yet, unknown mechanisms.  
The gene GIT2, which associates with Rho-GTPases, was observed to be differentially 
downregulated within kyphotic trabecular bone, and showed a dose-response relationship 
with vitamin A supplementation. Furthermore, kyphotic pigs were indicated to have 
reduced vitamin D status.  
This research has outlined the molecular basis of kyphosis in pigs, and has indicated vitamin 
A and vitamin D drive the disease. The research also outlines the role of how excessive 
vitamin A controls the expression of genes that regulate bio-mineralisation in trabecular 
bone. The thesis has also offered novel insights into vitamin A’s potential role in regulating 
gene expression during kyphotic development.  
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Chapter 1: Nutrition and bio-mineral tissue development in pigs 
1.1 General Introduction 
Bone is a unique and diverse tissue which composes the skeleton in all vertebrates; the 
basic purpose of the skeleton is to provide structural integrity to the growing organism and 
to deliver support in relation to movement (Burr and Allen, 2014). Therefore, abnormalities 
in the development of bones can seriously compromise welfare, and bone development 
remains a critical determinant of health in animal and human medicine. Disorders such as 
osteoporosis in humans (Manolagas, 2000) and rickets in pigs (Madson et al., 2012) are 
examples which demonstrate abnormal bone development. Lameness in pigs, characterised 
by weakness in legs, is often associated with osteochondrosis and subsequent lack of 
skeletal mineralisation (Dewey et al., 1993, Etterlin et al., 2015). Other bone disorders that 
can contribute to lameness include osteomalacia, which is also characterised by lack of 
sufficient mineralisation (Sedman et al., 1987, Dewey et al., 1993). Lameness holds 
significant economic losses for farmers, with surveys indicating bone fractures related to 
lameness are a significant cause towards a drop in profitability, as well as pain in animals 
(Jensen et al., 2012). Therefore, bone health remains a critical factor in determining animal 
welfare, and maintenance of the welfare of animals within farming systems remains a focus 
of the industry. 
One such bone disease that has been plaguing the commercial pig industry in recent 
decades is that of idiopathic lumbar kyphosis (Penny and Walters, 1986, Halanski et al., 
2018). The disease is adequately termed due to an uncanny resemblance to Scheurmanns 
kyphosis in humans and is characterised by an abnormal, outward curvature of the spine at 
the thoraco-lumbar junction (Nielsen et al., 2005). In all vertebrates, the vertebral skeleton 
is ultimately derived from two tissue types: bone and cartilage (Figure 1.1), and the 
formation of these two tissues types initially derive from Mesenchymal stem cells (MSCs). 
MSCs condense into sites of differentiation to form the initial template of the skeleton and 
have the potential to differentiate into osteoblasts, osteoclasts, adipocytes or chondrocytes 
cells. These cells govern bone formation, bone resorption, fat synthesis and cartilage 
metabolism respectively (Karsenty et al., 2009, Gimble et al., 2006, Burr and Allen, 2014). 
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Endochondral ossification is a process by which MSCs differentiate into chondrocytes, which 
then form a cartilaginous template surrounded by a fibrous membrane that resembles the 
shape of bone, which is subsequently replaced by ossified tissue and mineralised matrix by 
invading osteoblasts (Berendsen and Olsen, 2015). The process of endochondral bone 
growth is tightly controlled by a variety of molecular signalling pathways, these include Bone 
Morphogenetic Protein (BMP), and Transforming-Growth factor – Beta (TGF- β) signalling 
pathways (Kronenberg, 2003, Westendorf et al., 2004). A summary of these pathways can 
be viewed in Figure 1.2, and the depth of their relevance to bone growth will be further 
explored in this review. Knockout of genes related to these processes, or use of antagonists, 
are associated with the development of diseases such as osteoporosis, characterised by a 
reduction in skeletal mineralisation and growth (Li et al., 2007, Westendorf et al., 2004). Yet 
it is not known how a disturbance in the delicate process of bone growth has been affected 
in kyphotic pigs, or which pathways associate with the disease.  
Vitamin A is a fat soluble vitamin that is obtained from the diet. Excess vitamin A 
supplementation has been suggested to be a factor that contributes to the development of 
kyphosis (Belsue, 2010), and has been observed to induce fragility of bones and halt 
endochondral bone growth in pigs (Pryor et al., 1969, Wolke et al., 1968). The mechanisms 
by which vitamin A potentially contributes to kyphosis, however, remain unexplained; and 
the role of vitamin A in overall bone development sparks significant debate. It has also been 
demonstrated that excess vitamin A can regulate mRNA expression of genes related to Wnt 
signalling in bone marrow, but reduced Wnt signalling is observed in cortical bone  (Lind et 
al., 2012), and this demonstrates vitamin A’s apparent compartment-specific effects. 
However, exactly how excess vitamin A affects the molecular development of trabecular 
bone, which composes the main body of the vertebrae, remains unanswered. These 
questions need investigating not only to understand how vitamin A is contributing to 
vertebral trabecular bone development, but also to begin establishing a basis as to how 
vitamin A is associated with the development of kyphosis.    
In addition, extensive work from a research group in Wisconsin have shown that vitamin D 
deficiency is a factor that can contribute to the development of kyphosis, and that genes 
which regulate osteoblast mineralisation, such as osteocalcin (BGLAP), are downregulated in 
the bone tissue of these pigs (Amundson et al., 2016, Rortvedt and Crenshaw, 2012). 
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Vitamin A and vitamin D are critical factors in determining skeletal health, as demonstrated 
by studies associating them with bone abnormalities such as lameness, osteoporosis, and 
rickets (van Riet et al., 2013, Jackson and Sheehan, 2005, Ahmadieh and Arabi, 2011, 
Madson et al., 2012). There is also an observed interaction between vitamin A and vitamin 
D, with the consensus being that one vitamin has the potential to remedy toxic effects of 
the other. Studies in rats (Clark and Bassett, 1961), turkeys (Metz et al., 1985) and broilers 
(Aburto et al., 1998) have demonstrated vitamin A can counter toxic effects on bone tissue 
induced by vitamin D, and vice versa. The mechanisms that define these have not been fully 
clarified; it has been suggested that vitamin A antagonises serum vitamin D (25(OH)D) 
(Frankel et al., 1986) but the exact mechanisms are unclear.    
The underlying molecular basis of kyphosis requires further definition so as to broaden 
understanding of this idiopathic disease. The group in Wisconsin have yielded interesting 
results in relation to association between kyphosis and vitamin D, but there remains a need 
to confirm this on farms in the UK. The only study investigating the association between 
kyphosis and vitamin A suggested that excessive feeding of vitamin A to sows drives 
kyphosis in resultant offspring (Belsue, 2010). But this also demonstrated the requirement 
for more work to investigate the association. There are still questions remaining such as: 
which genes and pathways are vitamin A interacting with that explains its mechanistic 
association with kyphosis, and is vitamin A potentially antagonising serum vitamin D in 
kyphotic pigs? Furthermore, there remains a need to further characterise vitamin A’s roles 
in trabecular bone development, so as to broaden understanding of vitamin A’s roles in 
bone growth. The aim of the thesis was to elucidate the molecular basis of kyphotic tissues, 
understand how excessive vitamin A affects the molecular profile of vertebral trabecular 
bone, and clarify the association between kyphosis and vitamin A, both in terms of the 
molecular level and antagonism with vitamin D. The knowledge will assist in the design of 
intervention strategies for kyphosis and broaden understanding of vitamin A’s roles in 
maintaining skeletal health, all of which will contribute to the health and welfare of 
commercial pigs.  
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1.2 Skeletal Development   
1.2.1 Endochondral Bone Growth   
There are 4 types of bone that exist within all vertebrates: long, short, flat or irregular. A 
typical bone can be classed into having separate compartments: cortical, or compact, bone 
composes the outer, dense layer of the tissue (Thibodeau and Patton, 2010); meanwhile 
trabecular bone consists of a network of connections in a spongy-like structure on the 
endosteal, or inner, surface of cortical bone (Kenkre and Bassett, 2018). The vertebral 
column, otherwise known as the spine, is composed of separate, singular bones called 
vertebrae, which are classed as irregular bones (Thibodeau and Patton, 2010). The vertebral 
column is composed of a total of 5 constituents: the cervical, thoracic, lumbar, sacrum and 
coccyx sections (Thibodeau and Patton, 2010) (Figure 1.1). The vertebral body itself is 
composed of unique, defined sections, but the main body of the vertebrae consists of 
trabecular bone surrounded by a layer of cortical bone (Müller-Gerbl et al., 2008). Adjacent 
to vertebral bodies are sections of articular cartilage which make up the intervertebral disc 
(Thibodeau and Patton, 2010).   
There are various cell types that compose bone tissues, and these can be summarised into: 
osteoblasts, osteoclasts, chondrocytes, and adipocytes (Burr and Allen, 2014). Osteoblasts, 
chondrocytes, and adipocytes are all derived from a mesenchymal stem cell (MSC) lineage 
(Burr and Allen, 2014), while osteoclasts are multinucleated cells of a 
monocyte/macrophage lineage (Hoebertz et al., 2003). Overall, skeletal development can be 
classed into two processes: intramembranous ossification and endochondral ossification; 
both of these processes initially begin with MSCs condensing into locations that define the 
architecture of the skeleton. In regards to intramembranous ossification, MSC condensation 
occurs, and these cells differentiate into osteoblasts to directly synthesise bone tissue in 
regions such as the skull or collarbone (Burr and Allen, 2014). Osteoblasts, termed “bone-
formation cells”, produce various matrix proteins that compose bone extracellular matrix 
(ECM) including type 1 collagens, and non-collagenous proteins such as osteocalcin (Kim et 
al., 2012). Osteoblasts also play a role in  bone mineralisation through contributing to 
hydroxyapatite crystal formation, which forms the mineral component of bone (Kenkre and 
Bassett, 2018). On the other hand, endochondral ossification is a more complex process 
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Figure 1.1: A. The vertebral column is composed of 7 cervical, 12 thoracic, 5 lumbar, 1 
sacrum, and 1 coccyx vertebrae in adult mammals. B. Individual vertebrae are composed of 
defined structures, but the main vertebral body consists of trabecular bone surrounded by a 
layer of cortical bone. C. Intervertebral discs composed of articular cartilage are layered 
between individual vertebrae to provide mobility to the spine. Adapted from 
DayDreamAnatomy (2017) 
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which can be classed into two overall steps: chondrogenesis, followed by ossification. MSCs 
produce an ECM composed of type 1 collagens which forms the future template of the 
developing skeleton; these cells subsequently differentiate into proliferating chondrocytes, 
which produce an ECM composed of type 2 collagens (Karsenty et al., 2009). Chondrocytes 
continue to proliferate, and differentiate into hypertrophic chondrocytes which produce 
type X collagen, at this stage conditions are achieved such that the ECM surrounding 
hypertrophic chondrocytes is ready for mineralisation (Karsenty et al., 2009). 
Vascular invasion occurs at the site of hypertrophic chondrocyte maturation and this results 
in the formation of a primary centre of ossification (POC), it is within this region that 
osteoblast precursors, osteoclasts and epithelial cells are delivered to the cartilage (Maes et 
al., 2010, Kenkre and Bassett, 2018). Differentiated osteoblasts at the site initially lay down 
an ECM rich in type 1 collagen on top of the type X ECM, and this contributes to the 
formation of trabecular bone, meanwhile osteoblasts delivered to the perichondrium, or 
outer bone surface, deposit and form cortical bone (Karsenty et al., 2009, Berendsen and 
Olsen, 2015). In the structure of mineralised bone tissue are osteocytes, which were 
formerly osteoblasts, and these compose the lacunae of compact bone (Thibodeau and 
Patton, 2010). Calcification of the matrix results in death of chondrocytes and vascular 
invasion from primary blood vessels delivers endothelial cells to the template in order to 
form bone marrow (Yang et al., 2014, Maes et al., 2010, Karsenty et al., 2009).  
As bone continues to develop in this manner, the POC expands and secondary ossification 
centres form on the ends of long bones, afterwards the epiphyseal growth plate develops 
on the ends of long bones (Berendsen and Olsen, 2015). The epiphyseal growth plate is an 
essential component which determines overall longitudinal bone growth. The growth plate 
is composed of several zones which underpin its structure and function, however it is in its 
fourth region in which hypertrophic chondrocytes differentiate; as chondrocytes in the 
growth plate become hypertrophic, they express genes such as RUNX2 and Matrix 
metalloproteinases (MMPs) to degrade the ECM, and allow vascular invasion and 
subsequent mineralisation of matrix by osteoblasts (Woods et al., 2007, Burr and Allen, 
2014). The combined actions of osteoblasts, chondrocytes and osteoclasts, to remove 
calcified matrix before new bone is laid down by Osteoblasts, govern bone growth and 
modelling (Burr and Allen, 2014). The continuous mineralisation of the hypertrophic zone of 
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the growth plate allows for the growth of bones throughout life, eventually resulting in the 
thinning of the growth plate during puberty in humans (Berendsen and Olsen, 2015). 
Endochondral bone growth is a complex process which remains a key area of heavy research 
interest, and is essential for healthy growth and development of the organism. 
1.2.2 Bone Remodelling  
In contrast to osteoblasts and their roles in the regulation of bone formation, bone 
resorption is a process in which bone tissue is dissolved, and this is regulated by osteoclasts. 
During endochondral bone growth, osteoclasts have been observed to control skeletal 
shape through initiating resorption on the periosteal surface of bones to preserve the 
structure of the diaphysis (Kenkre and Bassett, 2018). Mature bone undergoes continuous 
remodelling, and the essential reasons for this are to alleviate skeletal damage, prevent the 
development of over-mineralised and brittle bones, and to maintain Calcium (Ca) and 
Phosphorus (P) homeostasis in bone and serum (Kenkre and Bassett, 2018). Osteoclasts 
migrate to bone surfaces and secrete proteolytic enzymes, predominantly Cathepsin K 
(CPK), to dissolve and remove the mineral component of bone as well as collagenous matrix 
(Hoebertz et al., 2003).  
1.2.3 Maintenance of Articular Cartilage    
The process of endochondral bone growth and bone remodelling defines the roles that 
cartilage and bone tissues play in the growth of the skeleton. However the articular 
cartilage, which composes the intervertebral disc, is also very relevant to bone biology. 
Articular cartilage is a unique tissue composed of collagen and proteoglycan (PG)-rich ECM, 
and the intervertebral disc provides the tissue with its ability to resist spinal compression 
and provide limited  stability to the skeleton (Craddock et al., 2018, Adams and Roughley, 
2006). Mature chondrocytes synthesise collagen, glycosaminoglycans (GAGs) and PGs to 
maintain the structure of the articular cartilage; PGs and GAGs also attract water molecules 
to give the disc its osmotic properties (Woods et al., 2007). Families of large and small PGs, 
such as Aggrecan and Decorin respectively, are dispersed among the nucleus pulposus (NP) 
and annulus pulposus (AP) of the intervertebral disc (Melrose et al., 2001). The 
combinations of type 2 collagens and PGs such as aggrecan provide the disc with its 
characteristic tensile and ability to resist tensile forces, indeed age-associated cartilage 
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degeneration is associated with loss of PGs such as aggrecan (Craddock et al., 2018). Small-
leucine rich proteoglycans (SLRPs) are another class of PGs observed in articular cartilage 
that compose the structure of the tissue; this specialised class of PGs hold small protein 
cores (36 kildaltons (kda) to 42 kda) and undergo post-translational modifications that allow 
them to perform their functions (Nikitovic et al., 2012). These modifications present SLRPs 
with side chains such as chondroitin, dermatan sulfate, or keratin sulfate (Nikitovic et al., 
2012). Active SLRPs are involved in the generation of type 1 collagen fibrillogenesis (Burton-
Wurster et al., 2003), maintain chondrocyte differentiation, and ensure GAG production is 
consistent throughout the growth of the tissue (Salinas and Anseth, 2009). The 
intervertebral disc is another constituent of bone biology that requires maintenance in 
order to contribute to healthy skeletal growth.   
1.3 Genetic Control of Bone Growth  
1.3.1 TGF-β and RANK Canonical Signalling Pathways 
As discussed above, the processes of bone and cartilage growth are extensive, unique, and 
diversely complex. The differentiation and function of osteoblasts and osteoclasts, from 
MSCs and macrophage precursors respectively, are tightly controlled by a variety of 
molecular signalling pathways. Should the lineage commitments of these cells become 
unbalanced, this is detrimental in the pathogenesis of various bone disorders; for example, 
enhanced adipogenesis of MSCs within bone marrow is associated with the development of 
osteoporosis and reduced bone mineral density (BMD) (Justesen et al., 2001, Kindblom et 
al., 2005). Increased bone resorption activity or a reduction in osteoblast cell numbers have 
also been attributed to osteoporosis (Li et al., 2011, Ruiz-Gaspa et al., 2010, Rodan and 
Martin, 2000). Understanding how molecular and biochemical pathways control these 
delicate processes is essential in order to pinpoint the mechanisms by which abnormalities 
in bone development can arise.    
Examples of critical pathways that control endochondral bone growth, for bone and 
cartilage tissues, include: Indian Hedgehog (IHH), Bone Morphogenetic Protein (BMP), 
Transforming-Growth factor – Beta (TGF- β), and Wnt signalling pathways (Kronenberg, 
2003, Westendorf et al., 2004) (Figure 1.2). Mutations in genes belonging to the TGF- β and 
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Figure 1.2: A summary of the different molecular signalling pathways that control chondrocyte and osteoblast differentiation. TGF-β binds to its 
receptor, which initiates phosphorylation of Smad2 and Smad3, the complex also binds Smad4 and trans-locates to the nucleus to control gene 
expression. BMPs bind to their receptors and initiate phosphorylation of Smad1/5/8, of which also associates with Smad4 and trans-locates to 
the nucleus. Hedgehog ligands bind to receptor Patch-1, and removes its inhibitory effect on Smoothened receptor. This allows for 
accumulation of Gli, which trans-locates to the nucleus to control gene expression. Wnt ligands bind to Frizzled receptor, which then associates 
with LDL co-receptor. The resultant complex disassociates the GSK3β, APC, Axin complex, which allows for accumulation of β-Catenin in the cell, 
which trans-locates to the nucleus to control expression of target genes.   
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BMP pathways are associated with the development of skeletal diseases (MacFarlane et al., 
2017).  The BMP signalling pathway, a component of the TGF- β signalling pathway, 
regulates skeletal development through controlling the differentiation of embryonic stem 
cells into osteoblasts, osteoclasts and chondrocytes. Activated BMP receptors, upon ligand 
binding, phosphorylate Smads 1,5, and 8; this trimeric complex then associates with smad4 
and the complex translocates to the nucleus to control gene expression (Wan & Cao 2005; 
Kamiya et al. 2016). In addition, there is also evidence that BMPs can control MAPK or Erk 
signalling to control chondrocyte and osteoblast differentiation (Wan and Cao, 2005). BMPs 
are able to commit MSCs into osteoblasts, particularly through upregulating Runt-related 
transcription factor 2 (RUNX2) or distal homeobox-5 (DXL5) which in turn regulates 
osteoblast specific genes such as osteocalcin and osteopontin (Manolagas, 2000). While 
BMPs concern committing progenitor cells towards an osteoblast lineage, it is through 
growth factors such as TGF- β that the differentiation and replication of commited 
osteoblast progenitors is initiated. Upon ligating to a TGF- β I or TGF- β II receptor, 
phosphorylation of smad2/3 and smad4 proteins are induced and the resultant complex 
translocate into the nucleus to initiate the expression of osteoblastic genes, such as RUNX2, 
that commit the cell to an osteoblastic lineage (Chen et al., 2012). TGF- β has also been 
observed to have an effect on positively regulating chondrocyte differentiation: incubation 
of TGF- β with MSCs, alongside dexamethasone treatment, induces chondrogenesis, marked 
by increased gene expression of type II collagen. In addition to the regulation of 
mineralisation, TGF- β and BMP pathways also regulate genes such as VEGF to control 
angiogenesis and blood vessel formation (Goumans et al., 2009), which is required for 
endochondral bone growth (Maes et al., 2010).  
Signalling pathways which contribute to osteoclast differentiation include: IKK, JNK, p38, 
ERK and Src (Boyle et al., 2003). Src and ERK signalling contribute to cytoskeletal 
rearrangement to allow for cell motility and adhesion, while the other pathways, including 
Notch signalling, control expression of osteoclast transcriptional factors such as NFAT2 
(Boyle et al., 2003, Jin et al., 2016). In physiological conditions, these pathways are 
controlled by the RANK signalling network, composed of Receptor Activator Of Nuclear 
Factor-Kappa B ligand (RANKL) binding to Receptor Activator Of Nuclear Factor-Kappa B 
(RANK) on the surface of macrophage precursors (Boyle et al., 2003, Boyce and Xing, 2007). 
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Osteoblasts have a degree of control over the RANK-RANKL axis through producing 
Osteoprotegerin (OPG), which acts as a decoy receptor for RANKL and prevents its bindingto 
RANK (Boyce and Xing, 2007). CSF1 is another regulator of osteoclast differentiation, and 
initiates proliferative effects on osteoclasts through activating PI3K and Erk signalling (Ross, 
2006).  
1.3.2 Contributions of Cytoskeletal Dynamics to Bone Development  
Another factor to consider in relation to regulation of endochondral growth and bone 
remodelling, aside from traditional receptor-ligand interactions and initiation of intracellular 
signalling, is that of the cellular cytoskeleton. The cytoskeleton is present in all eukaryotic 
cells and is composed of a total of 3 protein networks: actin microfilaments, microtubules 
and intermediate filaments (Lomri and Marie, 1996, Wangping et al., 2014). Actin filaments 
arise as a result of polymerisation of actin proteins, microtubules are composed of tubulin 
proteins, and intermediate filaments are composed of proteins such as vimentin (Langelier 
et al., 2000) . As a result of the organisation of these networks, the cytoskeleton provides 
morphology and motility to the cell. It has been demonstrated that disruption of either the 
microtubule or intermediate filaments of the cytoskeleton results in cellular apoptosis and 
inability to maintain cartilage ECM in chondrocytes (Wangping et al., 2014), and 
rearrangement of actin filaments has been shown to associate with osteoblast-mediated 
mineralisation in vitro (Goncharenko et al., 2016). Cells have specialised receptors on the 
surface termed integrin’s, composed of various αβ heterodimers, which substrates such as 
TGF- β may interact with (Munshi et al., 2004). Additionally, integrin’s on the surface of 
osteoblasts are able to adhere to and interact with the ECM; upon adherence, ECM proteins 
stimulate osteoblast differentiation through binding integrin’s and initiating pathways such 
as Extracellular signal related kinase (ERK) and Focal adhesion kinase (FAK) to control RUNX2 
expression and alkaline phosphatase (ALKp) activity (Oh et al., 2017, Moussa et al., 2014). 
The mechanical linkage between the cell and the ECM, that allows adherence between 
cellular integrin’s and the ECM, is referred to as a focal adhesion complex, and the 
formation of these complexes are regulated by the actin cytoskeleton (Lomri and Marie, 
1996). Reorganisation of the actin cytoskeleton is required to induce morphological changes 
in the cell, and these are associated with initiation of mineralisation activity in osteoblasts in 
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vitro (Goncharenko et al., 2016). Cytoskeletal reorganisation is also observed in response to 
integrin-mediated adhesion and subsequent differentiation of osteoblasts through ERK 
signalling (Hendesi et al., 2015). Furthermore, other studies have shown the composition of 
ECM proteins is able to influence the cytoskeletal arrangement of the osteoblast (Demais et 
al., 2014), and disorganisation of the cytoskeleton results in impaired morphology and 
differentiation of osteoblasts (Lomri and Marie, 1996). Cytoskeletal reorganisation is also 
very critical in controlling the differentiation of chondrocytes; this is based on evidence in 
which cytoskeletal reorganisation in embryonic stem cells (ESCs) was required in order to 
allow for the expression of differentiation factors such as SRY-Box 9 (SOX9) (Zhang et al., 
2006). Indeed, arrangement of the actin cytoskeleton has been demonstrated to induce a 
rounded cellular morphology of chondrocytes and this is consistently association with 
differentiation of chondrocytes (Loty et al., 1995, Zhang et al., 2006). There is additional 
evidence indicating actin reorganisation is also required for chondrocytes to enter a 
hypertrophic state prior to endochondral ossification (Woods et al., 2007). Aside from cell-
matrix interactions, cell-cell interactions can additionally influence the differentiation of 
chondrocytes, one such gene that regulates adhesiveness between cells is N-cadherin, 
which not only contributes to cytoskeletal function independently, but downstream targets 
can include the Rho-GTPases (Woods et al., 2007). Cell surface integrin’s are also on the 
surface of osteoclasts: in particular the αVβ3 complex, upon ligand binding, induces 
cytoskeletal reorganisation in order to allow formation of actin rings within the ruffled 
border membrane, and thus regulate proteolytic enzyme release (Teitelbaum, 2011).  
Regulation of actin cytoskeletal dynamics is controlled by a family of molecules termed the 
Rho-GTPases, these include: Cell Division Cycle 42 (CDC42), Rho, and Rac (Nobes and Hall, 
1995). A summary of Rho GTPase signalling can be viewed in Figure 1.3. Further evidence 
which demonstrates the cytoskeleton’s role in osteoclasts shows the mRNA expression of 
CDC42 is required for osteoclast differentiation and bone resorption activity in vitro (Ito et 
al., 2010). The Rho-GTPases switch between GTP-bound and GDP-bound states, 
representing activation and inactivation respectively, and these are regulated by Rho 
guanine nucleotide exchange factors (Rho-GEFs) (Gao et al., 2011). Active CDC42 and Rac 
can induce phosphorylation of p-21 activated kinase (PAK) to control lamellipodia and 
fillopodia formations in the actin cytoskeleton, which ultimately contribute to 
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Figure 1.3: An overview of Rho-GTPase signalling. Rho GEFs stimulate GTP binding to Rho-GTPases, allowing for their activation. Through 
phosphorylating and interacting with various downstream molecules, notably PAK and ROCK, the Rho-GTPases contribute to the formation and 
reorganisation of cytoskeletal components. The formation of stress fibres maintains adherence to the ECM.  
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rearrangement and extension of the cytoskeleton which comes to define cell morphology 
and motility (Hoefen and Berk, 2006, Rane and Minden, 2014, Nobes and Hall, 1995). PAKSs 
may also phosphorylate and activate a variety of other molecules in order to stabilise 
polymerised actin structures, these include: myosin light chains, filamins, and LIM kinases 
(Rane and Minden, 2014). Rho signals through Rho-associated, coiled-coil containing protein 
kinase (ROCK) in order to regulate stress fibre formation, which are polymerised actin 
structures that maintain focal adhesions, Rho-ROCK signalling has also been demonstrated 
to directly influence SOX gene expression and the differentiation of chondrocytes to a 
hypertrophic state (Woods et al., 2007, Rane and Minden, 2014). In contrast, PAKs can 
contribute to stress fibre dissolution (Rane and Minden, 2014), although this an event 
required for reorganisation of the cytoskeleton (Zhang et al., 2006). Therefore the actions of 
Rho-GTPases and their subsequent effects on cytoskeletal reorganisation and focal adhesion 
maintenance, through affecting fillopodia, lamellipodia and stress fibre polymerisation, 
must be coordinated in order to allow for regulation of cell morphology, motility and 
contact with the ECM.     
1.4 Idiopathic Lumbar Kyphosis  
1.4.1 Aetiological and Epidemiological Findings 
Kyphosis, also referred to as “humpy-back” syndrome, persists in commercial pigs (Figure 
1.4) (Done and Gresham, 1988, Done et al., 1999). The mature spine does require some 
degree of curvature in order to provide balance, support and strength (Thibodeau and 
Patton, 2010), but the characteristic, abnormal curvature at the thoraco-lumbar junction in 
kyphosis represents an unusual case of spinal development. Although kyphosis does not 
cause any obvious signs of pain in affected animals, it poses various challenges, with regards 
to economic consequences and the compromise of welfare, to the commercial producing 
industry. Inflicted pigs have been reported to have growth rate severely slowed in the 
finisher phase, often failing to reach slaughter weight (Straw et al., 2009), and further 
complications arise with handling the carcass within automatic slaughterhouse systems (Holl 
et al., 2008). From a welfare perspective, veterinary observations have observed a 
compression of the spinal cord between kinked vertebrae in severely affected animals, 
resulting in clinical signs of weakness and partial paralysis (Done and Pearson, 2004).  
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Figure 1.4: A clinical presentation of a severe case of kyphosis, characterised by the 
noticeable rising of the spine at the thoraco-lumbar junction, giving a “humpy-back” 
appearance. Adapted from Halanski et al. (2018).  
The information available in the literature indicates that, in 1988, the average prevalence of 
pigs affected within herds was 4.5% (Done and Gresham, 1988) and in 2005 a prevalence up 
to 11.4% was observed in herds (Straw et al., 2009). The disease has been identified on a  
global scale with cases appearing in the USA (Rortvedt and Crenshaw, 2012), Spain (Pallarés 
et al., 2013), Canada (Drolet et al., 2012), Denmark and Sweden (Straw et al., 2009); and was 
first identified on British farms in 1979 (Penny and Walters, 1986). In addition, symptoms 
have ranged in new-born pigs up to pigs weighing 60kg (Done and Pearson, 2004, Done and 
Gresham, 1988). In several cases, the condition has been attributed to having a genetic basis 
(Done et al., 1999, Done and Pearson, 2004), and additional work has been done in order to 
verify this association (Lindholm-Perry et al., 2010, Holl et al., 2008), but this is still up for 
debate among the academic and commercial communities. 
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1.4.2 Clinical Presentation of Kyphosis 
 The “humpy-back” syndrome has appeared sporadically among UK pig units, presenting at 
least 4 different variants of the disease, each characterised by their own aetiology and post-
mortem appearance. Penny and Walters (1986) first identified the disease on UK farms and 
observed indoor pigs, aged 3 weeks to 16 weeks of age, to develop symptoms on breeding 
and fattening farms. Done and Gresham (1988) observed a seasonal effect in that cases 
appeared after December, affected pigs had lower Ca and P values in bone, and there was 
occasional widening of the intervertebral disc. In a second variation of the disease, Done et 
al. (1999) observed the development of hemi-vertebrae within the thoracic region of 
affected pigs, and animals aged as early as 3-4 weeks showed symptoms. Nielsen et al. 
(2005) also observed hemi-vertebrae in kyphotic pigs in a separate case, and also noted 
insufficient vessels in these regions and incomplete mineralisation of the tissue. In a third 
variation, Done and Pearson (2004) observed the presentation of kyphosis was 
characterised by collapsing and loosening of intervertebral disc space between the 13th 
thoracic and 1st lumbar body of the spine. In this case, pigs showed clear signs of leg 
weakness and tremors, likely as a result of entrapment of the spinal cord. In Canada, 
another variant of kyphosis was observed in which piglets, up to 2 weeks of age, showed the 
characteristic symptoms with 6 out of 11 animals also showing signs of Alopecia Areata (AA), 
of which is an autoimmune disorder that results in hair loss (Drolet et al., 2012). Upon 
further examination it was also discovered that the thoracic rib-cages of humpy-back pigs 
bore multiple fractures one each side, along with nodular callus which appeared to be 
composed of demineralised cartilage (Drolet et al., 2012). 
These observations highlight kyphosis as a serious skeletal disease, but the biological basis 
of these aetiological changes remains unknown. No studies as of yet have attempted to 
investigate how genes and pathways relating to endochondral bone growth or bone 
remodelling are affected within the tissues of kyphotic pigs, and this presents a significant 
gap in our understanding of the disease.  
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1.5 Nutritional Influence on Bone Development 
1.5.1 Calcium and Phosphorus  
The processes of bone metabolism are tightly controlled by present biological factors in the 
body such as the cell cytoskeleton, and genetically coded growth factors such as TGF-β. Yet, 
external factors are able to form interactions with genetic and cellular machinery in order to 
define bone development in the organism, and one of these key external influences is 
nutrition. The minerals Ca and P are vital constituents that compose 98% and 80%, 
respectively, of the skeleton, and these are required to be obtained from the diet 
(Whittemore and Kyriazakis, 2006). The hydroxyapatite crystal, which composes the mineral 
component of bone, predominantly consists of Ca and P [Ca10 (P04)6(OH) 2], this crystal 
composes bone tissue alongside type 1 collagens, non-collagenous proteins and bone cells 
(Kenkre and Bassett, 2018). Consequently, a deficiency in the intake of Ca has significant 
effects on bone development. A reduction in dietary Ca intake induces bone resorption 
through a combined activation of Parathyroid Hormone (PTH) and 1,25(OH)2D, the 
dissolving of Ca from bone as a result of osteoclasts allows serum Ca to be restored (Eklou-
Kalonji et al., 1999, Lieben et al., 2012). In a separate study, low dietary Ca was found to 
reduce BMD in neonatal pigs (Mahajan et al., 2011). Aside from exerting control over bone 
resorption, in vitro evidence also indicates Ca may directly influence expression of 
osteoblast transcription factors such as RUNX2 (Mahajan et al., 2011), and is required for 
matrix mineralisation in combination with Vitamin D (Tourkova et al., 2017).  
The source of P in commercial diets is of plant origin and 2/3rds of supplementation consists 
of Phytate; this form of P is not readily digested in pigs therefore phytase is added in diets in 
order to allow for greater utilisation of P (Simons et al., 1990). P is a critical nutrient in 
maintaining bone development, a deficiency of P in diets clearly reduces bone mineral 
content (BMC) and BMD in pigs (Liesegang et al., 2002, Rortvedt and Crenshaw, 2012). P 
homeostasis is not as well clarified as Ca, but FGF23 has been identified as a regulator which 
controls P absorption from intestines, and reabsorption from kidney and bone (Crenshaw et 
al., 2011, Jurutka et al., 2007). Supplementation of Ca and P to growing pigs, without 
unbalancing the ratios between the two minerals, increases dry weight of the femur and 
tibia, as well as overall ash content (Nicodemo et al., 1998). Additional research also shows 
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bone breaking strength to increase in growing pigs fed a diet containing 0.65% Ca in 
comparison to 0.4% Ca (Libal et al., 1969). The authors also observed increasing the ratio of 
inorganic P to dietary Ca, from 0.3% of P to 0.7% of P, resulted in increases in bone breaking 
strength in comparison to pigs receiving 0.3% of P (Libal et al., 1969).    
This scientific evidence initially showcases the requirement of nutrition in relation to bone 
biology, and demonstrates how the processes of skeletal growth are influenced by 
nutritional input. Ca and P, however, are nutritional compounds that require homeostatic 
maintenance within a biological system, and one key regulator of these minerals, which also 
holds important roles in bone development, is vitamin D.  
1.5.2 Vitamin D 
1.5.2.1 Metabolism 
Vitamin D is a fat-soluble nutrient that is obtained either from the diet, or is synthesised in 
the skin upon UV exposure (Chen et al., 2010). Upon integration into circulation, vitamin D is 
first delivered to the liver where it is metabolised to 25(OH) D, and this metabolite is 
transferred to the kidney where it is further metabolised to 1,25(OH)2D (Holick, 2005). This 
particular metabolite is the form of vitamin D which binds vitamin D receptors (VDRs) in 
target tissues. Upon ligand binding, VDRs have the potential to form heterodimers with 
RXRs, or RARs, and the resultant complex trans-locates to the nucleus to control the 
expression of genes which hold vitamin D responsive elements (VDREs) (Schrader et al., 
1993). 
It is well-established that vitamin D, through influencing appropriate gene expression in 
target tissues, is responsible for mediating the absorption of Ca and P from intestines and 
reabsorption from kidney and bone (Haussler et al., 1997, Jurutka et al., 2007). In pigs, 
vitamin D supplementation has documented benefits in bone health, these include 
increasing cortical and total bone BMD and BMC, as well as the length of long bones 
(Witschi et al., 2011). Different doses of vitamin D, in the form of D3 or 25(OH)D, have also 
been tested experimentally, and above 800IU supplementation of D3 has been shown to 
improve bone strength in gilts (Lauridsen et al., 2010). In addition, vitamin D 
supplementation has also been reported to improve live weight of weaned pigs (Tousignant 
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et al., 2013), and increase the average litter weight of piglets born from sows which received 
25(OH) D supplementation (Coffey et al., 2012). Vitamin D, therefore, remains an item of 
significant interest to the producing industry.  
1.5.2.2 Relevance to Kyphosis  
It is established that one of the major consequences of vitamin D deficiency is the 
development of rickets, characterised by a failure in endochondral ossification (Madson et 
al., 2012). In 2012, the adverse effects of vitamin D deficiency were further demonstrated 
when Rortvedt and Crenshaw (2012) established a model of kyphosis in piglets that could be 
induced by reducing availability of Vitamin D to the sow. They observed piglets born from 
Vitamin D-deficient sows, combined with nursery diets deficient in Ca and P, showed the 
characteristic signs of kyphosis by 13 weeks of age (Rortvedt and Crenshaw, 2012) . The 
implication of sow involvement suggests entire litters are at risk of developing kyphosis. 
Another observation by Rortvedt and Crenshaw (2012) was that all pigs that did show signs 
of kyphosis had been on a nursery diet deficient in Ca and P, but piglets born from vitamin D 
deficient sows at week 13 showed 32% prevalence, as opposed to piglets born from vitamin 
D adequate sows which showed 26% prevalence. In a separate study, supplementing sows 
with vitamin D increased serum Ca and P values in resultant offspring (Amundson et al., 
2017). Complementing this, the authors also observed BMC to be lowered in pigs fed a diet 
deficient in Ca and P, in comparison to pigs fed a diet adequate in Ca and P, within both 
maternal dietary groups; and at week 9, pigs born from vitamin D deficient sows showed 
reduced BMD (Rortvedt and Crenshaw, 2012). Further work also demonstrated that BGLAP 
expression, a gene which regulates bone mineral deposition, in the bone of piglets was 
higher in response to those born from sows fed increased dietary Vitamin D, but there was 
no relationship established with dietary Ca and P (Amundson et al., 2016, Amundson et al., 
2017). The results from these studies make it clear that availability of Ca, P and vitamin D 
can contribute to the development of kyphosis, but it is with vitamin D that there are links 
to expression of bone metabolic genes and maintenance of serum Ca and P. These would 
suggest that vitamin D is the critical driver in kyphosis. Furthermore, in a separate trial, the 
hypovitaminosis-D kyphotic pig model was characterised in further detail, and it was 
observed, in line with previous observations, that kyphotic pigs showed incomplete 
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mineralisation of growing bones, accompanied by an increase in un-ossified hypertrophic 
chondrocytes (Halanski et al., 2018). 
 However in these studies, the pigs received specified dietary treatments of Vitamin D, Ca 
and P in controlled conditions, and the findings may not represent spontaneous kyphosis 
that occurs on affected farms. There remains a need to confirm if Vitamin D is associated 
with the development of kyphosis on farms that suffer from outbreaks, in order to 
determine if the molecular, histological and bone parameter findings from these studies are 
relevant to spontaneous cases. In addition to vitamin D, evidence now suggests there is a 
relationship between kyphosis and vitamin A (Belsue, 2010).  
1.5.3 Vitamin A  
1.5.3.1 Absorption, Storage and Metabolism 
Vitamin A is a fat-soluble micronutrient that is essential for controlling physiological 
processes due its ability to regulate the expression of hundreds of genes relating to stem 
cell differentiation and development of tissues (Kedishvili, 2013). Primary sources of Vitamin 
A include Retinyl esters (REs), long-chained fatty acid esters of retinol, and provitamin A 
carotenoids from the diet. REs are hydrolysed in the intestinal mucosa to retinol, or are re-
esterified and incorporated into chylomicrons, and are absorbed into the lymphatic system 
(Marill et al., 2003, Harrison, 2005). Vitamin A is then stored as REs in stellate cells in the 
liver; REs are hydrolysed to retinol, which binds serum-retinol binding proteins, which is the 
form of Vitamin A which is delivered to tissues (Harrison, 2005). RE concentrations of up to 
30-250 mg per kg of liver (approximately 0.09-0.827µmol/g of liver) have been observed in 
pig liver (Scotter et al., 1992), additionally Majchrzak et al. (2006) reported RE 
concentrations in commercial pigs ranged from 6.5 to 18.9mg per 100g of liver 
(approximately 0.215-0.625µmol/g of liver). Upon delivery to target tissues, Retinol 
undergoes a dehydrogenation reaction to convert into retinal, which is converted into all-
trans retinoic acid (ATRA) by retinal dehydrogenases (Kedishvili, 2013). Another retinoic acid 
isoform that exists physiologically is 9-cis retinoic acid (Levin et al., 1992).  
Retinoic acid serves as the active metabolite of Vitamin A; it exerts its effects on tissue 
development through binding one of three isoforms of the retinoic acid receptor (RAR), 
RARα, RARβ or RARG, which trans-locates to the nucleus and initiates expression of target 
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genes (Jacobson et al., 2004). Additionally, co-receptors associate with RARs known as 
Retinoid-X-receptors (RXRs), and agonist-stimulation of both of these receptors results in 
significantly greater transcriptional activity (de Lera et al., 2007). RXRs also exist to co-
stimulate transcriptional events in response to other compounds, such as PPARs and 
Vitamin D (de Lera et al., 2007, Zierold and DeLuca, 1998). RAR isoforms are predominant 
targets of ATRA, whereas 9-cis retinoic acid has shown a higher affinity for RXRs (Levin et al., 
1992). Both Osteoblasts and Osteoclasts express RAR isoforms (Conaway et al., 2011, 
Jacobson et al., 2004), therefore retinoic acid isoforms have the potential to control gene 
expression in both of these cell types and regulate bone formation and resorption 
processes. 
1.5.3.2 Vitamin A requirements for Pigs  
There is no global accepted standard for the specific nutritional requirements of pigs. 
Various manufacturers have contrasting claims as to the amounts of vitamins and minerals 
required for optimum growth and efficiency. Although it cannot be ruled out that different 
countries follow different husbandry practices and use different genotypes, figures from 
DSM reveal the UK supplies higher provisions of vitamin A to its pigs, unlike the US and 
Canada who follow recommendations from the National Research Council (2012) (Table 
1.1). The UK recommends a much higher provision of vitamin A to its pigs, this includes a 
range of 1500-6000µg/kg of diet for grower diets and 3000-4500µg/kg for lactation and 
gestation diets (DSM, 2016). This is in contrast to recommendations from NRC in the US, 
that propose much lower ranges of 390-660µg/kg of vitamin A in grower diets, 1200µg/kg 
for gestation diets, and 600µg/kg for lactation diets (National Research Council, 2012). In 
the US recommendations provided by the National Research Council (2012) govern feed 
composition, recommending an average of 660µg of vitamin A per kg of dry diet to growing 
pigs. However these findings are in stark contrast to DSM guidelines which recommend 
almost a 10-fold increase in nutritional supply for Vitamin A to growing pigs (Table 1.1). 
Although legislation is not restricting Vitamin A concentrations in feeds, EU panels have 
recommended vitamin A concentrations should not exceed values of 1950µg/kg of feed for 
fattening pigs, 3600µg/kg of feed for gestating sows, and 2100µg/kg of feed for lactating 
sows (European Food Safety Authority, 2008). 
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Table 1.1: A list of the current recommendations for vitamin A and vitamin D in commercial 
sow and grower diets, as indicated in µg/kg of feed. Data are adapted from National 
Research Council (2012) and DSM (2016).      
Indeed feeding vitamin A to pigs approximately 25’000% above EU recommendations raises 
issues in relation to bone development, these include: destruction and disorganisation of 
epiphyseal cartilage, and a decrease in length and width of long bones (Wolke et al., 1968). 
The observation that feeding diets to sows containing 15000mg/kg of vitamin A contributes 
to kyphosis (Belsue, 2010) further highlights the potential dangers of vitamin A intake.  
It is not uncommon in farming practices to supplement animals with vitamin concentrations 
slightly higher than official recommendations (Whittemore and Kyriazakis, 2006). A survey 
undertaken by Kansas State University revealed that industries across the US were feeding 
vitamin A to pigs up to 5 times higher than NRC recommendations in diets (Flohr et al., 
2015). A greater understanding of vitamin A’s effects on bone development, in which 
vitamin A is fed excessively above recommendations from organisational bodies, will need 
to be appreciated in order to provide further evidence of the potential dangers of over-
supplementation. 
 
Excessive Vitamin A intake and Bone Development  
 
Growing Pigs Ranges 
(5kg-120kg) 
Gestating Sows Lactating Sows 
Vitamin A µg/kg of 
feed 
   
NRC (2012) 390-660 1200 600 
DSM (2016) 1500-6000 3000 - 4500 3000 - 4500 
Vitamin D µg/kg of 
feed 
   
NRC (2012) 3.75-5.5 20 20 
DSM (2016) 25-50 37.5-50 37.5-50 
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1.5.3.3 Excessive Vitamin A intake and Bone Development  
It is established that excessive vitamin A intake contributes to increased risk of fracture in 
humans, and induces narrowing of cortical bone compartments, which leads to thinner and 
fragile bones (Kneissel et al., 2005, Lind et al., 2011, Navarro-Valverde et al., 2018, Jackson 
and Sheehan, 2005). Studies have also demonstrated 300µg/g of Vitamin A in diets to result 
in focal disappearance of the growth plate with replacement by bony tissue, in rats (Soeta et 
al., 2000), which was also observed in pigs receiving excessive vitamin A supplementation 
(Wolke et al., 1968). These would suggest that excess vitamin A intake disrupts 
endochondral bone growth. Other observations in the hypervitaminosis-A pig model include 
reduced numbers of osteoblasts within trabecular bone, and decreased length of long bones 
(Wolke et al., 1968). Osteoporosis, characterised by a reduction in mineralisation of bone 
matrix, is induced in the rat upon supplementation with 70mg/kg of vitamin A in diets for 14 
days (Wu et al., 1996). In addition, increasing serum retinol has been observed to share 
negative correlations with parameters such as BMD and ALKp activity in osteoporosis 
patients (Navarro-Valverde et al., 2018). Serum retinol has been analysed in studies to 
determine Vitamin A intake, and a general consensus is that serum retinol follows a u-curve 
in relation to BMD risk and osteoporosis, in that low or high concentrations of retinol can 
contribute to fracture risk (Promislow et al., 2002). However, it has been raised in later 
years that serum retinol is not the most accurate marker of Vitamin A status, and a review 
of studies investigating Vitamin A intake and osteoporosis have failed to identify a 
consistent relationship (Ahmadieh and Arabi, 2011).  Nonetheless, the aforementioned 
studies in pigs clearly show consuming vitamin A above recommendations results in skeletal 
problems (Wolke et al., 1968, Belsue, 2010). Laboratory studies have given more insight into 
how the biology of vitamin A associates with skeletal regulation.    
 
In vitro studies have ascertained that vitamin A is able to favour the differentiation and 
function of both osteoblasts and osteoclasts. Earlier laboratory studies found Retinoic acid, 
Retinol and β-Carotene all induce Pre-Osteoblastic cell lines towards an Osteoblast lineage 
(Park et al., 1997). In contrast, ATRA may promote release of CSF1 from bone stromal cells 
to commit progenitor cells to an osteoclast lineage (Nakajima et al., 1994). Another study 
also demonstrated ATRA’s ability to inhibit RANK-induced differentiation of progenitor cells 
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into Osteoclasts, (Hu et al., 2010); and treatment of Osteoblasts with ATRA has been 
observed to result in an increase in RANKL/OPG gene expression ratio (Jacobson et al., 
2004). ATRA signalling through RARα has been shown to both upregulate RANKL expression 
(Conaway et al., 2011), and inhibit RANKL-induced osteoclastogenesis in bone marrow 
monocytes (Balkan et al., 2011). Conversely, other studies have observed that ATRA, acting 
through RARα or RARγ, downregulates osteoblast associated genes in osteoprogenitors, 
pre-osteoblasts and mature osteoblasts; and markers of adipogenesis were also observed to 
be downregulated in response to RAR-stimulation (Green et al., 2017). It is clear from these 
studies that vitamin A has the potential to favour osteoblast as well as osteoclast-mediated 
functions in cells, depending upon cell line and experimental conditions. This raises 
questions as to how vitamin A controls gene expression in whole bone tissue which leads to 
the characteristic symptoms of vitamin A toxicity.  
It has now been determined that, in bone, vitamin A exerts different effects on osteoblasts 
and osteoclasts depending upon compartment within the tissue. Lind et al. (2011) showed 
that excess vitamin A intake, in rats, indeed induced narrowing of cortical bone, and that 
this was associated with increased osteoclast abundance on the periosteal surface of long 
bones. However, they observed the opposite effect when investigating endosteal and bone 
marrow compartments: there was increased expression of hypoxia and osteogenic genes in 
response to excess vitamin A (Lind et al., 2011). Further work from this group showed, via 
microarray analysis, the upregulation of osteogenic and hypoxia genes in marrow (Lind et 
al., 2012). A pathway which overlapped between marrow and cortical bone was the Wnt 
signalling pathway (Lind et al., 2012), and this demonstrates vitamin A’s ability to interact 
with molecular pathways that define the growth and development of bone. Vitamin A’s 
compartment-specific effects are further demonstrated based on observations in which 
osteoclast cell numbers are significantly induced in the endocranial surface, but not the 
periosteum or intracranial surfaces, in rats in response to Vitamin A (Lind et al., 2017). In 
addition, excessive ATRA treatment induces thinning of bones accompanied by increased 
osteoclast activity in the subperiostal compartments of cortical bone (Kneissel et al., 2005).  
There is, however, relatively less information on how vitamin A affects trabecular bone 
development. Belsue (2010) observed lowering the concentrations of vitamin A in sow diets 
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removed the prevalence of kyphosis, thereby suggesting excessive vitamin A 
supplementation is a factor that can contribute to kyphosis. Given that the majority of 
vertebral bodies is composed of trabecular bone, this raises questions as to how vitamin A 
has affected the biology of trabecular bone development; however vitamin A’s effects on 
trabecular bone remain relatively unclarified. Short-term exposure (8 days) to excess 
vitamin A reduces overall density of trabecular bone (Lind et al., 2011), but in other studies 
involving a longer exposure to vitamin A, there are no obvious changes in trabecular bone 
density (Kneissel et al., 2005, Wray et al., 2011). This is further complicated by the findings 
from the hypervitaminosis A pig from Wolke et al. (1968), in which pigs receiving excess 
vitamin A showed signs of reduced mineralisation within trabecular bone. The requirement 
for a greater understanding of the effects of vitamin A’s effects on trabecular bone have 
also been raised by other authors (Henning et al., 2015). This is a gap that requires 
addressing not just to understand the biological mechanisms by which vitamin A is 
contributing to kyphosis, but also to clarify vitamin A’s effects on trabecular bone and thus 
provide more significant understanding of vitamin A’s role in overall bone development.    
1.5.4 Vitamin A vs Vitamin D 
In addition to regulating gene expression within bone tissue, vitamin A can exert alternative, 
indirect effects on bone metabolism due to its antagonistic relationship with vitamin D. This 
holds potential relevance to kyphosis, given that there are indications of vitamin D 
deficiency in kyphosis (Rortvedt and Crenshaw, 2012), and that there is still no explanation 
as to how kyphotic pigs on commercial farms are potentially vitamin D -deficient. Growing 
pigs and sows are recommended an additional thousands of units of vitamin A over vitamin 
D by all institutional bodies (Table 1.1), therefore antagonism of vitamin D by vitamin A 
could potentially occur on farms within the UK. Early studies indicated feeding rats with 
60000 units of vitamin D induced narrowing of the epiphyses and increased resorption 
cavities in the diaphysis; however treatment groups receiving additional 30000 units of 
vitamin A did not show these pathological changes (Clark and Bassett, 1961). Other studies 
have demonstrated feeding turkeys with a diet high in vitamin A and vitamin D prevents 
physiological changes associated with vitamin A toxicity such as decreased BMC and tibia 
length (Metz et al., 1985). Furthermore, Aburto et al. (1998) observed high dietary vitamin A 
results in an increased requirement for 25(OH) D to maximise bone ash%, and an increased 
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1,25(OH)2D demand to reduce rickets. Interestingly the authors also noted 1,25(OH)2D 
decreased liver concentrations of vitamin A, and this effect was greater with birds given a 
high vitamin A diet (Aburto et al., 1998). It has also been demonstrated that analogues of 
vitamin D increase serum Ca and decrease serum P concentrations, however treatment with 
RA alters the ability of vitamin D to maintain these concentrations in a dose-dependent 
manner. This therefore suggests that RA antagonises vitamin-D mediated effects in vivo 
(Rohde and DeLuca, 2005). Overall, the results of these studies outline a clear antagonistic 
relationship between the two vitamins in relation to regulation of physiology, yet the exact 
mechanisms by which these occur have not been fully elucidated. 
1.6 Objectives of the Thesis 
There are unanswered questions regarding the associations between vitamin A and: 
trabecular bone development; relationship with vitamin D; and how vitamin A associates 
with the development of kyphosis. Furthermore, there have been relatively few efforts 
made to understand the biological basis of kyphotic bone and cartilage tissues. The gaps 
identified in this review have formed the objectives this thesis will experimentally address: 
 Define which genes and molecular pathways are significantly associated with
kyphotic tissues
 Confirm how excess vitamin A supplementation affects differential gene expression
in trabecular bone, and serum 25(OH) D
 Confirm the associations of vitamin A and vitamin D with kyphotic pigs
 Determine the overlap of differential gene expression between kyphotic and vitamin
A supplemented pigs
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Chapter 2: Methodologies 
2.1 Introduction 
In order to investigate the outlined objectives of this research, the thesis utilised two 
separate pig trials. Samples were obtained from pigs, and appropriate controls, from both 
trials in order to perform molecular investigations and nutritional analysis in tissue samples 
representative of kyphosis and excess vitamin A intake. A microarray methodology was 
performed in both experiments in order to establish a molecular basis within tissues, and 
samples selected for analysis are indicated. The experimental setup of each trial is discussed 
in more detail throughout the chapter.    
2.2 Kyphosis Trial  - Sampling and Experimental Design 
The animals used in this study consisted of a total of 97 pigs from 3 different age groups 
from PIC lines (Genus PIC Inc, Hendersonville, TN) on farms based in the south-east of the 
UK. Samples were collected from a total of 5 outdoor breeding units and 1 grower unit. 
Sampling on farms was performed on an ad-hoc basis in which kyphotic cases were present, 
between April 2015 and March 2016. Pre-weaning and weaning kyphotic cases and age 
matched controls were obtained from 2 breeding units in April 2015 and a further 3 units in 
March 2016, making a total of 5 units. Weaning and post-weaning kyphotic cases and age 
matched controls were obtained from a grower unit in June 2015.  
Animals with clear clinical signs of kyphosis, through visual identification of the 
characteristic kink at the thoraco-lumbar junction, were confirmed and identified by the 
farmer and veterinary team on all visits. Kyphotic animals from 3 age groups (pre-weaning, 
weaning and post-weaning) were selected for tissue sampling alongside age-matched 
controls. The study applied a 3x2 design, 3 age groups and 2 phenotypes, kyphosis or 
control. Kyphotic pigs in each age group were paired with age and weight matched controls. 
A summary of the characteristics of all sampled pigs are shown (Table 2.1) For the pre-
weaning group only a second control group was selected, so that a kyphotic affected pig  
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Age Group Phenotype N Bodyweight 
(Average/Kg) 
(SEM) 
Litter Size 
(SEM) 
Ca 
(mmol/L) 
(SEM) 
P 
(mmol/L) 
(SEM) 
Pre-Weaning 
(2 weeks) 
Control 17 4.7 (0.33) 11 (0.61) 2.66 
(0.05) 
2.77 
(0.07) 
Littermate 17 4.56 (0.36) 12 (0.95) 
Kyphosis 17 4 (0.28) 12 (0.95) 2.75 
(0.062) 
2.74 
(0.12) 
Weaning 
(4 weeks) 
Control 16 6.51 (0.42) 
Kyphosis 16 6.44 (0.63) 
Post-Weaning 
(13 weeks) 
Control 7 36.71 (2.25) 
Kyphosis 7 36.93 (2.37) 
Table 2.1: A summary of characteristics of sampled pigs used in the study. Pre-weaning (2 
weeks of age), weaning (4 weeks of age), and post-weaning (13 weeks of age) kyphotic and 
age-matched control pigs were sampled, and the numbers of individual pigs sampled per 
group are shown. Pigs were immediately weighed post-mortem and the average weight of 
kyphotic and control pigs per age group is shown. The average litter size of sows which gave 
birth to pre-weaning kyphotic and comparative control piglets is also provided, but data 
were not available for weaning and post-weaning groups. The average serum Calcium (Ca) 
and Phosphorus (P) concentrations were also calculated in pre-weaning kyphotic and non-
related control pigs.    
could be compared to a littermate control which showed no clinical signs of kyphosis, and 
an unrelated control from a contemporary litter in which no piglets presented the 
characteristic signs of kyphosis. Littermate controls were not possible for the other two 
sample classes given the management applied on the farms. In the UK, pigs from different 
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litters are transferred to nursery accommodation at weaning where they are mixed. 
Therefore identifying littermates after weaning was not possible.     
2.3 Vitamin A trial – Sampling and Experimental Design 
The trial was performed at Cockle Park farm, Newcastle University, and was approved by 
the Animal Welfare and Ethics review board at Newcastle University (PPL 70 8262).   
2.3.1 Pigs and Management 
Sow management and pre-weaning husbandry was applied according to standard UK farm 
practices for indoor, commercial pigs. Piglets were born from Large White x Landrace sows 
inseminated with Hylean boar semen (Hylean MQM; Hermitage Seaborough Ltd., Devon, 
UK). Pigs were weaned at approximately 4 weeks of age, and a total of 64 piglets were 
randomly selected and moved to experimental accommodation. Pigs were randomly 
allocated to 8 pens consisting of 8 animals of similar weights and composed of equal ratios 
of males and females (4 males and 4 females). Individual pen dimensions were 337cm x 
310cm, and contained space-feeders (120cm x 30cm) that allowed 4 pigs to feed 
simultaneously. Pens were also provided with 2 nipple drinkers which originated from a 
single pipeline, and had partially slatted concrete flooring. Pigs groups were kept in a total 
of 2 rooms throughout the experimental period, the temperature of both rooms was 
monitored via min-max thermometer. In room 1, the temperature was maintained between 
17.8°C and 27.2°C; in room 2, the temperature was maintained between 18.8°C and 25.5°C. 
Upon arrival to experimental accommodation, pigs had ad libitum access to water and feed, 
and were fed a 5-stage dry-pellet based diet (Table 2.2). Flatdeck 1 diet (4950µg vitamin 
A/kg) (A-One feed supplements, North Yorkshire, UK) was provided to pigs at 4 weeks of age 
for 1 week. At 5 weeks, pigs were given a Flatdeck 150 diet (4950µg vitamin A/kg) for 1 
week, and at 6 weeks of age, pigs were fed a Turbowean diet (4620µg vitamin A/kg) for 2 
weeks. At 8 weeks of age, pigs were fed a mixed grower ration diet (4526.74µg vitamin 
A/kg) for 5 weeks. At 13 weeks of age, the feed was changed to Olympic 501 (2145µg 
vitamin A/kg) (ForFarmers UK limited, Bury St Edmunds, UK) and pigs remained on this diet 
for the rest of the experimental period.
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Table 2.2 Chemical composition of diets offered to pigs throughout the experimental period 
from d28. Diet values are calculated, but were analysed for Mixed Grower Ration.  
Item  Diet 
% Ingredient Flatdeck 1 
(d28)* 
Flatdeck 150 
(d35)* 
Turbowean 
(d42)* 
Mixed 
Grower 
Ration (d56)* 
Olympic 
501 (d91)A 
 
Phosphorus 0.7 0.68 0.64 0.60 0.48 
Sodium 0.3 0.3 0.2 0.16 0.18 
Lysine 1.7 1.55 1.45 0.22 1.2 
Crude Protein 22.5 21 21 n/a 16.5 
Crude Fibre 2.5 3 3.5 n/a 6 
Calcium 0.75 0.74 0.75 0.96 0.6 
Crude Ash 6 5.5 5 2.93 4.5 
Methionine 0.63 0.63 0.57 0.1 0.28 
Crude Oils  8.5 6.5 6.25 n/a 5 
Additives per kg      
Vitamin A (µg) 4950 4950 4620 4526.744 
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Vitamin D3 (µg) 50 50 50 51.44 37.5 
Vitamin E (µg) 167.5 167.5 107.2 91.9 n/a 
Iron1 (mg) 500 500 500 205.78 258 
Iodine2(mg) 3.33 3.33 3.33 1.37 1.6 
Copper3(mg) 640 640 640 219.4 20 
Manganese4(mg) 187.5 187.5 187.5 41.15 40 
Zinc5(mg) 169 169 169 137.19 56 
Selenium6(mg) 0.65 0.65 0.65 0.41 0.67 
 
*Diets were provided by A-One feed supplements, Thirsk, North Yorkshire, UK. ADiets were 
provided by ForFarmers UK limited, Rougham, Bury St Edmunds, UK. Provided per kg of 
complete diet, 1Ferrous Sulfate Monohydrate, 2Calcium Iodate Anhydrous, 3Cupric Sulphate 
Pentahydrate, 4Manganous Sulfate Monohydrate, 5Zinc Oxide, 6Sodium Selenite
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Treatment Groups (Retinyl 
Propionate - µg/Kg of BW 
daily) 
Age at sampling 
(weeks) 
Dosing (weeks) 
Control (n=8) 22 0 
200µg/KG (n=8) 21 17 
500µg/kg (n=8) 21 17 
1250µg/KG (n=8) *20/21 16/17 
3000µg/KG (n=8) 20 16 
5250µg/KG (n=8) 20 16 
7500µg/KG (n=8) 19 15 
10000µg/KG (n=8) 19 15 
Table 2.3: Treatment groups used in the vitamin A trial, and numbers of pigs for each group 
are shown. Depending upon assigned dose group, pigs were orally supplemented daily with 
RP in µg per kg of BW. Age of pigs at the time of sampling as well as periods of RP dosing are 
indicated.  
2.3.2 Experimental Procedures  
Of the pigs composing the 8 pens in the current study, pigs in 7 pens received a dosage of 
retinyl propionate (RP) treatment, with one group receiving no dosing so as to serve as a 
control group (Table 2.3). Depending upon group, animals were orally supplemented, in µg 
per kg of bodyweight (BW), daily with RP in sunflower oil until tissue processing. Dosing 
began when pigs were 4 weeks old, periods of dosing and age of animals for each group 
upon tissue sampling are summarised in Table 2.3. The highest dose group in the current 
study (10000µg RP/kg BW) was prepared in order to ensure effects of excess vitamin A on 
biological development. For example, a 70kg pig on this diet would receive 700mg of RP 
daily which is over 200 times the safe upper limits set for human consumption (3mg/day) 
(Trumbo et al., 2001). In addition, the European Food Standards Agency (EFSA) advised 
vitamin A supplementation to fattening pigs should not exceed 1950µg/kg of feed 
(European Food Safety Authority, 2008). An 80kg pig will typically consume 3.2kg of food 
daily (ThePigSite, 2014), therefore on a 1950µg/kg diet this pig will accumulate 78µg/kg of 
BW of vitamin A daily. This would place daily consumption of vitamin A close to that of 
control pigs used in this trial (85.8µg/kg). This would also make vitamin A consumption, in 
µg/kg of BW, approximately 130 times below the accumulation pigs on the 10000µg RP/kg 
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BW treatment will receive. The other dose groups used in the study were prepared in order 
to determine dose-response relationships between vitamin A and dependent variables.  
2.4 Dissection Protocol 
In the kyphosis trial, all pigs were euthanized in accordance with Home Office regulations 
through a combined administration of midazolam for anaesthesia and lethal overdose of 
sodium pentothal. In the vitamin A trial, all pigs were euthanized in accordance with Home 
Office regulations through a combined administration of Ketamine, Midazolam and 
Lorazepam for anaesthesia, followed by a lethal overdose of Euthatal (Pentobarbital). 
Upon euthanasia, the jugular vein was sliced and during exsanguination, blood was collected 
in 10ml serum blood vacutainer tubes and allowed to stand for 30 minutes to allow 
sufficient clotting before centrifugation (3500RPM for 15 minutes). Serum was subsequently 
aliquoted into duplicate 2ml Eppendorf tubes and immediately placed on dry ice. An incision 
was made from the shoulders to the rump, and the attached muscle and connective tissue 
removed in order to expose the thoracic and lumbar regions of the spine. Depending upon 
the size of the spine and the animal, a pair of Liston bone cutters or cordless power saw was 
used to extract the region of spine from the 12th thoracic to 2nd lumbar vertebrae. The spinal 
section was de-fleshed and samples of intervertebral disc cartilage between T13 and L1 was 
obtained. The justification of the sampling site comes from observations that abnormal disc 
findings at the T13-L1 junction have been identified in kyphosis cases (Done and Pearson, 
2004). Upon extraction, the samples were immediately placed on dry ice. The cartilage was 
not sampled from vitamin A treated pigs; cartilage undergoes age-associated degeneration 
in mammals (Craddock et al., 2018) and due to these pigs being much older than kyphotic 
pre-weaners in the study (2 weeks old vs 19 weeks/22 weeks old), the comparisons between 
cartilage from these trials would not truly reflect the occurrences in healthy cartilage.   
Samples of bone from the vertebral body, containing trabecular bone, were obtained from 
the 13th thoracic vertebrae using Liston bone cutters, after removal of muscle and 
connective tissue from the vertebrae This site was sampled due to it resting within the 
region of where the kyphotic kink occurs (Nielsen et al, 2005) and to maintain consistency 
with sampling sites for both trials. Upon extraction, samples were immediately placed on 
dry ice.  
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The liver was also obtained and weighed from all pigs from the kyphosis and vitamin A trials. 
For the kyphosis trial, samples of the lower left lobe were placed in duplicate Eppendorf 
tubes and immediately placed on dry ice. For the vitamin A trial, samples from all 4 lobes of 
the liver were placed into duplicate tubes. All liver samples were rinsed with phosphate 
buffered saline (PBS) before being placed into their respective tubes.  
The duodenum of the small intestine was also sampled from all pigs from the kyphosis and 
vitamin A trials. The intestine was cut using surgical scissors to expose the inner epithelial 
lining, and was rinsed with PBS to remove digesta contamination. Samples of epithelium 
were then obtained by scraping the lining with a scalpel, and was deposited into duplicate 
2ml Eppendorf tubes filed with RNAlater (Sigma-Aldrich, Irvine, UK).  
2.5 Molecular Biology  
2.5.1 RNA Extraction  
Total RNA was extracted from tissue samples using the RNeasy lipid tissue mini-kit (Qiagen, 
Manchester, UK). 50mg of bone and cartilage tissues was snap-frozen in liquid nitrogen and 
ground to a fine powder using a steel mortar and pestle. The ground tissue was transferred 
to 1ml of Qiazol lysis reagent in a 1.5ml Eppendorf tube. 30mg of small intestine samples 
were homogenised using a plastic pestle by hand in 1ml of Qiazol reagent in a 1.5ml 
Eppendorf tube. After homogenisation, tubes were briefly vortexed and allowed to stand at 
room temperate for 5 minutes. 200µl of chloroform was added to each tube using a 
Hamilton syringe, vortexed for 15 seconds and allowed to stand at room temperature for 3 
minutes. The tubes were then centrifuged at 12000 x g for 15 minutes at 4°C. After 
centrifugation, the upper layer, aqueous layer from each tube was transferred to a new 2ml 
Eppendorf tube, and 1 volume of 70% ethanol was added to the tube which was 
subsequently vortexed briefly. 700µl of the sample was added to an RNeasy mini spin-
column and collection tube, the columns were then centrifuged at 8000 x g for 15 seconds 
and the flow-through was discarded. Using the same collection tube, the remainder of the 
sample in the 2ml Eppendorf tube was centrifuged and the flow-through discarded. 350µl of 
Buffer RW1 was added to the spin-column, and centrifuged (8000 x g for 15 seconds) to 
wash the membrane, before discarding the flow-through. 80µl of freshly prepared DNase I 
incubation mix (70ul of buffer RDD + 10µl of DNase I enzyme) was added to the membrane 
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in the RNeasy spin-column, and was allowed to incubate at room temperature for 15 
minutes to allow for DNA digestion. 350µl of Buffer RW1 was then added to the column 
before centrifugation (8000 x g for 15 seconds) and discarding of the flow-through. 500µl of 
buffer RPE was then added to the RNeasy spin-column and centrifuged (8000 x g for 15 
seconds) before discarding the flow-through; the column was washed again with 500µl of 
buffer RPE (8000 x g for 2 minutes) before discarding the flow-through. The membrane of 
the RNeasy spin-column was further dried after placing the column in a new 2ml collection 
tube, and centrifugation at 17’000 x g for 1 minute. The RNeasy column was then placed in a 
1.5ml Eppendorf tube, and 70µl of ultrapure deionised water was added to the membrane. 
The column was allowed to stand at room temperature for 10 minutes, before 
centrifugation (8000 x g for 1 minute); the Eppendorf tubes were labelled and placed on ice 
before discarding the RNeasy spin-column.     
The quantity (ng/µl) of RNA in each sample was quantified using the Nanodrop V2000 
spectrophotometer (Thermo-Fisher, MA, USA). The Nanodrop was blanked using 2µl of 
ultrapure deionsed water, and 2µl of RNA sample was added to the pedestal and read at 
260nm and 280nm. All samples were measured in duplicate. The ratio of the reading read at 
260nm and 280nm, and 260nm and 230nm was also recorded in order to indicate the purity 
and quality of the RNA. RNA was then stored at -80°C until downstream applications.  
2.5.2 Selection of RNA samples for Microarray Analysis from Kyphosis and Vitamin A trials  
After RNA extraction, bone samples from both trials were selected for microarray analysis. 
In addition, RNA from cartilage samples from the kyphosis trial, and duodenum samples 
from the vitamin A trial were selected for microarray analysis from both trials. For the 
kyphosis trial, the pre-weaning age group was selected for microarray analysis. Since the 
sow has a major effect on the prevalence of kyphosis within litters (Rortvedt and Crenshaw, 
2012), analysis of the pre-weaning group allowed to observe potential effects of gestation 
and lactation. A 2x2 design was implemented in selecting RNA samples for the microarray: 2 
phenotypes, kyphosis and non-related control, and 2 tissue types, trabecular bone and 
cartilage. 4 replicates, which were randomly selected from kyphotic and control groups, 
were included for each group, allowing for analysis of a total of 16 samples. The RNA quality, 
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indicated by 260/280 ratio on a Nanodrop, was shown to be above 1.9 for all RNA samples, 
therefore RNA quality did not factor into sample selection for microarray analysis.   
For the vitamin A trial, RNA samples from the control and 10000µg RP/kg BW groups were 
selected for microarray analysis. RNA from vertebral bone and duodenum tissues were 
selected to identify biomarkers which show differential expression in each tissue in 
response to excessive vitamin A intake. RNA from 4 male controls and 4 male pigs recieiving 
10000µg RP/kg BW, for both tissue types, were selected for microarray analysis. The male 
group was selected on the basis that bone tissue in females is subject to additional 
hormonal regulation in comparison to males, for example estrogen deficiency can prolong 
osteoclast lifespan (Goldberg et al., 2015). Therefore, in order to identify differential gene 
expression in response to vitamin A without interference from hormonal regulation, the 
male groups were selected for analysis.   
2.5.3 cRNA Preparation 
Total RNA of 200ng from each sample was reverse-transcribed into cRNA labelled with Cy3 
using the low input Quick Amp kit (one-colour) according to the manufacturers protocol 
(Agilent Technologies, Cheadle, UK). cRNA was purified using the RNeasy mini-kit (Qiagen, 
Manchester, UK) and the quality and quantity of each sample verified through 
spectrophotometric measurement on a Nanodrop V2000 (Fisher-Scientific, Loughborough, 
UK).  
2.5.4 Microarray Hybridisation  
Labelled cRNAs were used for hybridisation using the Quick Amp labelling with Tecan HS Pro 
Hybridisation kit (Agilent Technologies, Cheadle, UK). The arrays were hybridised at 65°C for 
17hrs in Agilent’s microarray hybridisation chambers. After hybridisation, arrays were 
washed according to the manufacturer’s instructions. Microarrays were hybridised, washed 
and scanned at the School of Veterinary Medicine and Science, University of Nottingham. 
Arrays were scanned at 5µM resolution using the Agilent microarray scanner. Data were 
extracted using the Feature Extraction software (Agilent Technologies, Cheadle, UK) and 
saved in a TIFF format.  
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2.5.5 Data and Pathway Analysis 
Data were normalized and analysed using the Genespring GX software version 13.0 (Agilent 
Technologies, Cheadle, UK). Differential expression of a gene was obtained if a fold-change 
greater than 2 was observed between groups in the kyphosis and vitamin A trials. Statistical 
analysis was performed using moderated T-Test and data were considered statistically 
significant if p values of p<0.05 were obtained.  
Ingenuity pathway analysis (IPA) (Qiagen, Manchester, UK) was used to identify biological 
networks and regulators most affected as a result of differential gene expression. Genes 
from the dataset that produced a p value of <0.05, and were associated with canonical 
pathways and biological functions, were accepted in the analysis. IPA was additionally used 
to generate networks of differentially expressed genes. Gene products were represented as 
nodes and the biological relationships between nodes represented by edges; these were 
supported by at least one reference from supporting literature.  
Although IPA offers powerful analysis in the interpretation of differential gene expression, 
the data extracted from IPA is representative of human and mouse models, and various cell 
lines. Therefore, the data might not be fully transferable to understanding differential 
regulation of gene expression within the pig. Thus, data on differentially expressed genes 
was also exported to Cytoscape, and biological networks were established (Kohl et al., 
2011). The ClueGo app was used to visualise the Gene Ontology terms (GO terms) which had 
shown to be influenced in the tissue type, and to identify the associated genes in these 
processes (Mlecnik et al., 2013 ). False discovery rate, or obtainment of false-positive 
results, was controlled using Benjamini- Hochberg method (Javanmard and Montanari, 
2017) in Cytoscape, and was used to calculate Term p-values for GO terms associated with 
tissues.   
2.5.6 cDNA Synthesis  
For the kyphosis samples, RNA was reverse-transcribed into cDNA using the Transcriptor 
first strand cDNA synthesis kit (Roche, Manchester, UK). 1µg of RNA was mixed with 1µl of 
random hexamer primers (600pmol/µl) and 2ul of oligo d (T) primers (50 pmol/µl), and 
diluted with ultrapure deionised water to a volume of 13µl. Samples were incubated at 65°C 
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for 10 minutes to ensure removal of RNA secondary structures. A mixture containing 4µl of 
5X buffer, 2µl of dNTPs (10mM), 0.5µl of Protector RNase inhibitor (40U/µl), and 0.5µl of 
Transcriptor reverse-transcriptase (20U/µl) was added to each sample. The samples were 
incubated for 10 minutes at 25°C, 30 minutes at 55°C, and for 5 minutes at 85°C. 
For the vitamin A samples, RNA was reverse-transcribed into cDNA using the iscript cDNA 
synthesis kit (Bio-Rad, CA, USA). 1µg of RNA was mixed with 4µl of 5x iscript reaction mix, 
containing random hexamer and oligo d (T) primers, 1µl of iscript reverse transcriptase, and 
diluted with ultrapure deionised water to a 20µl reaction volume. The samples were 
incubated for 5 minutes at 25°C, 20 minutes at 46°C, and 1 minute at 95°C.  
cDNA was diluted 1 in 10 in ultrapure deionised water, and aliquoted into 4x50µl aliquots 
which were stored at -20°C. An aliquot was taken from each sample, per tissue, and was 
pooled to form a calibrator for which to normalize samples during qPCR. The calibrator was 
then aliquoted into single-use aliquots for qPCR plate preparation.   
2.5.7 Primer Verification  
2.5.7.1 Primer Design 
The genomic and FASTA sequences for the gene of interest were obtained from the NCBI 
database, and aligned using the program Splign in order to identify exon-intron junctions 
within RNA sequences. Primers were designed to flank exon-intron junctions in RNA 
sequences; or if not possible, to bind in separate exons. Primers were designed using 
Primer3 (Untergasser et al., 2012). Obtained primer sequences were then entered into 
Nucleotide BLAST (Ladunga, 2009) in order to indicate primer target specificity. Upon BLAST, 
primers were ordered from Eurofins (Eurofins Genomics, Ebersberg, Germany).  
2.5.7.2 Primer Standard Curve  
Primers were reconstituted in ultrapure deionised water, and a 4µM working stock solution 
was prepared and aliquoted for each primer. A SYBR green master mix (FastStart Essential 
DNA Green Master, Roche, Manchester, UK) was prepared (Table 2.4), and a 1 in 3 dilution  
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Reagent Volume per 15µl reaction 
SYBR Green Mastermix 7.5µl 
Forward Primer (4µM) 0.75µl 
Reverse Primer (4µM) 0.75µl 
Ultrapure deionised water 2.25µl 
cDNA 3.75µl 
Table 2.4: Constituents of PCR mastermix, adding to a total reaction volume of 15µl 
series was prepared from cDNA, and each dilution point was prepared in triplicate. Reverse 
transcriptase minues (RT-) and non-template controls (NTC) were also prepared on plates, in 
order to indicate genomic DNA contamination and assay contamination respectively (Figure 
2.1). 
2.5.7.3 Standard Curve Efficiency Calculation  
The efficiency of all primer pairs was calculated automatically on the Roche lightcycler 96 
software. The average Cq of triplicates for each dilution series was obtained, and plotted 
against log RNA concentrations in order to obtain the slope of the standard curve. The 
following calculation was used to determine primer efficiency:  
E% = ((10(-1/slope) )-1)*100 
Current standards recommend primer pairs to achieve an efficiency between 1.9 and 2.1, 
equalling 90% and 110% efficiency respectively (Agilent, 2012). This was taken into 
consideration for selection of the best primer pairs. Also considered was the primers error, 
Cq in which amplification was detected, and R value of the standard curve.  
2.5.7.4 Gel Electrophoresis  
PCR products of primers were subsequently  run on 8% agarose gels in order to confirm 
product size and therefore primer specificity. 0.8g of agarose was prepared in 45ml of 1X 
TAE buffer in a conical flask, and placed in a microwave for approximately 45 – 60 seconds. 
The gel was allowed to cool before pipetting 4.5µl of SYBR safe DNA gel stain(Invitrogen, 
MA, USA) into the gel, and swirled.   
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 1 2 3 4 5 6 7 8 9 10 11 12 
A 1 1 1 1IN3 1IN3 1IN3 1IN9 1IN9 1IN9 1IN27 1IN27 1IN27 
B RT NTC           
 
 
 
Figure 2.1:  A standard curve calculated and prepared on the Roche lightcycler 96 software. Row A shows how dilution series were prepared on 
the 96-well plate, row B shows the reverse transcriptase minus (RT-), and non-template controls (NTC). Indicated are the calculated efficiency, 
error and R values, as well as the first Cq in which amplification is detected (Y-intercept). 
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The gel was then poured into a casting tray with a comb insert and allowed to stand. For 
PCR products and subsequent RT- and NTC products for each primer pair, 8µl of sample was 
pipetted from the 96 well plate into a 0.2ml PCR tube, and then 2µl of GelPilot loading dye 
5x (Qiagen, Manchester, UK) was pipetted into each tube.  
The gel and casting tray were placed in a gel tank and submerged in 1x TAE buffer. 5µl of 
DNA ladder IV (Invitrogen, MA, USA) was pipetted into the first well, and 10µl of samples 
were pipetted into subsequent wells. The gel was allowed to run at 90v to achieve migration 
of PCR products.  
2.5.7.5 Gel Image Viewing  
When gel dye bands were roughly 2/3 down the well, the gel was retrieved from the tank 
and placed in a LI-COR Odyssey gel viewing system (LI-COR, Cambridge, UK), and viewed at a 
wavelength of 600nm. Gels representing primers used in the thesis are in Figures 2.2 and 
2.3. Sequences for primers of genes analysed per chapter are shown in each chapter.  
2.5.8 Quantitative real-time PCR  
2.5.8.1 Housekeeper Gene Selection  
A total of 5 housekeeping (HK) genes were identified from literature (Kouadjo et al., 2007), 
and primers were designed for: Ribosomal Protein L37 (RPL37), Glyceraldehyde-3-
Phosphate Dehydrogenase (GAPDH), Eukaryotic translation Initiation factor 3 sub-unit D 
(EIF3D), Peptidylprolyl Isomerase A (PPIA) and Proteasome 26S Subunit, Non-ATPase 4 
(PSMD4). In the kyphosis trial, all 5 genes were analysed in bone and cartilage cDNA from all 
age groups in order to indicate the degree of deviation and error of primers between 
kyphotic and control groups (Table 2.5). In the vitamin A trial, all 5 genes were analysed in 
the control group and highest supplementation group (10000µg RP/kg BW) in order to 
indicate the deviation and error of primer pairs across these groups (Table 2.6). In regards to 
the standard curves, RPL37 and PPIA produced the best curves in regards to reproducibility, 
with RPL37 showing higher efficiency (Table 2.7). For cartilage tissues obtained from 
kyphotic and control pigs, RPL37 showed the lowest standard deviation, as well as the 
earliest Ct cycle to be detected. For bone tissues obtained from kyphotic and control pigs,  
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Figure 2.2: An 8% agarose gel electrophoresis image of primers used in the thesis. Lane 1: 
DNA ladder IV 100-1000bp Lane 2: TGF-β (151 bp) LANE 3: TGF- β RT- Lane 4: TGF- β NTC 
Lane 5: BMPR1A (162 bp) Lane 6: BMPR1A RT- Lane 7: BMPR1A NTC Lane 8: PTK2B (199 bp) 
Lane 9: PTK2B RT- Lane 10: PTK2B NTC Lane 11: ASPN (200 bp) Lane 12: ASPN RT- Lane 13: 
ASPN NTC  
 
Figure 2.3: An 8% agarose gel electrophoresis image of primers used in the thesis. Lane 1: 
DNA ladder IV 100-1000bp Lane 2: BGLAP (176 bp) Lane 3: BGLAP RT- Lane 4: BGLAP NTC 
Lane 5: DCN (159 bp) Lane 6: DCN RT- Lane 7: DCN NTC Lane 8: RPL37 (166 bp) Lane 9: 
RPL37 RT- Lane 10: RPL37 NTC  
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                             Cartilage                             Bone 
Gene Name Average Cq STDEV Average Cq STDEV 
RPL37 21.42 1.24 21.41 1.49 
GAPDH 24.50 1.79 24.70 1.50 
PSMD4 29.19 1.50 28.47 1.47 
PPIA 23.40 1.73 22.82 1.64 
EIF3D 26.60 1.53 25.88 1.50 
Table 2.5: The average Cq, and standard deviation (STDEV) for each of the 5 housekeeper 
genes (HKs) for each tissue for the kyphosis trial. HKs were ran in duplicate for all kyphotic 
and control samples.  
Gene Name Average Cq STDEV 
RPL37 23.07 1.01 
GAPDH 29.54 1.42 
PSMD4 35.27 1.1 
PPIA 26.45 1.55 
EIF3D 30 1.82 
Table 2.6: The average Cq, and standard deviation (STDEV) for each of the 5 housekeeper 
genes (HKs) for bone tissue for the vitamin A trial. HKs were ran in duplicate for all 10000µg 
RP/kg BW and control samples. 
 GAPDH PSMD4 EIF3D PPIA RPL37 
Slope -3.2772 -3.0626 -3.4279 -3.6549 -3.6268 
Efficiency 2.02 2.12 1.96 1.88 1.89 
Error 0.21 0.47 0.31 0.11 0.12 
R-value 0.99 0.97 0.99 1.0 1.0 
Table 2.7: The slope, efficiency, error and R-values for each primer pair calculated by 
generation of a standard curve using the Roche lightcycler 96 software. Dilutions were 
prepared in triplicate, and the standard curve was generated from 4 dilution points diluted 1 
in 5.   
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all 5 genes showed similar standard deviations, with PSMD4 showing the lowest deviation, 
yet it was detected very late in the PCR cycle. RPL37 showed the lowest average Ct cycle to 
be detected. For bone tissues obtained from pigs in the vitamin A trial, RPL37 showed the 
lowest standard deviation, as well as the earliest Ct cycle to be detected. Due to its early 
detection, relatively low standard deviation across all 3 tissues, and its reproducibility, 
RPL37 was selected as the HK gene of choice for experiments in this thesis.  
2.5.8.2 qPCR Plate Setup  
Real-time PCR was performed using SYBR green assays in a 15µl reaction composing 3.75µl 
of diluted cDNA, 4µM primers, 2.25µl PCR-grade water and 7.5µl FastStart Essential DNA 
green master mix (Roche, Manchester, UK) (Table 2.4). All samples were run on 96 well 
plates, and performed in triplicate in order to control the variation. All reactions were 
performed in a light cycler 96 system (Roche, Manchester, UK) with the following cycling 
conditions: a pre-incubation step of 95° for 10 minutes followed by 40 cycles of 95° for 15 
seconds, annealing at 60° for 15 seconds, and elongation at 72° for 20 seconds. A melting 
curve step was incorporated at the end of the cycles to determine the inclusion of non-
specific PCR products. (Table 2.8). A calibrator was also ran in triplicate for each gene on all 
96 well plates in order to normalise results between plates (Figure 2.4). 
  
Step Temperature Time Cycles 
Preincubation 95°C 10 mins 1 
3-step 
amplification  
95°C 15 sec 40 
60°C 15 sec 40 
72°C 20 sec 40 
Melting curve 
analysis 
95°C 10 sec  
65°C 60 sec  
97°C 1 sec 
continuous 
 
Table 2.8: Cycling conditions for all genes analysed by qPCR on a Roche lightcycler 96 
system. 
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 1 2 3 4 5 6 7 8 9 10 11 12 
A S1 S1 S1 S2 S2 S2 S3 S3 S3 S4 S4 S4 
B S5 S5 S5 S6 S6 S6 S7 S7 S7 S8 S8 S8 
C S9 S9 S9 S10 S10 S10 S11 S11 S11 S12 S12 S12 
D S13 S13 S13 S14 S14 S14 S15 S15 S15 CALIB CALIB CALIB 
E S1 S1 S1 S2 S2 S2 S3 S3 S3 S4 S4 S4 
F S5 S5 S5 S6 S6 S6 S7 S7 S7 S8 S8 S8 
G S9 S9 S9 S10 S10 S10 S11 S11 S11 S12 S12 S12 
H S13 S13 S13 S14 S14 S14 S15 S15 S15 CALIB CALIB CALIB 
 
Figure 2.4: A typical well map of analysis for 1 gene of interest in samples. Samples (S) were run in triplicate horizontally across the plate, with 
the calibrator (CALIB) placed at the end of each row for the gene.  Samples for the gene of interest are highlighted in blue, whereas samples for 
the housekeeper gene are highlighted in green.  
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2.5.8.3 Calculation of Normalized Expression  
Samples from the kyphosis and vitamin A trials were normalized using the housekeeper 
gene RPL37, and fold-changes in gene expression were calculated relative to the calibrator 
on each plate. The calibrator was used to remove inter-plate variability, and normalized 
expression of target genes in all samples was automatically calculated using the Pfaffl 
comparative method:  
Normalized Ratio = (Etarget) Ct target gene (calibrator-sample) / (Ereference) Ct reference gene (calibrator-sample) 
E is the calculated efficiency of primer pairs obtained from the standard curve. The 
calibrator was the calibrator sample prepared in triplicate on each plate. In the kyphosis 
trial, data were presented relative to the pre-weaner control; and in the vitamin A trial, data 
were presented as relative to the control group 
2.6 Analytical Chemistry  
2.6.1 Retinoid Extractions from Liver  
Liver samples from all pigs were extracted in duplicate. 150-200mg of liver were 
homogenised in 2ml of PBS in a glass PTFE 3ml tapered tissue grinder (Wheaton Science 
Products, NJ, USA). The homogenate was transferred to a 12ml glass tube using a glass 
Pasteur pipette, and the tissue grinder was washed with 2ml of Ethanol (0.01%BHT) before 
the homogenate was added to the same 12ml glass tube. 20µl of the internal standard 
(0.5mM Retinyl Acetate) was added directly to the ethanol phase, and the tube was 
vortexed for 10 seconds. 4ml of hexane (0.01% BHT) was added to each tube, and tubes 
were mixed for 1 hour at 1800rpm on an orbital shaker. The tubes were centrifuged at 
3000rpm for 5 minutes, and the supernatant was transferred to a new 12ml glass tube using 
a glass pasteur pipette. The samples were extracted a further 2 times with 4ml of hexane, 
however tubes were vortexed for 10 seconds, as opposed to 1 hour, in between steps. The 
combined hexane phases (12ml) in the new 12ml glass tubes were dried down under a 
gentle steam of nitrogen gas in a heat block set at 35°C. Residues were re-dissolved in 1ml 
of ethyl acetate and transferred to an amber vial before storage at -80°C until HPLC analysis. 
On every day of sample extraction, 20µl of the internal standard was added to 980µl of ethyl 
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acetate and was used to calculate % recovery of REs for samples extracted on that same 
day. The internal standard was stored at -80°C in an amber vial until HPLC analysis.  
2.6.2 HPLC  
The HPLC mobile phase consisted of Acetonitrile/1,4-Dioxane/Alcohol 
mixture/Triethylamine (79:14.8:6:0.2, v/v). The alcohol mixture consisted of 1:1 
methanol:isopropanol and 1.16g of Ammonium Acetate. The gradient flow was 1ml/min, all 
esters were resolved within 32 minutes and injection volume was 10µl. The column was a 
Sphereclone C18 5µm 250x4.6mm with a security guard column C18 4x3.00mm. All samples 
were analysed on a HPLC system with a Shimadzu SPD-M20A photodiode array detector set 
to 325nm. Intra and inter day variation of each batch run was calculated by extractions from 
the same source of liver, and these samples were placed at the beginning, middle and end 
of each analysis. Between these 3 samples at these points, intra-variation did not exceed 
0.75%, and inter-day variation was 6.25%. The retention times for each ester are listed in 
Table 2.9. All samples were run in duplicate. 
 
 
 
 
Table 2.9: Typical HPLC retention times (mins) for individual REs after a 10µl injection 
through a Sphereclone C18 5µm 250x46mm column with a Security guard column C18 
4x3.00mm.      
Compound Retention Time/mins 
Retinol 3.98 
Retinyl Acetate (Internal Standard) 4.30 
Retinyl Linoleate 14.64 
Retinyl Oleate 20.15 
Retinyl Palmitate 21.68 
Retinyl Stearate 30.14 
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2.7 ELISA Analysis for Serum 25(OH) D  
2.7.1 Plate Setup 
Serum samples were extracted from -80°C storage and kept for an hour at room 
temperature to allow thawing. 25(OH) D concentrations in serum were quantified using a 
25-Hydroxy vitamin D ELISA kit (Immunodiagnostic systems Inc, Boldon, UK). Samples of 
serum from each pig sample was pooled and aliquoted, and one aliquot prepared per plate 
to serve as a calibrator and measure coefficient variation.  
25µl of standards and samples were added to a borosilicate glass tube, before addition of 
1ml of 1X 25-D Biotin- buffer. The tube was vortexed for 10 seconds, and 200µl of sample 
was added to each well. Calibrators were placed at the beginning, middle and end of the 
plates (Figure 2.5). The plate was left to stand for 2 hours at room temperature, then the 
contents of the wells were discarded. 300µl of 1X wash buffer was added to all wells using a 
multi-channel pipette, the contents were discarded, and the plate was firmly tapped against 
blotting paper in order to fully discard the contents of the wells. The plates were manually 
washed 3 times, before addition of 200µl of enzyme-conjugate to all wells using a multi-
channel pipette. The plate was allowed to stand at room temperature for 30 minutes, 
before discarding the contents. The plate was washed with 1x wash buffer a further 3 times, 
before addition of 200µl of enzyme substrate to all wells using a multi-channel pipette. The 
plate was allowed to stand at room temperature for 30 minutes, then 100µl of stop solution 
was added to all wells using a multi-channel pipette. The concentrations of pre-prepared 
standards for each kit are provided (Table 2.10). The intra-variation of the kits did not 
exceed 10% on any plate and inter-variation was 7.7%. Each plate also contained a positive 
and negative control which represented elevated and reduced serum 25(OH) respectively. 
All samples, standards and controls were ran in duplicate.  
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 1 2 3 4 5 6 7 8 9 10 11 12 
A STD 0 STD4 Ctrl 2 WC6 WC10 WC14 PK2 PK5 PK9 PK13 PC1 PC5 
B STD 0 STD4 Ctrl 2 WC6 WC10 WC14 PK2 PK5 PK9 PK13 PC1 PC5 
C STD1 STD5 CALIB1 WC7 WC11 WC15 PK3 PK6 PK10 PK14 PC2 PC6 
D STD1 STD5 CALIB1 WC7 WC11 WC15 PK3 PK6 PK10 PK14 PC2 PC6 
E STD2 STD6 WC4 WC8 WC12 WC16 PK4 PK7 PK11 PK15 PC3 PC7 
F STD2 STD6 WC4 WC8 WC12 WC16 PK4 PK7 PK11 PK15 PC3 PC7 
G STD3 Ctrl 1 WC5 WC9 WC13 PK1 CALIB2 PK8 PK12 PK16 PC4 CALIB3 
H STD3 Ctrl 1 WC5 WC9 WC13 PK1 CALIB2 PK8 PK12 PK16 PC4 CALIB3 
 
Figure 2.5: A typical well map used for each ELISA plate. STD 0-6: Standards used to generate curve. Ctrl 1: Positive control Ctrl 2: Negative 
control CALIB1-3: Calibrators to measure CV%   
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Table 2.10: The concentrations (ng/ml) of each standard prepared on each 96 well ELISA 
plate. 
STD ng/ml 
0 0 
1 6.5 
2 11.5 
3 18.5 
4 32 
5 44 
6 94.4 
 
2.7.2 Data Analysis  
Upon addition of the stop solution, the plate was read at 450nm and 650nm on a Multiskan 
Go Spectrophotometer (Thermo-Fisher Scientific, MA, USA). 450nm represented the 
abundance of 25(OH) D in each well, while 650nm represented potential protein retained in 
the well. The OD of 650nm was subtracted from the OD of 450nm in order to obtain the 
final OD reading for each sample. Data were then exported to GraphPad prism (GraphPad 
Software, CA, USA) and the standard curve was automatically generated using non-linear 
regression. Standard concentrations can be viewed in table 2.10. The OD values for each 
sample were then calculated automatically in GraphPad, based on the standard curve.  
2.8 General Data Analysis  
All approaches for statistical analysis of data for all experiments in this thesis are indicated 
in each experimental chapter. Methods unique to each experimental chapter are also 
provided in each chapter. Outliers were determined in all data using the rule: µ ± 2σ. Values 
that fell outside of this range were excluded from the data.  
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Chapter 3: Molecular characterisation of idiopathic lumbar kyphosis in pigs 
3.1 Introduction  
The underlying cause of kyphosis in pigs remains elusive and unclear. Literature on the topic 
is relatively limited, however an estimated 11% of pigs born alive will show symptoms 
(Straw et al., 2009). The disease has doubled in incidence since 1980, when 5% of pigs had 
been diagnosed with the condition (Straw et al., 2009). The disease is a problem on-farm: 
affected pigs have shown signs of paralysis (Done and Pearson, 2004), are suspected of 
having a reduced growth rate (Straw et al., 2009) and automatic machinery within the 
slaughterhouse is not accustomed to accept a carcass with an abnormality of this nature 
(Holl et al., 2008). There remains a need for a more in-depth characterisation of the basis of 
the disease so intervention strategies can become implemented in practice.  
Upon anatomical examinations, kyphotic pigs have shown signs of mineralisation defects 
within bone tissue. There have been cases in which bone tissue content of Ca is clearly 
reduced (Done and Gresham, 1988) and severe cases have shown development of hemi-
vertebrae within the final thoracic sections of the spine (Nielsen et al., 2005, Done et al., 
1999). Following vascular invasion of the cartilage template, osteoblasts contribute to the 
formation of POCs, from which cartilage is eroded and replaced by mineralised bone matrix, 
allowing for endochondral bone growth (Karsenty et al., 2009, Maes et al., 2010). The 
development of hemi-vertebrae within kyphotic tissue reveals a loss of a POC, and indicates 
a reduction in endochondral bone growth or angiogenesis, which allows for osteoblasts to 
be delivered to the growing tissue (Nielsen et al., 2005, Maes et al., 2010). Subsequent 
failure of ossification results in incomplete mineralisation of the tissue, and provides a 
“kinked” morphology to the vertebrae that contributes to the characteristic kink of 
kyphosis. The differentiation and function of chondrocytes and osteoblasts, which regulate 
endochondral bone growth, are controlled by a variety of molecular signalling pathways, 
including: TGF- β, BMP, Wnt, or IHH pathways (Karsenty et al., 2009, Kronenberg, 2003, 
Chen et al., 2012). In addition, these pathways have also been demonstrated to regulate 
angiogenesis (Goumans et al., 2009, Olsen et al., 2017, David et al., 2009). Due to their roles 
in mediating osteoblast differentiation, targeting BMP, IHH or Wnt pathways have been 
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recommended in the treatment of bone diseases such as osteoporosis (Zhao et al., 2017, Li 
et al., 2016). However, studies have observed that mutations in genes belonging to TGF- β 
or BMP pathways not only associate with osteoporosis, but a variety of other skeletal 
disorders such as osteoarthritis and osteogenesis imperfecta (MacFarlane et al., 2017). It is 
therefore possible that downregulation of the TGF- β signalling pathway, which includes the 
BMPs, may be associated with kyphosis bone tissue, but there is currently no evidence to 
support this.   
Additionally, Done and Pearson (2004) observed increased disc space, and occasional 
collapsing of the disc, between the final thoracic and first lumbar vertebrae in kyphotic pigs. 
The intervertebral disc is composed of layers of chondrocytes, collagen fibres and PGs, 
which hold organisational roles in the coordination of fibrillogenesis to retaining the tissues 
structure (Melrose et al., 2001, Bock et al., 2001, Burton-Wurster et al., 2003). Evidence has 
indicated that during Osteoarthritis, a condition characterised by cartilage deterioration, a 
disruption in cytoskeletal organisation within chondrocytes, which subsequently impairs 
chondrocyte differentiation, contributes to articular cartilage degeneration (Loty et al., 
1995, Capin-Gutierrez et al., 2004). Actins are vital components of the cytoskeleton, and are 
required for cytoskeletal reorganisation in order to allow for cell migration, motility and 
interaction with the ECM (Liu et al., 2017). How genes which represent cytoskeletal 
components, such as actins, have been influenced in kyphotic articular cartilage has not 
been explored. In addition, PGs within the cartilage such as SLRPs may induce chondrocyte 
differentiation through upregulation of genes such as ACAN, and promote glyosaminoglycan 
(GAG) production (Salinas and Anseth, 2009). Yet in models of osteoarthritis, there is an 
observed upregulation of SLRPs within affected cartilage (Bock et al., 2001). The SLRPs have 
been demonstrated to facilitate TGF- β, BMP and Wnt pathways (Nikitovic et al., 2012), yet 
evidence shows that they also have the potential to inhibit TGF- β signalling in particular 
(Yao et al., 2016). TGF- β signalling is critical in allowing the differentiation of chondrocytes 
(Ying et al., 2018), yet there is no evidence in current literature that could explain its 
potential association within kyphotic cartilage. The TGF- β pathway has very clear roles in 
promoting the differentiation of MSCs into chondrocytes and osteoblasts, therefore it could 
be hypothesised that this pathway is potentially responsible for abnormal bone and 
cartilage development during kyphosis, but there is currently no evidence to support this.  
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The molecular events that occur during kyphosis require clarity and definition in order to 
further our understanding of this idiopathic disease. Thus, the objectives of this study were 
to determine if the TGF- β signalling pathway is associated with kyphotic bone and cartilage 
tissue. The hypotheses for the study are as follows:  
 TGF- β signalling pathway will be downregulated in kyphotic trabecular bone, due to 
endochondral mineralisation and angiogenesis being potentially disrupted during 
kyphosis (Nielsen et al., 2005, Done et al., 1999), and because of the TGF- β 
pathways associations with skeletal disorders (MacFarlane et al., 2017). 
 Actin genes will be downregulated within kyphotic cartilage, due to their regulatory 
roles in chondrogenesis (Liu et al., 2017); and SLRPs, due to their associations with 
osteoarthritis, will show upregulation within kyphotic cartilage, and this will 
associate with the TGF- β signalling pathway.  
 The TGF- β pathway will overlap in kyphotic bone and cartilage tissues.  
3.2 Materials and Methods  
3.2.1 General Methods 
The experimental design and seletion of kyphotic pigs, as well as methods related to this 
chapter, can be found in Chapter 2. This includes methods for: Tissue extraction, RNA 
extraction, cDNA synthesis, Microarray Analysis, Microarray Data and Pathway Analysis, 
qPCR analysis, and calculation and presentation of qPCR data.    
Gene biomarkers were selected for qPCR verification based on their consistency among GO 
terms in Cytoscape, overlap between GO terms and canonical pathway analysis in IPA, and 
the biological role and relevance of affected genes to the context of bone metabolism was 
also considered. If initial analysis of gene expression between kyphosis and non-related 
control pre-weaners showed only marginal fold-changes, these genes were not investigated 
in the older age groups. 
3.2.2 Statistical Analysis  
Before statistical analysis, data were tested for normal distribution using Shapiro-Wilk test 
and observing skewness and kurtosis (SPSS Software). Data were ln transformed to achieve 
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normal distribution, however normal distribution could not be achieved for all variables. 
Therefore, the non-parametric Kruskal-Wallis test was used to observe the effects of age 
and phenotype on dependent variables, and Mann-Whitney test was used to observe 
effects between kyphotic and control pigs in individual age groups. A p value <0.05 was 
considered as statistically significant. 
3.3 Results   
3.3.1 Microarray Profiling of Kyphotic Trabecular Bone  
In the trabecular bone of kyphotic pre-weaners, a total of 1196 transcripts were found to be 
differentially expressed with a fold change greater than 2. Of these, 477 were upregulated 
(39.9%) and 719 were downregulated (60.1%) in comparison to age-matched non-related 
control piglets. The top 5 upregulated and downregulated genes which showed the greatest 
fold-changes in kyphotic trabecular bone are shown in Table 3.1.  
IPA identified the top canonical signalling pathways affected in the bone of kyphosis pre-
weaners (Table 3.2). “TGF- β signalling” and “BMP signalling” were the pathways most 
significantly associated with kyphotic trabecular bone (p<0.05), and IPA identified TGF- β as 
the most significantly affected regulatory gene to associated with this tissue (Table 3.2). The 
TGF- β signalling pathway was significantly downregulated within kyphotic trabecular bone 
(p<0.01). Furthermore, many of the genes that showed differential expression were found 
to share associations with TGF- β, including mineralization genes such as BGLAP, Bone 
Morphogenetic protein Receptor 1A (BMPR1A), and Asporin (ASPN). These relationships are 
presented in Figure 3.1. 
Cytoscape identified a total of 59 GO terms affected by differential gene expression in the 
trabecular bone of kyphosis pre-weaners with a total of 19 associated genes. The most 
significantly affected GO terms, ranked by Term p-value corrected with Benjamini-
Hochberg, related to “BMP signalling”, “Regulation of Biomineral Tissue Development,” and 
“Biomineral Tissue Development” (Table 3.3). Genes such as BMPR1A, ASPN, Protein 
Tyrosine kinase 2 Beta (PTK2B), and BGLAP showed consistency among IPA and Cytoscape, 
and “BMP signalling” was identified in both of types of analysis. 
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Table 3.1: The top 5 up and downregulated genes, with regards to fold-change, in the 
trabecular bone of kyphotic pre-weaners, as determined by Genespring. Indicated is the gene 
name, the process the gene regulates, fold-change and p-value calculated by moderated T-
Test.  
The genes that showed consistency among IPA and Cytoscape, and had relevant biological 
roles in the context of bone metabolism, were selected for qPCR verification in order to 
validate the findings. The genes: TGF-β, BMPR1A, ASPN, BGLAP, and PTK2B were analysed. 
PTK2B was analysed in the pre-weaning group, but was not analysed in the older age groups 
due to showing marginal fold-changes and no indications of significance in expression.   
Gene 
Symbol 
Gene Title  Molecular Function  Fold-change  p-value 
SNCG 
 
synuclein, gamma (breast 
cancer-specific protein 1) 
beta-tubulin binding 11.92↑ 
 
0.0143 
 RH Rh protein ammonium 
transmembrane 
transporter activity 
8.16↑ 
 
0.0308 
 CD5L 
 
CD5 molecule-like scavenger receptor 
activity 
7.32↑ 
 
0.0229 
 ALOX12 Arachidonate 12-
lipoxygenase 
Adipocyte 
Differentiation 
7.25↑ 
 
0.0042 
 HP Haptoglobin Osteoclast activation 5.23↑ 
 
0.0097 
 POSTN periostin, osteoblast 
specific factor, transcript 
variant 2 
Differentiation of 
Osteoblasts 
59.13↓ 7.79E-04 
 ACAN 
 
Aggrecan extracellular matrix 
structural constituent 
14.83↓ 0.00107 
 C1QTNF3 
 
C1q and tumor necrosis 
factor related protein 3 
Osteoclast activation 14.07↓ 4.46E-05 
 IGF2 Insulin-like growth factor 2 Differentiation of 
Osteoblasts 
13.72↓ 
 
7.82E-04 
 BGLAP Bone gamma-
carboxyglutamate (gla) 
protein (osteocalcin) 
Differentiation of 
Osteoblasts 
13.32↓ 
 
9.68E-04 
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Table 3.2: The top upstream regulators, and Canonical pathways affected in the bone and 
cartilage of pre-weaning kyphotic pigs in comparison to non-related controls, as indicated by 
IPA. The direction of differential expression for each gene is shown, as well as p-values 
calculated by Fishers-Exact test.  
Kyphotic Bone Kyphotic Cartilage 
Top Upstream 
Regulator  
p-value  Top Upstream 
Regulator  
p-value  
TGF-β - Inhibited 4.69E-27 TGF-β - 
Activated 
3.16E-15 
Pathway p-value Genes Pathway p-value Genes 
Role of 
Osteoblasts, 
Osteoclasts and 
Chondrocytes in 
Rheumatoid 
Arthritis 
 
7.4131E
-05 
 
 
BGLAP↓, 
TGFB1↓, 
TNFSRF1A↓, 
MAPK12↓, 
BMPR1A↓, 
PT2KB↑, 
SMAD7↑ 
Gap Junction 
Signalling 
 
1.47911
E-06 
 
GNAS↑, ACTB↑, 
ACTC1↑, ACTA2↑, 
ACTA1↑ 
BMP signalling 0.00039 
 
BMPR1A↓, 
SMAD7↑, 
BMP1↓, 
MAPK12↓ 
Remodelling 
of Epithelial 
Adherens 
Junctions 
 
2.39883
E-06 
ACTB↑, ACTC1↑, 
ACTA2↑, ACTA1↑ 
Integrin 
Signalling 
0.00055 
 
ARPC2↓, 
ASAP1↓, FYN↓, 
ACTA2↓, 
ACTA1↓ 
EIF2 signalling 
 
4.16869
E-06 
 
ACTB↑, ACTC1↑, 
ACTA2↑, EIF4A2↑, 
ACTA1↑ 
TGF- β Signalling 
 
0.00088 
 
BMPR1A↓, 
TGFB3↓, 
SMAD7↑, 
TGFB1↓, 
MAPK12↓ 
Integrin 
signalling 
 
0.00145 
 
ACTB↑, ACTC1↑, 
ACTA2↑, ACTA1↑ 
FAK signalling 
 
0.0019 
 
ASAP1↓, FYN↓, 
GIT2↓, ACTA2↓, 
ACTA1↓ 
Osteoarthritis 
Pathway 
 
0.0066 
 
ACAN↑, DCN↑, 
ATF4↑, RARRES2↑ 
56 
 
  
Figure 3.1: Graphic representation of the most relevant genes differentially expressed in pre-
wenaing kyphotic bone, identified by IPA. Genes are represented by nodes, and relationships 
by edges 
3.3.2 Microarray Profiling of Kyphotic Intervertebral Cartilage  
In the intervertebral cartilage of kyphotic pre-weaners, a total of 348 transcripts were found 
to be differentially expressed >2-fold. Of these transcripts, 310 were upregulated (89.1%) 
whereas only 38 were downregulated (10.9%) in comparison to age-matched non-related 
control piglets. The top 5 upregulated and downregulated genes with the greatest fold-
changes are shown in Table 3.4. IPA identified the top canonical signalling pathways 
affected in the cartilage of kyphotic pre-weaners (Table 3.2). 
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Table 3.3: Gene ontology pathways affected by differential gene expression in bone and 
cartilage tissues of kyphotic piglets in comparison to age-matched non related controls. 
Term Pvalue corrected with Benjamini-Hochberg *P<0.01 
Actin-associated genes showed consistency among top canonical pathways, which is in 
agreement with the original hypotheses in that there would be a differential regulation of 
these genes. However, unlike the original hypotheses stating these genes would be 
downregulated, the analysis has indicated these genes were upregulated. The 
“Osteoarthritis pathway” also showed in canonical pathways (p<0.05) and this showed an 
upregulation of the SLRP Decorin (DCN). Cytoscape identified a total of 20 GO terms 
affected by differential gene expression in the intervertebral cartilage of kyphotic pre-
weaners with a total of 7 associated genes. The most relevant and significantly affected GO 
terms, ranked by Term P-value corrected with Benjamini-Hochberg, related to “negative 
regulation of insulin-like growth factor receptor signalling” and “peptide cross-linking via 
chondroitin 4-sulfate glycosaminoglycan”, which associated genes in these pathways, were 
Cartilage intermediate later protein (CILP) and DCN respectively (Table 3.3). 
GO TERM Kyphosis Differential Gene Expression - Bone 
BMP signalling* BMPR1A↓ ID1↓ SMAD7↓ 
 
Reg. of Biomineral 
Tissue 
Development* 
BMPR1A↓ ASPN↓ BGLAP↓ PTK2B↑ 
Biomineral Tissue 
Development* 
BMPR1A↓ ASPN↓ BGLAP↓ PTK2B↑ 
Regulation of 
ossification* 
BGLAP↓ BMPR1A↓ ID1↓ PTK2B↑ 
Ossification* BMPR1A↓ ASPN↓ BGLAP↓ ID1↓ 
 
Kyphosis Differential Gene Expression - Cartilage 
Peptide 
Crosslinking* 
DCN↑ 
   
Neg. reg. of insulin-
like growth factor 
receptor signalling* 
CILP↑ 
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Gene 
Symbol 
Gene Title Molecular Function Fold-change p-value 
COMP 
 
cartilage oligomeric 
matrix protein 
calcium ion binding 25.07↑ 
 
0.0101 
 ACAN 
 
Aggrecan extracellular matrix 
structural constituent 
23.91↑ 
 
0.0404 
 MGP 
 
matrix Gla protein calcium ion binding 21.79↑ 
 
0.0493 
 COL14A1 
 
collagen, type XIV, alpha 
1 
extracellular matrix 
structural constituent 
19.70↑ 
 
0.0018 
 THBS3 
 
thrombospondin 3 calcium ion binding 16.20↑ 0.0157 
 LCN2 
 
lipocalin 2 protein 
homodimerization 
activity 
13.02↓ 
 
0.0233 
 RPS6KC1 
 
ribosomal protein S6 
kinase, 52kDa, 
polypeptide 1 
transferase activity 4.32↓ 
 
0.0393 
 SLC16A12 
 
solute carrier family 16, 
member 12 
symporter activity 4.17↓ 
 
 
0.0472 
 SPRYD7 
 
SPRY Domain Containing 
7 
protein binding 4.07↓ 
 
0.0314 
 INHBB inhibin beta(b)-subunit growth factor activity 3.54↓ 0.0497 
 Table 3.4: The top 5 up and downregulated genes, in regards to fold-change, in the 
intervertebral cartilage of kyphotic pre-weaners, as indicated by Genespring. Indicated is the 
gene name, the process this gene regulates, fold-change and p-value calculated by 
moderated T-Test.    
The relationships among genes identified in IPA and Cytoscape are presented in Figure 3.2. 
DCN therefore showed consistency among IPA and Cytsocape and so was selected for qPCR 
verification. Actin, Alpha, Cardiac Muscle 1 (ACTC1) was analysed in the pre-weaning group, 
but was not analysed in the older age groups due to showing marginal fold-changes and no 
indications of significance in expression.   
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Figure 3.2: Graphic representation of the most relevant genes differentially expressed in pre-
weaning kyphotic cartilage, identified by IPA. Genes are represented by nodes, and 
relationships by edges.  
3.3.3 Verification of Gene Expression in Kyphotic Tissues using qPCR  
A list of primer sequences for all genes of interest can be seen in Table 3.5.  
3.3.3.1 Expression of TGF- β in Kyphotic Bone  
There were no significant differences in expression between kyphotic pre-weaners and non-
related controls (Fold-change (FC) -1.31, p=0.235), or with littermates (FC -1.02, p=0.442), 
but a tendency was observed between littermates and non-related controls (FC -1.27, 
p=0.084) (Figure 3.3). No significant differences in expression were observed in kyphotic 
weaners (FC-1.03, p=0.631) or kyphotic post-weaners (FC -1.18, p=0.180). There was no 
significant effect of phenotype (p=0.803) or age (p=0.175) on gene expression. The results 
indicate that, TGF- β was not differentially expressed in kyphosis bone tissue. 
3.3.3.2 Expression of BMPR1A in Kyphotic Bone 
There was a tendency for BMPR1A expression to be downregulated in kyphotic pre-weaners 
in comparison to non-related controls (FC -1.86, p=0.097), but not with littermates (FC-1.01, 
p=0.693), or between littermates and non-related controls (FC-1.84, p= 0.136) (Figure 3.4). 
60 
 
Table 3.5: List of primer sequences for genes of interest for quantification of gene expression 
by real-time quantitative polymerase chain-reaction (q.PCR) 
 
PRIMER ID SEQUENCE 5’-3’ 
RPL37 (HK) F: GCCTACCATCTCCAGAAGTC 
R: CTTCACGGAATCCATGCCTG 
TGF- Β1 F:GGAGCTATACCAGAAATACAGCA 
R:GCGAAAACCCTCTATAGCCTC 
BMPR1A F:GCCCTACATAATGGCTGATATCT 
R:TTGACACACACAACCTCACG 
BGLAP F:TGAAGAGACTCAGGCGCTAC 
R:CTGCGAGGTCTAGGCTATGC 
ASPN F:ACCCCTTCTTCCCATTCGAT 
R:AGCATAAAGTGAGGTGAGTCC 
PTK2B F: GTGGAAGCTGAGTGGAGGTA 
R: CTTTGAAGAACCGCCTGAGC 
ACTC1 F: ACTGCTGAGCGTGAAATTGT  
R: TACCAATGAAGGAGGGCTGG 
DCN F:AAAATCAGCCCTGGAGCATT 
R:GTGCCAAGTTCTACGACGAT 
 
RPL37, Ribosomal protein sub-unit L37, TGF-β, Transforming Growth Factor Beta, BMPR1A, 
Bone Morphogenetic Protein Receptor Type 1A, BGLAP, Osteocalcin, ASPN, Asporin, 
PTK2B, Protein Tyrosine Kinase 2 Beta, ACTC1, Actin, Alpha, Cardiac Muscle 1, DCN, 
Decorin.   
 
There were no significant differences observed in kyphotic weaners (FC+1.10, p=0.740) or in 
kyphotic post-weaners (FC-1.11, p=1.0). A clear effect of age was observed on gene 
expression (p<0.01) in that biomarker expression decreased after the pre-weaning stage, 
but not with phenotype (p=0.486).  
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Figure 3.3: Relative real-time PCR expression of TGF-β in the trabecular bone of pre-weaning 
(PreW) (n=17 per group), weaning (n=16 per group), and post-weaning (PostW) (n=7 per 
group) kyphotic and control pigs, calculated by qPCR. Data are presented as relative to the 
pre-weaner control, and in boxplots with median, 25th and 75th quartile ranges, and upper 
and lower limits. Mann-whitney AB p=0.084. 
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Figure 3.4: Relative real-time PCR expression of BMPR1A in the trabecular bone of pre-
weaning (PreW) (n=17 per group), weaning (n=16 per group), and post-weaning (PostW) 
(n=7 per group) kyphotic and control pigs, calculated by qPCR. Data are presented as relative 
to the pre-weaner control, and in boxplots with median, 25th and 75th quartile ranges, and 
upper and lower limits. Kruskal-Wallis Age p<0.01, Mann-Whitney AB p=0.097 
 
3.3.3.3 Expression of BGLAP in Kyphotic Bone   
There were no significant differences in expression in kyphotic pre-weaners in comparison 
to non-related controls (FC+1.01, p=0.603), or with littermates (FC+1.73, p=0.129), or 
between littermates and non-related controls (FC+1.75, p=0.250) (Figure 3.5). No significant 
differences were observed in kyphotic weaners (FC-1.05, p= 0.931) or kyphotic post-
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Figure 3.5: Relative real-time PCR expression of BGLAP in the trabecular bone of pre-
weaning (PreW) (n=17 per group), weaning (n=16 per group), and post-weaning (PostW) 
(n=7 per group) kyphotic and control pigs, calculated by qPCR. Data are presented as relative 
to the pre-weaner control, and in boxplots with median, 25th and 75th quartile range, and 
upper and lower limits. Kruskal-Wallis Age p<0.01  
weaners (FC+1.06, p= 0.519). A clear effect of age (p<0.01) was observed on BGLAP 
expression in that biomarker expression decreases after the pre-weaning stage, but no 
effects were observed for phenotype to have an effect on gene expression (p=0.713).  
3.3.3.4 Expression of ASPN in Kyphotic Bone 
There were no significant differences in ASPN expression in kyphotic pre-weaners in 
comparison to non-related controls (FC-1.30, p=0.155), or between kyphotic pre-weaners 
and littermate piglets (FC -1.28, p=0.210), or between littermate piglets and non-related 
controls (FC-1.01, p=0.973) (Figure 3.6). There were no significant differences in expression 
observed in kyphotic weaners (FC-1.28, p=0.901), but a significant difference was observed 
in kyphotic post-weaners (FC -1.40, p=0.025). There was no overall effect of phenotype 
(p=0.209), but there was an effect of age (p<0.01) due to biomarker expression decreasing 
over time. The current data suggests ASPN is downregulated in kyphotic bone at the post-
weaning stage. 
3.3.3.5 Expression of PTK2B in Kyphotic Bone  
The differences in PTK2B expression in the bone of kyphotic pre-weaners did not indicate 
significance (FC-1.05, p=0.395) (Figure 3.7). Due to these marginal changes, PTK2B was not   
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Figure 3.6: Relative real-time PCR expression of ASPN in the trabecular bone of pre-weaning 
(PreW) (n=17 per group), weaning (n=16 per group), and post-weaning (PostW) (n=7 per 
group) kyphotic and control pigs, calculated by qPCR. Data are presented as boxplots 
showing medians, 25th and 75th quartiles and upper and lower limits. Kruskal-Wallis Age 
p<0.01, Mann-Whitney AB p=0.025).  
 
P
re
W
 C
o
n
tr
o
l
P
re
W
 K
y
p
h
o
s
is
0 .0
0 .5
1 .0
1 .5
2 .0
R
e
la
ti
v
e
 E
x
p
re
s
s
io
n
 
Figure 3.7: Relative real-time PCR expression of PTK2B in the bone of pre-weaning (PreW) 
kyphotic (n=17) and control (n=17) pigs, calculated by qPCR. Data are presented as boxplots 
showing medians, 25th and 75th quartiles and upper and lower limits. 
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Due to these marginal changes, PTK2B was not analysed in the older age groups. 
3.3.3.6 Expression of ACTC1 in Kyphotic Cartilage   
The differences in ACTC1 expression in the cartilage of kyphotic pre-weaners was notable, 
but not significant (FC-1.51, p=0.308) (Figure 3.8). ACTC1 did not show changes that were as 
significant as the changes in gene expression for DCN and was not analysed in the older age 
groups.   
3.3.3.7 Expression of DCN in Kyphotic Cartilage 
DCN was observed to be upregulated in kyphotic pre-weaners in comparison to non-related 
controls (FC+1.30, p=0.04), but not in comparison to littermates (FC-1.43, p=0.664), and 
DCN was significantly upregulated in littermates in comparison to non-related controls 
(FC+1.87, p=0.011) (Figure 3.9). There were no significant differences in expression 
observed in kyphotic weaners (FC+1.15, p=0.462) or in kyphotic post-weaners (FC+2.09, 
p=0.568). There were no overall effects of phenotype (p=0.133) or age (p=0.166) on 
expression. The results indicate that DCN is upregulated within kyphotic cartilage at the pre-
weaning stage, and that this effect is confined to the litter.    
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Figure 3.8: Relative real-time PCR expression of ACTC1 in the cartilage of pre-weaning 
(PreW) kyphotic (n=17) and control (n=17) pigs, calculated by qPCR. Data are presented as 
boxplots showing medians, 25th and 75th quartiles and upper and lower limits 
65 
 
P
re
W
 C
o
n
tr
o
l
P
re
W
 L
it
te
rm
a t
e
P
re
W
 K
y p
h
o
s i
s
W
e a
n
e r
 C
o
n
tr
o
l
W
e a
n
e r
 K
y p
h
o
s i
s
P
o
s t
W
 C
o
n
tr
o
l
P
o
s t
W
 K
y p
h
o
s i
s
0
2
4
6
8
R
e
la
ti
v
e
 E
x
p
re
s
s
io
n
A
B C
 
Figure 3.9: Relative real-time PCR expression of DCN in the cartilage of pre-weaning (PreW) 
(n=17 per group), weaning (n=16 per group), and post-weaning (PostW) (n=7 per group) 
kyphotic and control pigs, calculated by qPCR. Data are presented as boxplots showing 
medians, 25th and 75th quartiles and upper and lower limits.  Mann-Whitney AB p=0.011 AC 
p=0.04.  
 3.4 Discussion  
The original hypotheses stated that the TGF- β signalling pathway will be downregulated in 
kyphotic bone, SLRPs and actin genes will show upregulation in kyphotic cartilage tissues, 
and the TGF- β pathway will associate with both tissue types. However qPCR analysis 
indicated the TGF- β pathway is not downregulated in kyphotic trabecular bone. Nor were 
actin genes associated with kyphotic cartilage. However, the results agree with the original 
hypotheses in that SLRPs are upregulated in kyphotic cartilage, in particular DCN. The 
analysis also showed the SLRPs ASPN and DCN to associate with kyphotic bone and cartilage 
tissues respectively, and both of these genes influence TGF- β signalling (Yao et al., 2016, 
Nakajima et al., 2007). This finding therefore overlaps the TGF- β signalling pathway in 
kyphotic bone and cartilage tissues, and agrees with the original hypotheses. With 
biomarkers such as BMPR1A, BGLAP and ASPN, there were effects of age observed in that 
biomarker expression decreased over time, however only ASPN was indicated to be 
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differentially regulated in the post-weaning stage. Otherwise, in all cases, the greatest 
effects in regards to fold-changes and p-values were observed within the pre-weaning 
group.  
3.4.1. TGF-β Pathways and Bone Mineralisation in Kyphotic Bone  
In the present study, TGF-β was identified as the molecular regulator most significantly 
associated with kyphotic bone and cartilage tissues, as opposed to other pathways that 
regulate bone growth such as IHH or Wnt signalling. However, qPCR analysis showed that 
although TGF- β followed the trend in the microarray in that this gene was downregulated in 
the bone of kyphotic pre-weaners in comparison to controls, this was not observed to be 
significant (Figure 3.3). However, TGF- β showed a tendency to be downregulated in 
littermates in comparison to non-related controls (Figure 3.3), which might suggest the 
effect is confined to the litter. TGF- β belongs to the TGF- β superfamily composed of over 
40 molecules, also including BMPs, and functions by transmitting signals across the plasma 
membrane through ligating with TGF- β receptors and inducing signalling cascades through 
phosphorylation of smad 2/3 proteins to control gene expression of bone formation genes 
(Chen et al., 2012). However, in low physiological doses, TGF- β has been observed to induce 
osteoclast differentiation, and this outlines the pathways dual roles in regulating bone 
homeostasis (MacFarlane et al., 2017). Yet, TGF- β has been observed in separate 
experiments to regulate genes related to osteoblast differentiation that showed in the 
current study: TGF- β positively regulates expression of genes such as Actins (Xu et al., 
2001), IGF2 (Goel et al., 2013), and BMP1 (Lee et al., 1997). The relevance of actins to bone 
mineralisation is that reorganisation of the cell cytoskeleton, which is composed of actin 
filaments, is associated with mineralisation of in vitro cell cultures (Goncharenko et al., 
2016). However the lack of differential expression of TGF- β by qPCR indicates this pathway, 
and the aforementioned genes induced by TGF- β that regulate mineralisation, is not 
associated with the development of kyphotic bone.    
The expression of other genes in the study that associate with TGF- β, and regulate 
mineralisation, were also investigated. GO term “BMP signalling” was identified by both IPA 
and Cytoscape analysis, and BMPR1A showed consistency among these. qPCR analysis 
showed BMPR1A had a tendency to be downregulated within trabecular bone of kyphotic 
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pre-weaners, thus following the trend indicated by the microarray (Figure 3.4). The BMP 
signalling pathway serves as a component of the TGF- β pathway; though TGF- β promotes 
the cellular differentiation of committed progenitor cells towards an osteoblast lineage, 
BMPs are required to commit uncommitted MSCs towards an osteoblast lineage and thus 
initiate the initial stages of organ morphogenesis (Manolagas, 2000). BMPR1A codes for the 
BMP type I receptor, which interacts with BMP ligands and therefore associates with the 
TGF- β signalling pathway (Chen et al., 2012). Specific knockout of BMPR1A in vivo results in 
a failure of mesenchymal condensation preceding endochondral ossification (Lim et al., 
2015), an increase in immature osteocyte abundance in bone (Kamiya et al., 2016); yet 
other experiments have indicated the expression of this gene is required to promote 
adipogenesis differentiation (Chen et al., 1998). A downregulation of BMPR1A could 
therefore indicate either: a reduction in endochondral bone growth, or adipocyte 
differentiation, or potentially both processes.   
A prominent marker of bone formation observed in the current study was BGLAP, which 
regulates hydroxyapatite crystal deposition that forms the mineral component of bone 
(Tsao et al., 2017). Although BGLAP was identified as a differentially expressed gene in a 
vitamin-D induced model of kyphosis (Amundson et al., 2016), qPCR analysis did not return 
significant, differential expression of BGLAP between kyphotic or control pigs in the present 
study (Figure 3.5). This finding suggests BGLAP expression, unlike the hypovitaminosis D 
model of kyphosis, is not affected in the bone of spontaneous kyphotic cases.     
Yet, qPCR analysis showed that ASPN, a regulator of TGF- β, was significantly downregulated 
in the bone of kyphotic post-weaners in comparison to age-matched controls (Figure 3.6). 
ASPN has been observed to inhibit TGF- β binding to TGF- β receptor II and therefore silence 
expression of TGF- β target genes; likewise, TGF- β also induces ASPN expression, indicating 
a regulatory feedback mechanism between the two genes (Nakajima et al., 2007). Separate 
studies confirm positive regulation of ASPN by TGF- β, but also observe an induction of TGF- 
β by ASPN (Kou et al., 2007), therefore highlighting the regulatory role ASPN has on TGF- β 
signalling. In regards to regulation of mineralisation, ASPN has been demonstrated to 
upregulate RUNX2 and OSTERIX at the developing cartilage template and induce osteoblast 
differentiation and mineralization to form ossified bone (Kalamajski et al., 2009). Yet in 
periodontal tissue, ASPN has been demonstrated to negatively regulate mineralisation 
(Tomoeda et al., 2008), in contrast to the findings of Kalamajski et al. (2009). This could 
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indicate a difference in function between tissue types, but ASPN’s role as a regulator of 
bone mineralisation is clear. Therefore a downregulation of this gene at the post-weaning 
stage could either: be a factor that contributes to reduced bone mineralisation in kyphotic 
pigs (Nielsen et al., 2005, Done et al., 1999, Done and Gresham, 1988) ; or potentially is a 
compensatory mechanism induced by the tissue to upregulate the TGF- β pathway and 
restore osteoblast differentiation. Overall, these indicate osteoblast differentiation and 
subsequent activity is reduced in post-weaning kyphotic trabecular bone.    
In summary, the TGF- β signalling pathway, as a result of ASPN differential expression, is 
associated with the trabecular bone of kyphotic post-weaners, but there were no clear 
indications that the pathway is downregulated in kyphotic trabecular bone. Downregulation 
of ASPN in post-weaning kyphotic trabecular bone could indicate reduced endochondral 
bone growth. The BMP signalling pathway could also be downregulated in the bone of 
kyphotic pre-weaners as a result of BMPR1A showing a trend to be downregulated.  
3.4.2. Angiogenesis in Kyphotic Bone  
From the list of differentially expressed genes, genes that associate with TGF- β and BMPs 
appear to associate with regulation of angiogenesis. BMPR1A and PTK2B are associated with 
regulation of angiogenesis (Xiao et al., 2015, Weis et al., 2008), and were analysed by qPCR 
in the current study. As discussed above, microarray and qPCR analysis indicated BMPR1A to 
be potentially downregulated within the bone of kyphotic pre-weaners (Figure 3.4). 
Selective inhibition of BMPR1A, with subsequent silencing of smad/ID signalling, disrupts 
angiogenesis in vitro (Xiao et al., 2015). qPCR analysis showed PTK2B followed the trend in 
the microarray in that this gene was upregulated in kyphotic trabecular bone (Figure 3.7), 
but this change was not significant. The current data supports the hypotheses that the 
process of angiogenesis has been disrupted in kyphotic trabecular bone tissue, due to 
BMPR1A showing a tendency to be downregulated in kyphotic pre-weaners. Other genes in 
the microarray such as SMAD7, indicated to be upregulated, is associated with angiogenesis, 
particularly in that it inhibits the TGF- β signalling pathway so as to prevent induction of 
VEGF (Peng et al. 2013). ID1, a downstream molecule of BMPR1A, was indicated to be 
downregulated by Cytoscape and IPA; through activation of NF-kB pathway, ID1 induces 
angiogenesis in vitro (Su et al. 2013). 
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Nielsen et al. (2005) observed that a lack of blood supply to the bone was also contributing 
to the development of kyphosis. During endochondral ossification, the extending cartilage 
template requires vascular invasion in order to deliver osteoblasts that will replace the 
cartilage template with ossified tissue and thus allow the growth of the tissue (Burr and 
Allen, 2014, Karsenty et al., 2009, Maes et al., 2010) . This has not been observed in any 
other reported case of kyphosis, yet the current study provides evidence that regulation of 
angiogenesis could potentially be disrupted as a result of fluctuations in genes such as 
BMPR1A. These findings once again demonstrate the critical role of the TGF-β and BMP 
pathways in regulating organ morphogenesis, and that there are other biological processes, 
as opposed to osteoblast differentiation, affected by these pathways that could be 
contributing to kyphosis.  
3.4.3 Actin Regulation in Kyphotic Cartilage  
In IPA canonical pathways, the genes ACTC1, ACTA1 and ACTA2 showed frequent 
consistency (Table 3.2). ACTC1 was selected for qPCR verification, based on evidence that 
the expression of this gene can influence the expression of the other skeletal actins (Kumar 
et al., 1997). However, qPCR indicated the expression of ACTC1 to be downregulated 1.56-
fold in the cartilage of pre-weaning kyphotic pig in comparison to non-related controls, but 
this was not significant (Figure 3.8). Therefore, the original hypotheses which stated that 
genes relating to actin regulation will be affected within kyphotic pigs is rejected. 
3.4.4 TGF-β Pathway and Cartilage Metabolism in Kyphotic Cartilage  
In kyphotic cartilage, IPA identified TGF- β as the top upstream regulator, yet TGF- β was not 
identified as a differentially expressed gene. DCN was observed in “osteoarthritis pathway” 
canonical pathway (Table 3.2). However, Cytoscape analysis indicated two genes 
differentially expressed within the cartilage, CILP and DCN, to be upregulated in kyphotic 
cartilage (Table 3.3). Both of these genes have been identified to influence TGF- β signalling 
(Yao et al., 2016, Mori et al., 2006). Upon qPCR verification, DCN was shown be upregulated 
in the cartilage of pre-weaning kyphotic piglets and littermate pre-weaners in comparison to 
non-related controls (Figure 3.9), thereby suggesting the effect is confined to the litter. This 
result agrees with the original hypotheses in that SLRPs will show upregulation in kyphotic 
cartilage, and that the TGF- β pathway will associate with kyphotic cartilage.     
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DCN belongs to the family of SLRPs which compose cartilage ECM, and holds an established 
role in regulating collagen fibrillogenesis by aiding fibril growth, inducing expression of 
collagens, and maintaining cartilage ECM (Gubbiotti et al., 2016, Salinas and Anseth, 2009). 
Elevated expression of DCN is also associated with the development of osteoarthritis (Bock 
et al., 2001) , as well as experimental models of disc decay (Melrose et al., 1997). Whether 
this is a cause or effect remains up to debate; Bock et al. (2001) suggested increased 
synthesis of Decorin was to restore PG losses that have occurred during osteoarthritis. 
Nonetheless, the observed upregulation of DCN within the cartilage of kyphotic and 
littermate pre-weaners suggests these pigs are experiencing the early stages of disc 
degeneration.   
DCN interacts with TGF- β, in that it binds TGF- β and prevents subsequent signalling (Yao et 
al., 2016), although other studies also showcase DCNs ability to facilitate binding of TGF- β 
to its receptors (Takeuchi et al., 1994). Therefore, based on these observations, the 
upregulation of DCN could indicate either: a compensatory mechanism induced by the 
cartilage to re-upregulate TGF- β signalling, or that DCN is binding TGF- β and preventing 
subsequent Smad signalling. TGF-Smad signalling has been demonstrated to be critical in 
cartilage growth and repair (Ying et al., 2018), and upregulation of type II collagen 
expression, a marker of differentiating chondrocytes has been observed in response to TGF- 
β treatment in vitro (Johnstone et al., 1998). However, Smad molecules were not indicated 
to be differentially expressed in kyphotic cartilage, therefore suggesting that TGF-Smad 
signalling has possibly not been compromised by DCN. Rather, it is likely that DCN may be 
attempting to facilitate TGF- β binding to its receptors (Takeuchi et al., 1994) in an attempt 
to repair the cartilage.     
The anatomical examinations of the intervertebral cartilage from previous cases (Done and 
Pearson, 2004) were performed on older, finishing pigs; therefore it would be useful to 
confirm if similar changes in cartilage morphology are occurring at pre-weaning in order to 
confirm or deny the possibilities suggested by differential expressions of these genes. 
Though Done and Pearson (2004) identified a collapsing of the thoraco-lumbar junction, this 
has not been observed in other cases of kyphosis; therefore the collapsing of the junction 
might indeed be contributed to by increased muscle mass in older, kyphotic pigs. However 
the data obtained in the current study also suggests biological changes are occurring in the 
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cartilage of very young kyphotic pigs that could potentially lead to a collapse of the thoraco-
lumbar junction.  
3.4.5 Overlap between Kyphotic Bone and Cartilage Tissues  
ASPN belongs to the SLRP family alongside DCN, DCN mirrors ASPNs functions in sharing a 
regulatory relationship with TGF- β (Kalamajski et al., 2009). Furthermore, DCN and ASPN 
compete for collagen binding during cartilage bio mineralisation (Kalamajski et al., 2009); 
therefore an upregulation of DCN within the cartilage at pre-weaning may prevent Asporin-
collagen interactions and inhibit subsequent endochondral ossification. This could be 
another mechanism that contributes to reduced mineralisation and growth of vertebrae in 
kyphosis.   
These findings therefore associates the family of SLRPs with the pathogenesis of kyphosis. 
Due to their roles in regulation of TGF- β activity, the differential expression of ASPN and 
DCN in bone and cartilage tissues suggests the TGF- β pathway has been affected in both 
tissues.  
3.5 Conclusions 
Upregulation of SLRPs in kyphotic cartilage, and overlap of the TGF-β pathway in kyphotic 
bone and cartilage tissues agrees with the original hypotheses. The study suggests the TGF- 
β pathway does not directly contribute to kyphosis, but differential regulation of ASPN and 
DCN in bone and cartilage tissues could indicate this pathway is rather being utilised in an 
attempt to repair kyphotic tissue. Due to its associations with cartilage deterioration and 
potential reduction of endochondral bone growth, the current study highlights a critical role 
for DCN in bone pathogenesis. DCN should be considered as a diagnostic marker for 
kyphosis in pigs.   
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Chapter 4: The effect of vitamin A supplementation on vitamin D status and 
differential gene expression in the trabecular bone of growing pigs 
4.1 Introduction  
Vitamin A and vitamin D are fat-soluble nutrients obtained from the diet (Harrison, 2005, 
Holick, 2005). These vitamins share an interaction, but the basis of this relationship is 
subject to debate. Early studies in rats and turkeys indicated vitamin A antagonises 
physiological effects brought about by vitamin D toxicity on bone tissue, and vice versa 
(Clark and Bassett, 1961, Metz et al., 1985). Furthermore, Aburto et al. (1998) observed high 
dietary vitamin A to increase requirements for 25(OH) D and 1,25(OH)2D to maximise bone 
ash %, and to reduce rickets severity respectively in broilers. In rats, vitamin D increases 
serum Ca and decreases serum P concentrations, however vitamin A reduces the ability of 
Vitamin D to maintain these concentrations in a dose-dependent manner (Rohde and 
DeLuca, 2005). Overall, the results of these studies suggest an antagonistic relationship 
between the two vitamins in regulation of skeletal physiology, yet the basis of this 
antagonism has not been fully elucidated.  
Studies in salmon have shown vitamin A decreases plasma 1,25(OH)2D after 5 days (Ornsrud 
et al., 2009), and exposure to vitamin A decreased serum 25(OH) D in rats in a time-
dependent manner (Frankel et al., 1986). These studies therefore suggest vitamin A 
antagonises serum 25(OH) D and thus lowers vitamin D availability to tissues. Vitamin A and 
vitamin D have been proposed to have their intestinal absorption regulated by cholesterol 
transporters (Harrison, 2005, Reboul, 2015), therefore excess vitamin A could potentially 
outcompete vitamin D for absorption. Vitamin D holds significant, commercial relevance to 
pigs due to its positive regulatory effects on skeletal health and growth (Holick, 2005, 
Witschi et al., 2011, Crenshaw et al., 2011). Therefore there is a requirement to further 
characterise the vitamin A-vitamin D relationship in pigs. While vitamin D has been 
demonstrated to antagonise liver RE storage dose-dependently in broilers (Aburto et al., 
1998), it is not known whether vitamin A will also affect serum 25(OH) D in a dose-
dependent manner.  
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Excessive vitamin A supplementation has been observed to induce narrowing and fragility of 
bones in pigs and rats (Pryor et al., 1969, Broulik et al., 2013, Kneissel et al., 2005), as well as 
disrupt endochondral bone growth in pigs (Anderson et al., 1966). Over-supplementation 
with vitamin A has also been suggested to contribute to lameness (van Riet et al., 2013) and 
the development of kyphosis in pigs (Belsue, 2010). There is a requirement to further 
characterise the mechanisms of excess vitamin A’s effects on skeletal development in pigs. 
Kneissel et al. (2005) observed excess vitamin A to induce thinning of the cortical 
compartment of long bones, yet trabecular BMC remained unchanged. However Lind et al. 
(2011) observed trabecular BMD to decrease in response to excessive vitamin A. This is 
further complicated by findings which also show feeding rats vitamin A over a period of up 
to 20 months did not induce changes in trabecular bone mass (Wray et al., 2011). Lind et al. 
(2012) demonstrated excess vitamin A upregulates expression of osteoblast-associated 
genes within the marrow compartments of long bones, but these changes do not persist in 
cortical bone. These findings demonstrate the compartment-specific effects of excess 
vitamin A supplementation on bone development, but it is not clear as to whether excess 
vitamin A will affect differential gene expression in trabecular bone similar to what was 
observed within endosteal and marrow compartments (Lind et al., 2011, Lind et al., 2012). 
The effect of vitamin A supplementation on trabecular bone development requires further 
investigation, if we are to understand the full scope of excess vitamin A’s effects on skeletal 
development.  
The present study set out to investigate how high doses of vitamin A supplementation will 
affect serum 25(OH) D and differential gene expression in the trabecular bone of growing 
pigs. The hypotheses for the study are as follows: 
 Based on Frankel et al. (1986) findings that suggest an antagonistic relationship 
between vitamin A and serum 25(OH) D, the hypotheses is that vitamin A will 
antagonise serum 25(OH) D in a dose-dependent manner, and this will likely relate 
to intestinal absorption.  
 Based on Lind et al. (2012) findings that excessive vitamin A induces expression of 
mineralisation genes in interior bone compartments, and that trabecular bone mass 
remains unchanged over time in response to vitamin A (Wray et al., 2011, Kneissel 
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et al., 2005), the hypotheses is that genes which regulate osteoblast differentiation 
will show upregulation in trabecular bone in response to excess vitamin A.  
4.2 Materials and Methods   
The trial was performed at Cockle Park farm, Newcastle University, and was approved by 
the Animal Welfare and Ethics review board at Newcastle University (PPL 70 8262).   
4.2.1 Pigs and Experimental Procedures  
The experimental setup of the trial, as well as laboratory procedures relating to RNA 
extraction, cDNA synthesis, Microarray analysis, Microarray Pathway Analysis, qPCR 
analysis, qPCR data analysis, HPLC, and ELISA are summarised in Chapter 2. Other methods 
specific to this experiment are indicated below.  
4.2.2 Feed Intake  
Individual feed intake was not monitored throughout the trial period, but it is estimated 
that a pig will consume approximately 4% of its BW per day. These data were then used to 
calculate the total average intake of vitamin A from diets, and dose, both in total µg over 
time and µg per kg of BW over time, for all pigs throughout the experimental period.  
4.2.3 Serum Biochemistry  
Serum Ca, P and ALKp were determined in control and treated pigs; samples were analysed 
at the Laboratory of Blood Sciences in the Royal Victoria Infirmary. ALKp is routinely 
measured in serum in order to indicate early pre-osteoblast differentiation, and thus act as 
a serum marker of bone formation activity (Skillington et al., 2002). The assays were 
performed on a Roche Cobas 8000 analytical line with kits for each assay, SOPs can be 
viewed in the appendix (B-D).    
4.2.4 Confocal Microscopy  
Samples from all 4 lobes of the liver were taken (roughly 0.1cm dimensions) and submerged 
in 1% glutaraldehyde solution before storage at 4°C. Confocal microscopy was performed on 
liver samples in order to allow for visualisation of the abundance and distribution of REs in 
response to vitamin A dose. Optimal focal plane within the tissue was determined through 
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excitation at 488nm and observing autofluorescence (emission between 495-
562nm).  Single plane confocal images were then acquired - using minimal noise reduction 
to avoid photobleaching - through excitation at 360nm (long pass) with emission between 
415-548nm (blue) followed by collection of autofluorescence through excitation at 488nm 
and emission between 495-562nm at the same plane.  All sections were scanned under 
identical conditions and any manipulation of images was applied to all equally. Image J 
software was used to visualise fluorescent changes in tissues.   
4.2.5 Statistical Analysis 
Before statistical analysis, data were tested for normal distribution using Shapiro-Wilk test 
and observing skewness and kurtosis (SPSS Software). Data were ln transformed to 
normalise the distribution for all data sets, however this was not possible to achieve normal 
distribution for all data. Therefore, the non-parametric Kruskal-Wallis test was used to 
determine the effects of vitamin A dose on dependent variables, and the Mann-Whitney 
test was used to determine significant differences between individual groups.  A p value 
<0.05 was considered statistically significant. 
4.3 Results  
In the 5250µg RP/kg BW group, 1 pig had to be sampled 2 weeks earlier due to signs of 
compromised welfare. In the 10000µg RP/kg BW group, 2 pigs had to be sampled 2 weeks 
earlier due to signs of compromised welfare. In both cases, the animals showed signs of 
severe tremors and difficulties with movement.  
4.3.1 Vitamin A consumption and Bodyweight  
The average vitamin A intake, in terms of total intake and intake in µg/kg of BW, was 
calculated for each treatment group based on diet and assigned RP dosage (Figure 4.1). The 
average BW was also measured for all pigs on a weekly basis (Figure 4.1). At the time of 
tissue sampling, the average total vitamin A consumed in µg per week ranged from 7849µg 
for controls, to 778310µg for pigs receiving 10000µg RP/kg BW.
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Figure 4.1: Bodyweight (BW) and estimated vitamin A intake from diet and dose per pig group (n=8 per group) calculated over the experimental period from 
4 weeks to 22 weeks of age. The assumptions of the calculations were that each pig will eat approximately 4% of its BW daily, and that pigs were fully 
supplemented with their assigned RP dosage.  A. The average BW of pigs per group B. The average total intake of vitamin A, in µg, over time per pig group. 
Y-axis is in a log10 scale to allow for presentation of data. C The average intake of vitamin A, in µg per kg of BW, per pig group. Y-axis is in a log2 scale to 
allow for presentation of data.  All data are presented as Mean ± SEM. 
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At the time of tissue sampling, the average vitamin A consumed in µg/kg BW ranged from 
85.8µg/kg BW for controls, to 10106µg/kg BW for pigs receiving 10000µg RP/kg BW. The 
data indicates that the assigned doses for the study were successful in mediating vitamin A 
accumulation according to dose group, taking into consideration the differences in time of 
which pigs were sampled. No significant differences in BW were observed between control 
pigs or treated pigs at any time points. At the time of sampling, average BWs for all pigs 
ranged from 91.48kg for controls, to 77.33kg for pigs receiving 10000µg RP/kg BW.  
4.3.2 Retinol and Retinyl Ester Concentrations in Liver 
Retinol and RE concentrations (µmol/g of liver) were calculated in the livers of control and 
treated pigs (Figure 4.2). From control to 3000µg RP/kg BW, there was a clear dose-
response relationship in the saturation of the liver with total REs, these concentrations 
increased from 0.43µmol/g of liver to 12.46µmol/g of liver (p<0.01). Between 3000µg RP/kg 
BW and 5250µg RP/kg BW, there was a tendency for total REs to drop from 12.46µmol/g of 
liver to 7.16µmol/g of liver (p=0.078), and no significant differences were observed between 
treatment groups between the 3000µg RP/kg BW and 10000µg RP/kg BW groups. The 
results indicate that the liver is saturated around the intake of 3000µg RP/kg BW, and that 
no further increase in liver RE concentrations can be achieved.  Confocal microscopy also 
showed that pigs receiving 3000µg RP/kg BW showed extreme saturation of REs in liver 
stellate cells in comparison to control pigs (Appendix A). This analysis offers a visual 
confirmation of RE storage in the livers of pigs receiving 3000µg RP/kg BW.
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Figure 4.2: The concentrations (µmol/g of liver) of total retinyl esters in the livers of pigs 
receiving different doses of Retinyl Propionate (RP) (n=8 per group) post-mortem. Data are 
presented in boxplots showing the median, 25th and 75th quartile ranges, and upper and 
lower limits.  
Mann-Whitney: 
*p<0.05 from all    
$ p<0.05 from all except 7500µg/kg and 10000µg/kg  
& p<0.05 from all except 7500µg/kg     
% P<0.05 from all except 3000µg/kg, 5250µg/kg and 10000µg/kg 
¢ p<0.05 from all except 3000µg/kg and 7500µg/kg  
4.3.3 25(OH) Vitamin D Serum Concentrations  
The average serum concentrations of 25(OH) D were calculated in control and treated pigs 
(Figure 4.3). Overall, there was an effect of supplemented vitamin A to affect 25(OH) D 
serum concentrations (p<0.05). Between controls and pigs receiving 500µg RP/kg BW, 
serum 25(OH) D decreased from 21.48ng/ml to 18.73ng/ml (p<0.05). Between controls and 
pigs receiving 1250µg RP/kg BW, serum 25(OH) D had a tendency to be reduced from  
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Figure 4.3: The concentrations of 25(OH) D (ng/ml) in the serum of pigs receiving different 
doses of RP treatment (n=8 per group) post-mortem. Data are presented in boxplots showing 
the median, 25th and 75th quartile ranges, and upper and lower limits. Mann-Whitney Test 
AB p<0.05, AC p=0.074, BD p=0.059, CD p<0.05  
 21.48ng/ml to 18.48ng/ml (p=0.074). From 1250µg RP/kg BW to 3000µg RP/kg BW, serum 
25(OH) D increased from 18.48ng/ml to 20.38ng/ml (p<0.05).      
4.3.4 Serum Biochemistry  
There were no effects of treatment observed on the serum concentrations of Ca or P in 
control or treated pigs during the experimental period. There were also no effects of 
treatment on serum ALKp during the experimental period (Table 4.1).  
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Treatment Groups (Retinyl 
Propionate - µg/Kg of BW daily) 
ALKp (U/L) (SEM) Ca 
(mmol/L) 
(SEM) 
PO4 
(mmol/L) 
(SEM) 
Control (n=8) 129.38(7.67) 2.60 (0.04) 2.82 (0.10) 
200µg/KG (n=8) 134.50 (12.74) 2.57 (0.03) 2.82 (0.03) 
500µg/kg (n=8) 137 (11.30) 2.65 (0.04) 2.79 (0.12) 
1250µg/KG (n=8) 125.38 (8.85) 2.59 (0.03) 2.82 (0.11) 
3000µg/KG (n=8) 112.25 (12.13) 2.60 (0.03) 2.71 (0.07) 
5250µg/KG (n=8) 104.00 (4.26) 2.64 (0.03) 2.62 (0.05) 
7500µg/KG (n=8) 116.86 (7.78) 2.63 (0.03) 2.57 (0.06) 
10000µg/KG (n=8) 121.14 (14.88) 2.60 (0.02) 2.63 (0.08) 
Table 4.1: The average serum concentrations of Alkaline Phosphatase (ALKp), a serum 
marker of bone formation, Calcium (Ca) and Phosphorus (P) in control and treated pigs (n=8 
per group) post-mortem are shown.  
4.3.5 Microarray Profiling of Duodenum of Vitamin A treated Pigs  
In the duodenum of pigs receiving 10000µg RP/kg BW, a total of 5953 transcripts were 
found to be differentially expressed > 2-fold. Of these transcripts, 4813 were found to be 
upregulated (80.85%) and 1140 were downregulated (19.25%) in comparison to control pigs 
receiving no vitamin A supplementation.  
Genes which hold roles in the apical and basolateral absorption of vitamin D were 
investigated in the data. From the list of differentially expressed genes, the results showed 
the genes Cluster Determinant-36 (CD36), Scavenger Receptor Class B member 1 (SR-BI) and 
ATP Binding Cassette Subfamily A member 1 (ABC1) are differentially expressed in response 
to 10000µg RP/kg BW (Table 4.2). These genes regulate intestinal absorption of vitamin D 
(Reboul, 2015, Harrison, 2005, Silva and Furlanetto, 2018). The gene Transient Receptor 
Potential Cation Channel Subfamily V Member 6 (TRPV6), which regulates Ca absorption, 
was also regulated in the intestines of pigs receiving 10000µg RP/kg BW (Table 4.2). 
Furthermore, Cytochrome p450, family 27, sub-unit B1, (CYP27B1), a gene which synthesises 
the active metabolite of vitamin D: 1,25 (OH)2 D (Holick, 2005), was upregulated in response 
to 10000µg RP/kg BW (Table 4.2). 
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Gene Name Regulated Process Fold-Change p-value 
Cluster Determinant 
36/ CD36 
Vitamin D absorption 
– Apical 
2.52↑ 0.02 
Scavenger Receptor 
Class B member 1 
/SR-B1 
Vitamin D absorption 
– Apical 
4.45↓ 0.0067 
ATP Binding Cassette 
Subfamily A member 1 
/ABC1 
Vitamin D absorption 
– Basolateral 
3.45↑ 0.01 
Cytochrome p450, 
family 27, sub-unit B1, 
/CYP27B1 
1,25(OH)2D synthesis 
from 25(OH)D 
3.32↑ 0.008 
Transient Receptor 
Potential Cation 
Channel Subfamily V 
Member 6/TRPV6 
Ca absorption – Apical 4.64↓ 0.0015 
Table 4.2: Differential expression of transporters related to vitamin D absorption in the small 
intestines of pigs receiving 10000µg RP/kg BW. The direction and fold-changes in gene 
expression in comparison to control pigs are shown, as well as the p-value calculated by 
moderated T-Test in Genespring.  
4.3.6 Microarray Profiling of Trabecular bone of Vitamin A-treated Pigs  
In the trabecular bone of pigs receiving 10000µg RP/kg BW, a total of 318 transcripts were 
found to be differentially expressed >2-fold. Of these transcripts, 199 were found to be 
upregulated (62.58%) and 119 were downregulated (37.42%) in comparison to control pigs 
receiving no vitamin A supplementation. The most affected genes, in regards to fold-
changes, are shown in Table 4.3. Cytoscape identified a total of 5 genes to be differentially 
expressed in the trabecular bone of pigs treated with 10000µg RP/kg BW. Various GO terms 
were associated with each gene, but no GO terms overlapped between any genes. 
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Gene Symbol Gene Title Molecular 
Function 
Fold-change p-value 
CLSTN1 
 
Calsyntenin-1 calcium ion 
binding 
18.68↑ 
 
0.0193 
 
MAP3K2 
 
mitogen-activated 
protein kinase 
kinase kinase 2 
MAPK 
signalling 
15.49↑ 
 
0.0140 
 
CDC5L 
 
cell division cycle 5-
like 
Cell Cycle 14.38↑ 0.0324 
 
PI4KB 
 
phosphatidylinositol 
4-kinase, catalytic, 
beta 
transferase 
activity 
13.47↑ 
 
0.0363 
 
ZFP36L1 
 
ZFP36 ring finger 
protein-like 1 
Adipocyte 
Differentiation 
12.49↑ 
 
0.0366 
 
NDUFS2 
 
NADH 
dehydrogenase 
(ubiquinone) Fe-S 
protein 2 
NADH 
dehydrogenase 
(ubiquinone) 
activity 
12.99↓ 0.0152 
 
ARHGAP31 
 
Rho GTPase 
Activating Protein 31 
GTPase 
activator 
activity 
6.07↓ 
 
0.0282 
 
KIFAP3 
 
kinesin-associated 
protein 3 
kinesin binding 4.36↓ 8.92E-04 
 
FAM175B 
 
family with 
sequence similarity 
175, member B 
deubiquitination 3.36↓ 2.50E-04 
 
CSN1S2 
 
alpha(s2)-casein transporter 
activity 
3.08↓ 
 
6.08E-04 
 
Table 4.3: The top 5 up and downregulated genes in the trabecular bone of pigs receiving 
10000µg RP/kg BW, as indicated by Genespring. The gene name, the process this gene 
regulates, fold-change and p-value are indicated. P-value was calculated by moderated T-
Test.   
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Biomarkers GO Terms 
MESP1*↓ Negative 
Regulation of 
Gastrulation 
endodermal 
cell fate 
specification 
negative 
regulation of 
mesodermal 
cell fate 
specification 
positive 
regulation of 
cell fate 
commitment 
mesodermal 
cell migration 
ARID4A*↓ Peptidyl-lysine 
trimethylation 
histone H3-K4 
trimethylation 
histone H3-K9 
trimethylation 
histone H4-
K20 
methylation 
histone H4-
K20 
trimethylation 
NR1H4*↓ negative 
regulation of 
bile acid 
biosynthetic 
process 
positive 
regulation of 
ammonia 
assimilation 
cycle 
positive 
regulation of 
cellular amino 
acid 
metabolic 
process 
regulation of 
glutamate 
metabolic 
process 
 
PRNP*↓ negative 
regulation of 
calcineurin-
NFAT 
signalling 
cascade 
negative 
regulation of 
calcium-
mediated 
signalling 
   
ZFP36L1*↑ proepicardium 
development 
septum 
transversum 
development 
   
Table 4.4: Gene ontology pathways affected by differential gene expression in the trabecular 
bone of pigs receiving 10000µg RP/kg BW, as indicated by Cytoscape. Term pvalue corrected 
with Benjamini-Hochberg *p<0.01 
The most relevant and significantly affected GO terms, ranked by Term P-value corrected 
with Benjamini-Hochberg, related to “negative regulation of gastrulation” , “positive 
regulation of cell fate commitment” , “histone h3-k4 trimethylation” and “regulation of 
gamma delta T cell activation” (Table 4.4). The genes AT-Rich Interacting Domain 4A 
(ARID4A), ZFP36 ring finger protein-like 1 (ZFP36L1), and Nuclear Receptor Subfamily 1 
Group H Member 4 (NR1H4) were found to share associations with osteoblast 
differentiation (Tseng et al., 2017, Monroe et al., 2010). IPA observed canonical pathways 
relating to “ILK signalling”, “Actin Nucleation by ARP-WASP Complex”, and “Actin 
Cytoskeletal signalling” to be significantly associated in the trabecular bone of pigs receiving 
10000µg RP/kg BW (Table 4.5). The genes that consisted most among these pathways were 
CDC42, followed by Filamin A (FLNA).  
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Table 4.5: Canonical pathways affected in the trabecular bone of pigs receiving 10000µg 
RP/kg BW, as indicated by IPA. The p-value, as determined by Fishers-Exact test in IPA, and 
genes belonging to each pathway are also shown. 
Both of these genes relate to actin cytoskeletal dynamics and integrin related signalling. A 
gene network representing some of the relationships between identified genes and vitamin 
A is presented in Figure 4.4. 
4.3.7 Candidate Gene Expression Verification  
No genes were observed to overlap between IPA and Cytoscape in the current study. 
Cytoscape indicated ZFP36L1 to be differentially expressed (Table 4.4), and the microarray 
indicated ZFP36L1 to be in the top 5 differentially expressed genes in regards to fold-change 
(Table 4.3). ZFP36L1 has also been demonstrated to influence osteoblast differentiation 
(Tseng et al., 2017), and was thus selected for qPCR analysis. CDC42 and FLNA consisted 
among canonical pathways in IPA (Table 4.5), and both of these genes interact with one 
another to regulate cytoskeletal dynamics (Hu et al., 2017). Cytoskeletal dynamics have 
been illustrated to influence osteoblast differentiation and osteoclast activity (Lomri and 
Marie, 1996). Therefore, CDC42 and FLNA were also selected for qPCR verification. Primer 
sequences for all genes of interest analysed in the current study can be seen in Table 4.6.  
Vitamin A supplementation – Bone 
Pathway p-value Genes 
ILK signalling 
 
0.00630957 
 
CDC42↑, FLNA↓, MYH4↑, RHOF↓ 
Caveolar-mediated 
Endocytosis signalling 
 
0.00851138 
 
MAP3K2↑, FLNA↓ 
Actin Nucleation by ARP-
WASP Complex 
 
0.04365158 
 
CDC42↑,RHOF↓ 
 
Actin Cytoskeleton 
signalling 
 
0.04570882 
 
CDC42↑,MYH4↑,FLNA↓,TMSB10/TMSB4X↓ 
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Figure 4.4: Graphic representation of differential gene expression in the trabecular bone of 
pigs receiving 10000µg RP/kg BW, synthesised in IPA. Genes are represented by nodes, and 
relationships by edges.   
 
Table 4.6: List of primer sequences for genes of interest for quantification of gene expression 
by real-time quantitative polymerase chain-reaction (q.PCR) 
PRIMER ID SEQUENCE 5’-3’ 
RPL37 (HK) F: GCCTACCATCTCCAGAAGTC 
R: CTTCACGGAATCCATGCCTG 
CDC42 F: AGAAAAGTGGGTGCCTGAGA 
R: ACTCCACATACTTGACAGCCT 
FLNA  F: GTCTTCAGGAGTCAGGGCTAA 
R: TCAATCAGGTAGACGCCGTT 
ZFP36L1 F: GCGAAGTTTTATGCAAGGGTAAC 
R: CTGAGGAGCTGGTTCTGGTG 
RPL37, Ribosomal protein sub-unit L37, CDC42, cell division cycle 42, FLNA, Filamin A, 
ZFP36L1, Zinc-finger protein C3H Type-Like 1 
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The following groups were selected for qPCR analysis in the current study: Controls, 200µg 
RP/kg BW, 1250µg RP/kg BW, 3000µg RP/kg BW, 5250µg RP/kg BW, and 10000µg RP/kg 
BW. This was due to these particular groups showing the most notable changes in RE liver 
storage when livers were analysed for REs post-mortem (Figure 4.2).  
4.3.7.1 Expression of ZFP36L1 in Trabecular Bone 
There was a tendency for treatment (p=0.085) to have an effect on ZFP36L1 expression in 
trabecular bone. Between controls pigs and pigs receiving 3000µg RP/kg BW, gene 
expression increased (Fold Change (FC) +1.47, p=0.037) (Figure 4.5). No significant 
differences were observed between controls or other treated groups.  
4.3.7.2 Expression of CDC42 in Trabecular Bone 
There was not an effect of treatment (p=0.147) observed on CDC42 expression in trabecular 
bone (Figure 4.6). This suggests no dose-response relationship exists between CDC42 
expression in trabecular bone and with vitamin A. Between control pigs and pigs receiving 
3000µg RP/kg BW as well as 10000µg RP/kg BW, differences were observed (FC +1.32, 
p=0.036; FC + 1.70 fold, p=0.032, respectively), however these were not significant to the 
extent to conclude an overall effect of treatment.  
4.3.7.3 Expression of FLNA in Trabecular Bone 
There was a clear effect of treatment (p<0.01) on FLNA expression in trabecular bone 
(Figure 4.7), which verifies a relationship between FLNA expression in trabecular bone and 
vitamin A dose. Between control pigs and pigs receiving 3000µg RP/kg BW, FLNA expression 
increased (FC +8.17-fold, p<0.01), but no significant differences were observed in the earlier 
treatment groups in comparison to control pigs. Between pigs receiving 3000µg RP/kg BW 
and 5250µg RP/kg BW, FLNA expression decreased such that gene expression was increased 
3.16-fold relative to control pigs (p=0.024). Pigs receiving 10000µg RP/kg BW showed an 
increase in FLNA expression relative to control pigs, but this was not observed to be 
significant (FC +1.30-fold, p=0.269). The results indicate that FLNA expression in trabecular 
bone is most significantly upregulated in response to 3000µg RP/kg BW, but is not as 
significantly upregulated in expression in response to higher doses of RP.  
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Figure 4.5: Relative real-time PCR expression of Zinc-finger protein C3H Type-Like 1 
(ZFP36L1) in the trabecular bone of pigs receiving different doses of RP treatment (n=8 per 
group) post-mortem. Data are presented in boxplots showing the median, 25th and 75th 
quartile ranges, and upper and lower limits. Mann-Whitney Test AB p=0.021    
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Figure 4.6: Relative real-time PCR expression of Cell Division Cycle 42 (CDC42) in the 
trabecular bone of pigs receiving different doses of RP treatment (n=8 per group) post-
mortem. Data are presented in boxplots showing the median, 25th and 75th quartile ranges, 
and upper and lower limits. Mann-Whitney Test AB p=0.036 AC p=0.032 
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Figure 4.7: Relative real-time PCR expression of Filamin A (FLNA) in the trabecular bone of 
pigs receiving different doses of RP treatment (n=8 per group). Data are presented in 
boxplots showing the median, 25th and 75th quartile ranges, and upper and lower limits. 
Mann-Whitney Test AB p<0.01 AC p=0.024 
 4.4 Discussion  
The objectives of this study were to characterise how doses of Vitamin A supplementation 
affect serum 25(OH) D, and to identify genes and gene pathways affected by vitamin A 
supplementation in trabecular bone tissue. Based on previous results showcasing chronic 
treatment of Vitamin A to antagonise serum 25(OH) D in rats (Frankel et al., 1986), the 
hypotheses was that vitamin A dosing would reduce serum 25(OH) D. Between control pigs 
and pigs receiving 500µg RP/kg BW, serum 25(OH) D was reduced by 2.75ng/ml. Serum 
25(OH) D was then restored to concentrations similar to controls at 3000µg RP/kg BW. The 
results agree with the hypotheses in that vitamin A will antagonise serum 25(OH) D, but the 
data also suggests that this is not done in a consistent dose-dependent manner. 
Transporters related to vitamin D and Ca intestinal absorption were differentially regulated 
in response to 10000µg RP/kg BW, and this could imply that vitamin A is affecting 
absorption of these minerals. No differences in serum ALKp or Ca or P were observed in 
response to treatment. The hypotheses also stated that genes related to osteoblast 
mineralisation will be upregulated in trabecular bone in response to excess vitamin A doses. 
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This was due to Lind et al. (2012) identifying upregulation of mineralisation genes in interior 
bone compartments in response to excessive vitamin A, and due to findings that trabecular 
bone mass remains unchanged over a period of exposure to vitamin A supplementation 
(Wray et al., 2011, Kneissel et al., 2005). Microarray and qPCR analysis indicated the Rho-
GTPase associated gene FLNA to be most significantly affected in trabecular bone in 
response to 3000µg RP/kg BW. FLNA has been indicated to regulate bone formation in vitro 
and in vivo (Lian et al., 2017, Hong et al., 2010). Evidence also shows FLNA can regulate 
osteoclast activity (Goldberg et al., 2015, Leung et al., 2010). The original hypotheses 
predicted vitamin A supplementation will favour bone formation processes in trabecular 
bone. An upregulation of FLNA now suggests bone resorption has also been upregulated in 
trabecular bone as a result of vitamin A. This now suggests vitamin A supplementation 
promotes overall bone metabolism in trabecular bone.     
4.4.1 Vitamin A and Vitamin D Relationship    
Serum 25(OH) D was reduced in pigs receiving 500µg RP/kg BW in comparison to controls, 
however serum 25(OH) D was restored to the same levels as controls at 3000µg RP/kg BW 
(Figure 4.3). The results in the current study suggest that prolonged exposure to excess 
vitamin A will initially antagonise serum 25(OH) D dose-dependently, but not at doses above 
500µg RP/kg BW. Serum 25(OH) D has been observed to be decreased in rats in response to 
chronic Vitamin A treatment over 9 weeks, and 1,25(OH)2D has been observed to be 
decreased in plasma in response to 100µg/g of BW of Vitamin A treatment after 5 days 
(Frankel et al., 1986, Ornsrud et al., 2009). Aburto et al. (1998) observed increasing dietary 
concentrations of 1, 25(OH)2 D reduced RE concentrations in the liver in a dose-dependent 
manner over a period of 16 days. Rohde and DeLuca (2005) reported, over a period of 33 
days, feeding rats 400µg of RA and 5ng of Vitamin D inhibited Vitamin D-mediated effects 
on Ca and P, but rats fed 10ng of Vitamin D maintained serum Ca and P despite being fed 
400µg of Vitamin A. The finding that 500µg RP/kg BW reduced serum 25(OH) D is in 
agreement with these studies in that vitamin A antagonises vitamin D. It is possible this is 
due to increased competition between vitamin A and vitamin D for transporter binding in 
the small intestines. However, the lack of a consistent dose-response decrease indicates a 
more complex relationship than previously thought between serum 25(OH) D and excess 
vitamin A. A critical difference between other experiments investigating the vitamin A-
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vitamin D relationship and the current study is that the current experiment was performed 
over a much longer period (at least 15 weeks of dosing). It is possible in response to doses 
above 3000µg RP/kg BW over a prolonged period of time, compensatory mechanisms have 
been induced in an attempt to restore serum 25(OH) D.  
Systematic studies have determined that Vitamin D potentially competes with free fatty 
acids for intestinal absorption, particularly for the transporters CD36 and SR-BI (Silva and 
Furlanetto, 2018, Harrison, 2005).  CD36 and SR-BI have been identified in other reviews as 
regulators of vitamin D intestinal absorption, particularly absorption through the apical 
membrane (Reboul, 2015, Borel et al., 2015). This therefore raises the question of whether 
vitamin A could affect the expression of transporters that could control vitamin D 
absorption through the basolateral membrane. Vitamin D, in association with chylomicrons, 
is secreted into the lymph from the basolateral membrane, yet evidence suggests it may 
also be secreted into lymph via the transporter ABCA1 (Reboul, 2015). In line with all of 
these findings, microarray analysis of intestinal samples from pigs receiving 10000µg RP/kg 
BW indicated CD36 and ABCA1 to be upregulated, and SR-BI to be downregulated (Table 
4.2). These biomarkers should be assessed by qPCR in future studies, and ascertain how 
intestinal absorption of vitamin D has been influenced according to vitamin A dose. One 
hypotheses could be that these transporters become differentially upregulated at doses 
3000µg RP/kg BW and above. This is based on evidence in the current study which shows 
vitamin A doses above 3000µg RP/kg BW do not affect serum 25(OH) D in comparison to 
controls, and that serum 25(OH) D increases between 1250µg RP/kg BW and 3000µg RP/kg 
BW. It is possible the restoration in serum 25(OH) D between these groups could be due to 
the expression of identified transporters in small intestine.   
There were no differences observed in serum Ca in the groups in which serum 25(OH) D 
showed differences (Table 4.1). Rohde and DeLuca (2005) observed Vitamin A to antagonise 
the intake of Ca into serum in response to Vitamin D, and Johansson and Melhus (2001) 
observed vitamin A to abolish absorption of Ca in response to vitamin D after 8 hours. These 
studies suggest vitamin A antagonises the absorption of Ca alongside vitamin D. However, 
other studies show treatment with vitamin A antagonises plasma 1, 25 (OH)2 D, but not 
serum Ca, over a period of 7 days (Ornsrud et al., 2009). The current study was performed 
over a longer time period than these previous studies, and this raised the question as to 
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whether, similar to serum 25(OH) D, prolonged exposure to excess vitamin A has also 
maintained serum Ca. Microarray analysis of intestinal tissue samples revealed the genes 
CYP27B1, which synthesises 1,25 (OH)2D from 25(OH) D was upregulated in pigs receiving 
10000µg RP/kg BW (Table 4.2). Yet TRPV6, a Ca transporter, was observed to be 
downregulated in the intestines of pigs receiving 10000µg RP/kg BW (Table 4.2). 1,25(OH)2D 
is the hormonally active metabolite of vitamin D which directly regulates TRPV6 expression 
to absorb Ca in the intestines (Jurutka et al., 2007); its differential expression in small 
intestines could be an attempt to re-upregulate TRPV6.  A downregulation of TRPV6 could 
suggest, in response to excess vitamin A, Ca absorption is compromised, which would agree 
with previous studies that vitamin A antagonises Ca (Rohde and DeLuca, 2005, Johansson 
and Melhus, 2001). However, it is also known from previous studies that excess vitamin A 
induces bone resorption in the cortical compartment of bone, which would release 
dissolved Ca into circulation (Lind et al., 2011, Lind et al., 2012). Cortical bone was not 
sampled for gene expression in the current study to confirm if there is an upregulation of 
osteoclast activity. Yet elevated Ca deposition into serum as a result of bone resorption 
could likely contribute to downregulation of TRPV6 to prevent hypercalcemia. TPRV6 should 
be verified in future qPCR experiments in order to confirm how different vitamin A doses 
affect genes that govern Ca absorption. Overall, the data obtained for vitamin D and Ca 
suggest that excess vitamin A, over a period of time, induces differential gene expression in 
the small intestines, and these could be responsible for maintaining serum concentrations 
of these nutrients.   
In addition, serum P was not affected by vitamin A dose (Table 4.1). This is consistent with 
other studies (Ornsrud et al., 2009, Broulik et al., 2013), apart from findings reported by 
Rohde and DeLuca (2005) who observed vitamin A to increase serum P, however no 
potential mechanism was explained or provided.   Furthermore, microarray analysis 
observed no transporters of P to be differentially regulated in small intestine or kidney 
tissues. The study, therefore, suggests there is no effect on P homeostasis.  
Overall, these results and findings suggest that vitamin A has the potential to antagonise 
vitamin D absorption, but compensatory effects in the small intestine likely maintain vitamin 
D, and Ca, in response to very high doses of vitamin A. These identified biomarkers should 
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be assessed in future qPCR studies in order to illustrate the molecular mechanisms by which 
excess vitamin A affects vitamin D and Ca intestinal absorption.     
4.4.2 Excess Vitamin A and Differential Gene Expression in Trabecular Bone 
IPA and Cytoscape identified different sets of genes to be affected in the trabecular bone of 
pigs receiving 10000µg RP/kg BW. Cytoscape identified genes such as ZFP36L1 and ARID4A 
to be differentially regulated in response to vitamin A: both of these genes have been 
demonstrated to control osteoblast differentiation (Tseng et al., 2017, Monroe et al., 2010). 
ZFP36L1 was selected for qPCR verification, however qPCR analysis did not determine there 
was a significant effect of treatment on gene expression (Figure 4.5).   
IPA observed the differential regulation of genes such as CDC42 and FLNA to be associated 
with vitamin A supplementation, both of these genes are associated with the Rho-GTPase 
family of signalling molecules (Nobes and Hall, 1995, Hu et al., 2017). But upon qPCR 
analysis, there was no clear overall effect of vitamin A dose on CDC42 differential expression 
(Figure 4.6). Yet there was a more clear effect of vitamin A dose to affect FLNA: FLNA was 
observed to be upregulated 8.17-fold in response to 3000µg RP/kg BW, and then decreased 
in expression in later treatment groups (Figure 4.7). Interestingly, 3000µg RP/kg BW also 
induced the first significant fold-change in expression of CDC42 (FC, +1.32). As FLNA 
expression decreased in groups beyond 3000µg RP/kg BW, CDC42 expression increased at 
10000µg RP/kg BW. FLNA binds CDC42 and directs actin stress fibre formation (Hu et al., 
2017). Through upregulating FLNA, vitamin A could be indirectly influencing CDC42 activity.  
This could also explain as to why no clear responses to vitamin A dose were observed with 
CDC42. 
The family of Rho-GTPases control cytoskeletal reorganisation, and regulate the formation 
of lamellipodia, fillopodia, through activation of p-21 activated kinase (PAK), and assembly 
of actin stress fibres (Nobes and Hall, 1995, Rane and Minden, 2014, Hoefen and Berk, 
2006). CDC42, which codes for cell division cycle 2, is one of the three Rho-GTPases that 
directly control PAK phosphorylation and subsequent cytoskeletal dynamics (Hoefen and 
Berk, 2006, Nobes and Hall, 1995). FLNA codes for Filamin A, which is an actin-binding 
protein which has been demonstrated to bind and stabilise Rho-GTPases, including CDC42 
(Hu et al., 2017). Furthermore, FLNA contributes to the stabilisation of the actin 
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cytoskeleton, as well as inducing F-actin stress fibre formation and cell spreading (Hu et al., 
2017).  
Given the role of the cytoskeleton in mediating osteoblast differentiation through integrin-
mediated adhesion to the ECM (Lomri and Marie, 1996, Hendesi et al., 2015) and Rho-
GTPases in controlling cytoskeletal dynamics, it could be hypothesised that silencing of FLNA 
expression or activation would result in decreased bone formation. Indeed, FLNA-null mice 
show indications of reduced bone formation, evidenced by underdeveloped vertebrae (Lian 
et al., 2017). In addition, FLNA has been observed to be upregulated in differentiating 
osteoblasts in vitro (Hong et al., 2010). FLNA’s combined actions on stress fibre formation, 
which are required to maintain focal adhesions (Rane and Minden, 2014), and actin 
polymerisation (Hu et al., 2017) could be responsible for these effects on bone formation. 
However, the cytoskeleton also holds a role in mediating osteoclastic cell function, as well as 
mediating osteoblast differentiation. In osteoclasts, reorganisation of the actin cytoskeleton 
plays a role in cell migration, adhesion to bone surfaces, and vesicle trafficking of proteolytic 
enzymes which dissolve bone matrix (Lomri and Marie, 1996, Teitelbaum, 2011). Leung et 
al. (2010) observed FLNA to control monocyte migration prior to osteoclast differentiation, 
and that this was accomplished in association with CDC42. Surprisingly, the authors also 
noted knock out of FLNA induced bone mineralisation losses reminiscent of osteoporosis, 
and credited the changes to low turnover osteoporosis of which is characterised by reduced 
BMD, osteoblast and osteoclast cell numbers (Leung et al., 2010). Additionally, knock-out of 
FLNA in ovariectomized mice do not show changes in trabecular bone mechanical properties 
in comparison to control mice, despite estrogen deficiency promoting bone resorption  
(Goldberg et al., 2015). This result therefore suggests that FLNA regulates osteoclast 
resorption of bone matrix. Due to an upregulation of FLNA in trabecular bone at 3000µg 
RP/kg BW, the results therefore indicate that both bone formation and resorption processes 
have been upregulated. FLNA upregulation in trabecular bone in response to 3000µg RP/kg 
BW also provides evidence that the physiological changes occurring in the tissue occur as a 
result of actin cytoskeletal dynamics.    
FLNA is a critical regulator of both osteoblasts and osteoclasts. The results obtained in the 
current study suggest, at the molecular level, excess vitamin A favours bone formation and 
resorption, which is not observed in either cortical or marrow compartments in response to 
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excess vitamin A (Lind et al., 2012). This finding suggests overall bone metabolism is 
promoted in the trabecular bone of pigs receiving vitamin A supplementation.  
4.5 Conclusions 
This study has shown that prolonged exposure to vitamin A can antagonise serum 25(OH) D, 
but very high doses of vitamin A, above 3000µg RP/kg BW, maintain serum 25(OH) D 
through, as of yet, unverified mechanisms. However, the study has identified potential 
biomarkers in small intestines which could regulate vitamin D absorption in response to 
excess vitamin A intake, and these should be investigated in future work. The study has also 
demonstrated excess vitamin A intake upregulates FLNA in trabecular bone, which possibly 
leads to increased bone metabolism in trabecular bone. The study has further highlighted 
the compartment-specific roles excess vitamin A has on overall bone development, and has 
also elaborated on vitamin A’s association with Rho-GTPases.   
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Chapter 5: The associations of vitamin A and vitamin D with kyphosis in 
growing pigs 
5.1 Introduction  
In recent years, nutrition has been identified as a potential driver in the development of 
kyphosis in growing pigs. Reducing the concentrations of Vitamin A in sow diets, from 
15,000mg/kg of diet to 8,500mg/kg of diet, has been observed to remove the prevalence of 
kyphosis from the herd, which suggests excessive vitamin A may be involved in the 
syndrome (Belsue, 2010). Yet, Belsue (2010) did not verify individual vitamin A 
concentrations in the livers of kyphotic and healthy pigs so as to assess vitamin A status. An 
association between kyphosis and vitamin A is possible as vitamin A has a clear influence on 
the expression of genes which regulate bone growth and mineralisation (Lind et al., 2011, 
Lind et al., 2012). Furthermore, vitamin D deficiency has been demonstrated to be a factor 
that drives kyphosis (Halanski et al., 2018, Amundson et al., 2016, Rortvedt and Crenshaw, 
2012). Frankel et al. (1986) showed that exposure to vitamin A supplementation over a 
period of 9 weeks reduces serum 25(OH) D, thus demonstrating vitamin A has the potential 
to antagonise serum vitamin D availability. Thus, the association between kyphosis and 
vitamin A warrants further investigation.  
Reduction of vitamin D in sow diets resulted in 30% of pigs within a litter showing symptoms 
by 13 weeks of age (Rortvedt and Crenshaw, 2012, Amundson et al., 2016). Indeed, some 
kyphotic cases, in outdoor farms, have been reported to occur in the winter periods (Done 
et al., 1999). During these periods, there is less available sunlight and therefore less natural 
vitamin D synthesis. This body of evidence supports the hypothesis in that vitamin D 
deficiency drives kyphosis, but there remains a need to confirm if pigs on units which suffer 
from spontaneous outbreaks show reduced vitamin D status. The question of how kyphotic 
pigs become potentially vitamin D-deficient requires investigation. It could be argued that 
vitamin A-associated antagonism of vitamin D (Frankel et al., 1986) occurs in kyphotic pigs, 
but there is no evidence that suggests this particular interaction is occurring in kyphotic 
pigs. This is a question that requires answering if the scope of vitamin A’s effects during 
kyphosis are to be clarified.  
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Vitamin A deficiency has been observed to drive scoliosis, which bears significant 
resemblance to kyphosis in that the spine suffers from curvature (Li et al., 2012). Skeletal 
growth and development is controlled by the processes of endochondral bone growth and 
remodelling (Karsenty et al., 2009, Kronenberg, 2003). The end-result of various signalling 
pathways that control endochondral bone growth is to regulate genes, which allow for 
osteoblast differentiation and the production of non-collagenous proteins to regulate bone 
metabolism (Kronenberg, 2003, Al-Qtaitat and Aldalaen, 2014). The loss of a POC in the 
vertebral trabecular bone of kyphotic pigs (Nielsen et al., 2005, Done et al., 1999) could 
suggest that either pathways which regulate osteoblast differentiation, or expression of 
non-collagenous proteins which regulate bone metabolism, are downregulated in kyphotic 
trabecular bone. There is currently no published data which indicates how vitamin A 
regulates gene expression within vertebral trabecular bone, but studies have demonstrated 
that excess vitamin A can induce the expression of genes, such as BMPs or Wnt genes, 
which stimulate osteoblast differentiation within the marrow compartments of long bones 
(Lind et al., 2012). Various in vitro experiments also show vitamin A contributes to 
regulation of non-collagenous proteins that control mineralisation, such as Osteonectin 
(SPARC) (Ng et al., 1989). Given that vitamin A deficiency can drive skeletal diseases 
characterised by spine curvature (Li et al., 2012) and that vitamin A supplementation can 
drive the expression of mineralisation genes (Lind et al., 2012, Ng et al., 1989), it could be 
hypothesised that a reduced vitamin A status will associate with kyphosis. A reduction in 
vitamin A could also contribute to the downregulation of mineralisation genes in vertebral 
trabecular bone preceding the characteristic POC formation in kyphosis, but it is not known 
how, or if, vitamin A-regulated biomarkers that control bone formation are affected in 
kyphosis.  
The objectives of this study were to investigate overlap of differential gene expression in 
trabecular bone between the kyphosis and vitamin A trials in order to identify vitamin A-
regulated biomarkers in kyphosis. Additionally, the study aimed to verify the associations of 
vitamin A and vitamin D with kyphosis. The hypotheses are as follows:  
 Kyphotic pigs will show reduced vitamin D status due to the diseases prevalence in 
winter months, and due to previous trials showing that vitamin D deficiency drives 
kyphosis. 
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 Kyphotic pigs will show reduced concentrations of liver REs, and therefore reduced 
vitamin A status.   
 Vitamin A-regulated genes representing bone mineralisation will be downregulated 
within kyphotic trabecular bone, but will be upregulated in response to vitamin A 
supplementation for the vitamin A trial. 
5.2 Materials and Methods  
5.2.1 Kyphosis Trial   
Details of the experimental design for the kyphosis trial can be viewed in Chapter 2.  
5.2.2 Vitamin A Trial  
Details of the experimental design for the vitamin A trial can be viewed in Chapter 2.  
5.2.3 General Methods  
All methods relating to this chapter can be seen in Chapter 2. This includes: Tissue 
Extraction, RNA extraction, cDNA synthesis, Microarray Analysis, Microarray Data and 
Pathway Analysis, qPCR analysis, and qPCR data analysis and presentation, HPLC and ELISA. 
5.2.4 Statistical Analysis  
Before statistical analysis, data were tested for normal distribution using Shapiro-Wilk test 
and observing skewness and kurtosis (SPSS Software). Data were ln transformed to 
normalise data distribution, however it was not possible to achieve normal distribution for 
all data sets. Therefore, the non-parametric Kruskal-Wallis test was used to determine the 
effects of treatments (vitamin A dose or phenotype in kyphosis trial) on dependent 
variables, and the Mann-Whitney test was used to determine significant differences 
between individual groups. A p value <0.05 was considered statistically significant. 
In addition, Spearman’s test was used to determine correlations between serum 25(OH) D 
and liver REs in kyphotic pigs.  
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5.3 Results   
5.3.1 Vitamin A and Vitamin D in Kyphotic Pigs   
5.3.1.1 Serum 25(OH) D  
There was a significant effect of phenotype on 25(OH) D concentrations (p=0.012), but not 
age (p=0.783) (Figure 5.1). 25(OH) D serum concentrations were decreased in kyphotic pre-
weaners and their littermates in comparison to non-related controls (Kyphosis: -5.42ng/ml, 
p=0.028; Littermates: -5.17ng/ml, p=0.011). There were no significant differences observed 
between pre-weaning kyphotic and littermate piglets (-0.25ng/ml, p= 0.763). There were no 
significant differences observed in kyphotic weaners (-2.74ng/ml, p=0.190) or kyphotic post 
weaners (-1.11ng/ml, p=0.475) in comparison to age-matched controls. Serum Ca and P was 
also measured in the serum of pre-weaning kyphotic and non-related controls, but no 
differences were observed (Appendix A).  
5.3.1.2 Liver Retinol and Retinyl Esters  
Individual and total retinol ester concentrations, µmol per g of liver, were determined in the 
livers of kyphotic and control pigs (Figure 5.2). There was an effect of age (p<0.01) and 
phenotype (p=0.012) on µmol/g of total REs, with an average decrease of 0.033µmol/G in 
kyphotic pigs when compared to control pigs. There was a tendency for REs to be decreased 
in kyphotic pre-weaners in comparison to non-related control pre-weaners (-0.0173µmol/G, 
p=0.09), but there were no significant differences observed between pre-weaning kyphotic 
and littermate piglets (-0.0035µmol/G, p=0.474), or between littermates and non-related 
controls (-0.0137µmol/G, p=0.296). There were no significant differences observed in 
kyphotic weaners (-0.0176µmol/G, p=0.664), however kyphotic post-weaners showed a 
significant reduction of REs (-0.07µmol/G, p<0.01). The results indicate that overall REs 
stored in liver (µmol/G of liver) are decreased within kyphotic as opposed to control pigs, 
particularly at the post-weaning stage.     
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Figure 5.1:  25(OH) D concentrations (ng/ml) in the serum of Pre-weaning (PreW) (n=17 per 
group), Weaning (n=16 per group), and Post-weaning (PostW) (n=7 per group) kyphotic and 
control pigs post-mortem. Data are presented as boxplots showing the median, 25th and 75th 
quartile ranges, and upper and lower limits. Mann-Whitney AB p<0.05  
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Figure 5.2: Total retinol and retinyl esters (µmol/g of liver) stored in the livers of Pre-
weaning (PreW) (n=17 per group), Weaning (n=16 per group), and Post-weaning (PostW) 
(n=7 per group) kyphotic and control pigs post-mortem. Data are presented as boxplots 
showing the median, 25th and 75th quartile ranges, and upper and lower limits. Kruskal-
Wallis Age p<0.01 Phenotype p=0.021, Mann-Whitney AB p=0.09 CD p<0.01  
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5.3.1.3 Vitamin A and Vitamin D Interaction  
The data obtained for vitamin A and vitamin D indicates both of these vitamins are reduced 
in kyphotic pigs. In order to investigate this further, REs in liver and serum 25(OH) D were 
analysed to indicate if a correlation exists between these data. The results indicate that 
there is no antagonistic relationship between vitamin A and vitamin D during kyphosis 
(r=0.089, p=0.590).   
5.3.2 Overlap of Differential Gene Expression between Kyphotic and Vitamin A-Pigs  
A total of 11 genes were found to share overlap in the trabecular bone of pre-weaning 
kyphotic pigs and pigs receiving 10000µg RP/kg BW. Of these genes, 45% were shown to be 
regulated in opposite directions by kyphotic pre-weaners and pigs receiving 10000µg RP/kg 
BW, whereas 55% of genes were regulated in the same direction in both pig groups. Genes 
regulated by kyphotic pre-weaners and pigs receiving 10000µg RP/kg BW can be viewed in 
Table 5.1.  
Two genes were observed from this list that have direct influence on bone metabolism: 
SPARC and G Protein-Coupled Receptor Kinase Interacting ArfGAP 2 (GIT2). SPARC codes for 
osteonectin, which is secreted by osteoblasts and regulates both osteoblast and osteoclast 
activity, thus identifying this gene as a critical regulator of bone remodelling (Rosset and 
Bradshaw, 2016). GIT2 codes for G Protein-Coupled Receptor Kinase Interacting ArfGAP 2. 
GIT proteins act as scaffolding molecules for: Rho-GTPases, kinases such as MEK1 and PAK, 
and also regulate G-protein coupled receptor internalisation and sequestration through 
their ARF-GAP domains (Hoefen and Berk, 2006). This gene holds relevance to bone 
metabolism, due to a knock-out of this gene resulting in reduced bone mineralisation in rats 
(Wang et al., 2012).  
In addition, retinoic acid receptor gamma (RARG) was observed to share overlap between 
the two trials. RARG is one of 3 retinoic acid receptor isoforms; evidence demonstrates it 
has a role in inhibiting gene expression of osteoblast-mineralisation genes in vitro (Green et 
al., 2017), while knockout of RARG in a mouse results in increased bone resorption activity 
(Green et al., 2015). Due to its roles in modulating retinoic acid signalling and in bone 
metabolism, this gene holds significant relevance to the study.   
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Gene 
Symbol  
Gene Name Kyphosis Vitamin A 
Fold-
change  
p-value Fold-
change  
p-value 
CLSTN1 Calsyntenin 1 2.93↓ 
 
0.0393 
 
18.68↑ 0.0193 
 
FHL3 Four And A Half LIM 
Domains 3 
4.05↓ 0.0114 
 
2.45↓ 0.0453 
 
MICAL3 Microtubule 
Associated 
Monooxygenase 
3.29↓ 
 
0.0223 
 
2.06↑ 0.0255 
 
CHCHD10 Coiled-Coil-Helix-
Coiled-Coil-Helix 
Domain Containing 
10 
3.23↓ 
 
0.0175 
 
2.28↓ 0.019 
 
MESP1 Mesoderm Posterior 
BHLH Transcription 
Factor 1 
3.33↓ 0.0255 
 
2.91↓ 0.0376 
RARG Retinoic Acid 
Receptor Gamma 
6.23↓ 0.00364 2.63↑ 7.88E-04 
MYH4 Myosin Heavy Chain 
4 
2.90↑ 0.0449 
 
2.21↑ 0.0129 
 
SPARC Osteonectin 3.87↓ 0.0212 
 
2.06↓ 0.0255 
 
GIT2  
GIT ArfGAP 2 
 
3.11↓ 0.0395 
 
13.08↑ 0.0377 
 
PRNP  
Prion Protein 
 
3.59↓ 
 
0.0254 
 
2.06↓ 0.0255 
 
BIN1 Bridging Integrator 1 4.39↓ 
 
0.0112 
 
2.21↑ 
 
0.0314 
 
 Table 5.1: Classification of genes that were differentially expressed in the trabecular bone of 
pre-weaning kyphotic pigs, and pigs receiving 10000µg RP/kg BW of vitamin A 
supplementation. The results were generated from Genespring. The fold change and p-value, 
calculated by moderated T-Test, are shown.  
102 
 
 
5.3.3 Candidate Gene Expression Verification using qPCR   
Due to their associations with bone metabolism and retinoid signalling: SPARC, GIT2, and 
RARG were selected for qPCR analysis. A table showing the sequences of primers used to 
analyse genes of interest is in Table 5.2.  
5.3.3.1 Expression of RARG in Trabecular Bone of Kyphotic and Vitamin A Pigs 
In the kyphosis trial, RARG showed a tendency to be downregulated in the trabecular bone 
of kyphotic pre-weaners in comparison to non-related controls (Fold-change, (FC) -1.40, 
p=0.087) (Figure 5.3). There were no significant differences in RARG expression observed 
between pre-weaning kyphotic and littermate piglets (FC-1.11, p=0.585), or in pre-weaning 
littermates in comparison to non-related controls (FC-1.26, p=0.249).  
In the vitamin A trial, there was an effect of vitamin A dose on RARG gene expression 
(p=0.036) (Figure 5.3). From controls to 1250µg RP/kg BW, RARG expression decreased in 
the trabecular bone (FC-3.92, p=0.027), yet from 1250µg RP/kg BW to 3000µg RP/kg BW, 
RARG expression increased (FC +2.50, p<0.01). No significant differences were observed in 
the later treatment groups in comparison to controls.      
Table 5.2: List of primer sequences for genes of interest for quantification of gene expression 
by real-time quantitative polymerase chain-reaction (q.PCR) 
GENE NAME PRIMER SEQUENCE 5’ -3’ 
GIT2 F: CTCCAACATTGCTTCAGATGGT 
R: GCGGTGGACAAATGCTAACA 
SPARC F: GGACCTTGCAAATACATCCCC 
R: CGTGGATCTTCTTCACTCGC 
RARG F: GATGACACAGAGACAGGGCT 
R: CCTTTCTGCTCCCTTGGTG 
RPL37 (HK) F: GCCTACCATCTCCAGAAGTC 
R: CTTCACGGAATCCATGCCTG 
RPL37, Ribosomal Protein L37, RARG, Retinoic Acid Receptor Gamma, SPARC, Osteonectin, 
GIT2, G Protein-Coupled Receptor Kinase Interacting ArfGAP 2 
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Figure 5.3: Relative real-time PCR expression of Retinoic Acid Receptor Gamma (RARG) in the 
trabecular bone of 1. Pre-weaning (PreW) kyphotic (n=17), littermate (n=17) control pigs 
(n=17) post-mortem, and 2. Pigs receiving vitamin A supplementation (n=8 per group) post-
mortem, y-axis is in a log2 scale. are presented boxplots showing the median, 25th and 75th 
quartile ranges, and upper and lower limits. Mann-Whitney XY p= 0.087, AB p=0.027, BC 
p<0.01 
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5.3.3.2 Expression of SPARC in Trabecular Bone of Kyphotic and Vitamin A Pigs 
In the kyphosis trial, SPARC was not observed to be differentially expressed between 
kyphotic or littermate (FC -1.31, p=0.692) or control piglets (FC+1.56, p=0.264) (Figure 5.4). 
Due to the non-significant results in gene expression, SPARC was not analysed in the 
remaining age groups.  
In the vitamin A trial, there was an effect of vitamin A dose on SPARC expression (p=0.039) 
(Figure 5.4). SPARC significantly increased in expression in response to 3000µg RP/kg BW (FC 
+4.66, p<0.01). No significant fold-changes were observed in later treatment groups in 
comparison to controls.   
5.3.3.3 Expression of GIT2 in Trabecular Bone of Kyphotic and Vitamin A Pigs 
In the kyphosis trial, GIT2 was observed to be downregulated in the trabecular bone of 
kyphotic pre-weaners in comparison to controls (FC -1.88 p<0.01), and in the trabecular 
bone of littermate pre-weaners in comparison to non-related controls (FC-1.68, p=0.013) 
(Figure 5.5). There were no significant differences between pre-weaning kyphotic and 
littermate piglets (FC-1.12, p=0.418). Due to the significant and notable differences in gene 
expression, GIT2 was analysed in the older kyphotic age groups. There was a tendency for 
an effect from age in that GIT2 expression was reduced in the weaning and post-weaning 
groups (p=0.097), but no significant differences were observed between kyphotic and 
control pigs in either of these age groups.  
In the vitamin A trial, there was a significant effect of vitamin A dose on gene expression of 
GIT2 (p<0.01) (Figure 5.5). The expression of GIT2 was significantly different in all dose 
groups in comparison to controls, and GIT2 followed a dose-response relationship with 
vitamin A up until 3000µg RP/kg BW, where gene expression peaked in expression (FC 
+8.34, p<0.01). 
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Figure 5.4: Relative real-time PCR expression of Osteonectin (SPARC) in the trabecular bone 
of 1. Pre-weaning (PreW) kyphotic (n=17), littermate (n=17) and control pigs (n=17) post-
mortem, and 2. pigs receiving vitamin A supplementation (n=8 per group) post-mortem. 
Data are presented in boxplots showing the median, 25th and 75th quartile ranges, and upper 
and lower limits. Mann-Whitney AB p=0.081 AC p<0.01 AD p=0.07  
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Figure 5.5: Relative real-time PCR expression of G Protein-Coupled Receptor Kinase 
Interacting ArfGAP 2 (GIT2) in the trabecular bone of 1. Pre-Weaning (PreW) (n=17 per 
group), Weaning (n=16 per group), and Post-weaning (PostW) (n=7 per group) kyphotic and 
Control pigs post-mortem, and 2. Pigs receiving vitamin A supplementation (n=8 per group) 
post-mortem, data are presented in a log2 scale. Data are presented in boxplots showing the 
median, 25th and 75th quartile ranges, and upper and lower limits. Mann-Whitney AB p<0.05, 
AC p<0.01  
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5.4 Discussion  
In this study, the overlap of differential gene expression was investigated in pigs from the 
kyphosis and vitamin A trials, as was the vitamin A-vitamin D relationship in kyphotic pigs. 
The hypotheses stated that kyphotic pigs would show reduced vitamin A and vitamin D 
status in comparison to control pigs. Liver REs were reduced in kyphotic post-weaners, and 
serum 25(OH) D was reduced in pre-weaning kyphotic and littermate piglets in comparison 
to non-related controls. Therefore, these results support the original hypotheses. No 
negative correlations between vitamin A and vitamin D were observed in kyphotic pigs, 
therefore it is likely vitamin A does not antagonise vitamin D in growing kyphotic pigs.  
Additionally, the hypotheses also stated that genes which control bone mineralisation will 
overlap between the kyphosis and vitamin A trials. These genes were predicted to show 
downregulation within kyphotic bone, and upregulation in response to vitamin A. In 
particular, GIT2 showed a dose-response relationship to vitamin A supplementation in the 
vitamin A trial, and was downregulated in the trabecular bone of kyphotic and littermate 
pre-weaners in comparison to age-matched non-related controls. GIT2 promotes bone 
formation and mineralisation, but also regulates osteoclast function (Wang et al., 2012). 
Therefore, the original hypotheses can be accepted in that vitamin A regulates bone 
formation genes that are associated with kyphosis. But the findings from the current study 
now suggest bone resorption is also affected by vitamin A in kyphotic pigs as a result of GIT2 
differential regulation.  
5.4.1 Vitamin A and Vitamin D in Kyphosis  
Serum 25(OH) D was observed to be reduced in pre-weaning kyphotic pigs and littermate 
piglets in comparison to non-related controls (Figure 5.1). Due to the observation being 
confined to the litter, this suggests the sow has had an effect on the vitamin D status of 
these piglets. Supplementing gilts with vitamin D has been demonstrated to improve the 
vitamin D status of the developing foetus (Coffey et al., 2012). In addition, piglets, from 0 to 
7 weeks of age, had serum 25(OH) D concentrations that increased depending upon the 
level of vitamin D supplementation offered to the sow (Amundson et al., 2017). Piglets born 
from vitamin D deficient sows also showed a higher prevalence of kyphosis development 
(Amundson et al., 2017). The results from these studies clearly demonstrate the effect of 
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the sow in relation to the piglet’s vitamin D status, and support the findings in the current 
study which suggests a link between vitamin D status, the sow, and kyphosis. Nonetheless, 
these findings are in agreement with previous studies which have shown Vitamin D supply 
to the sow to be a critical factor that contributes to the development of kyphosis (Rortvedt 
and Crenshaw, 2012, Halanski et al., 2018, Amundson et al., 2016). Due to findings that 
demonstrated BMD is reduced in the hypovitaminosis-D kyphosis model (Rortvedt and 
Crenshaw, 2012) and given vitamin D’s role in regulating skeletal growth in pigs (Witschi et 
al., 2011), the results support a role of vitamin D deficiency contributing to reduced bone 
mineralisation. The results obtained in the current study support an association of vitamin D 
supply with kyphotic pigs on UK outdoor farms.    
The current study also showed RE stores in liver to be reduced particularly in post-weaning 
kyphotic pigs (Figure 5.2). Pre-weaning kyphotic piglets did show a tendency to have 
reduced liver RE stores in comparison to non-related controls, but there were no clear 
indications that there was an effect confined to the litter.  The reduction of liver RE stores, 
in kyphotic post-weaners and potentially kyphotic pre-weaners, could indicate farm 
management factors are responsible for this effect. Epidemiological studies should be 
pursued in future work in order to identify if there is an effect of management. The results 
in the current study are in contrast to the  findings of Belsue (2010), which suggested 
vitamin A supplementation drives kyphosis. Studies which support the findings in the 
current study are results which show vitamin A deficiency drives curvature of the spine, in 
the form of scoliosis in rats (Li et al., 2012). Yet meta-analysis studies also demonstrate that 
high and low serum retinol can contribute to osteoporotic fractures (Navarro-Valverde et 
al., 2018, Wu et al., 2014), the results of which support both the current study and Belsue 
(2010) study. While the current study does not conclude a maternal effect in relation to 
vitamin A and kyphosis, the Belsue (2010) study showed there is a maternal effect when the 
sow is supplemented with vitamin A. It is possible the vitamin A-vitamin D antagonistic 
relationship (Aburto et al., 1998, Clark and Bassett, 1961, Frankel et al., 1986) is attributable 
to the abnormal skeletal development in the Belsue (2010) study, however serum 25(OH) D 
was not measured so there is no evidence to support this. Furthermore, a vitamin A-vitamin 
D antagonistic relationship was not identified to be associated with kyphotic pigs in the 
current study. Overall, it is likely that both excess and deficient vitamin A intake has the 
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potential to contribute to kyphosis, depending upon maternal exposure to vitamin A. 
Supporting this, the pigs in the vitamin A trial for the current study did not develop kyphosis, 
but the pigs received no effect from the sow due to entering the experimental period at 4 
weeks of age.  
In summary, the results of the current study indicate kyphotic pigs have reduced status of 
both vitamin A and vitamin D. The results support a justification to incorporate these 
vitamins into intervention trials in order to confirm their associations with kyphosis.   
5.4.2 Differential Gene Expression in Trabecular Bone  
The kyphosis and vitamin A trials in the current study represent two different scenarios, but 
both have an impact on bone development. This is highlighted by kyphotic pigs showing 
decreased bone mineralisation (Nielsen et al., 2005, Done et al., 1999), and excess vitamin A 
inducing narrowing and fragility of bones in rats and pigs (Pryor et al., 1969, Lind et al., 
2011). Due to post-weaning, and potentially pre-weaning, kyphotic pigs showing reduced 
liver REs, biological effects observed in kyphotic pigs could be representative of reduced 
vitamin A status. Meanwhile, liver REs markedly increased for pigs in the vitamin A trial, as 
shown in Chapter 4; therefore this trial represents the effects of excess intake of vitamin A.  
In the kyphosis and vitamin A trials, microarray analysis indicated RARG to be 
downregulated within the trabecular bone of kyphotic pre-weaners in comparison to non-
related controls, and upregulated in pigs receiving vitamin A supplementation. qPCR 
analysis showed that the difference in RARG expression between kyphotic pre-weaners and 
non-related controls was not significant, but did show a tendency to be downregulated in 
kyphotic pre-weaners (Figure 5.3). There were no significant upregulations of RARG 
observed in any dose groups in comparison to controls for the vitamin A trial (Figure 5.3). 
This could suggest that RARG is not the most accurate predictor of excess vitamin A intake, 
and raises questions as to how this gene has been regulated in trabecular bone. RARG codes 
for retinoic acid receptor gamma, which is one of the three isoforms of the retinoic acid 
receptor. Knock-out of RARG in mice abrogates the effects of excess vitamin A, although it 
must be noted that bone tissue was not included in the investigations (Ross et al., 2000, 
Look et al., 1995). However, given that vitamin A, in combination with RAR and RXR 
isoforms, has the potential to regulate over 500 proposed genes (Balmer and Blomhoff, 
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2002), this can make it difficult to ascertain which exact pathways and genes have been 
affected as a result of RARG differential regulation in trabecular bone tissue.  
Due to RARG not showing any clear dose response relationships to vitamin A in the vitamin 
A trial, this suggests that the ligands for RARG, all-trans retinoic acid (ATRA) or 9-cis retinoic 
acid, might not be responsible for the observed interaction. Studies have demonstrated RAR 
and RXRs have the potential to form heterodimers with vitamin D receptors (VDRs), and a 
combination of ATRA and vitamin D facilitated binding of a RARα-VDR complex to 
responsive elements to mediate gene expression (Schrader et al., 1993). More recent 
evidence has demonstrated vitamin D responsive elements (VDREs) do bind RARG as well as 
VDRs (Koszewski et al., 2010). These studies imply that vitamin D holds a role in regulating 
the actions of RARG on target gene expression. In addition, kyphotic pigs showed reduced 
serum 25(OH) D (Figure 5.1), and showed a tendency to have reduced RARG expression in 
comparison to controls. However, data from Chapter 4 indicated there is no difference in 
serum 25(OH) D between control pigs and pigs receiving 1250µg RP/kg BW, between which 
a difference in RARG expression was observed. However, in neither of the trials was 1, 
25(OH)2D assessed in serum, which serves as the metabolite of vitamin D which binds the 
VDR. Analysing 1,25(OH)2D in the serum of kyphotic and vitamin A treated pigs in future 
studies could offer more insight into the relationship between RARG expression and vitamin 
D metabolism. In summary, analysis of both trials shows that RARG does not serve as a 
biomarker of vitamin A supplementation, but highlights the requirement to assess RARG’s 
association with vitamin D metabolism.  
Microarray and qPCR analysis showed SPARC and GIT2 to associate with kyphotic and 
vitamin A-supplemented pigs; however qPCR confirmed SPARC to not be a differentially 
regulated gene in kyphotic trabecular bone (Figure 5.4). GIT2 was downregulated in pre-
weaning kyphotic pigs (Figure 5.5), and these pigs showed a tendency to have reduced 
vitamin A status. Yet GIT2 was upregulated in response to vitamin A supplementation in the 
vitamin A trial (Figure 5.5). These findings offer evidence that the regulation of GIT2 in 
trabecular bone is controlled by vitamin A. Furthermore, pre-weaning littermates also 
showed a reduced expression of GIT2 in comparison to non-related controls, therefore 
suggesting the effect is confined to the litter. GIT2 codes for G Protein-Coupled Receptor 
Kinase Interacting ArfGAP 2. Knock out of GIT2 has a detrimental effect on bone 
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development, this includes: loss of function for osteoclasts, decreased bone mass, and MSCs 
are favoured towards an adipocyte, over an osteoblast, lineage (Wang et al., 2012). SPARC 
codes for osteonectin, of which is a secreted non-collagenous protein that has been 
demonstrated to regulate osteoblast differentiation, as well as osteoclast activity (Delany 
and Hankenson, 2009, Delany et al., 2003, Delany et al., 2000). A critical difference between 
these two genes is that while SPARC is a non-collagenous protein, GIT2 is an intracellular 
scaffolding molecule that controls cell differentiation. The results could suggest that vitamin 
A has not affected expression of non-collagenous protein synthesis in pre-weaning kyphotic 
pigs; indeed the vitamin A trial demonstrated doses up to 3000µg RP/kg BW of vitamin A are 
required to induce differential expression of SPARC.  
GIT2 is a scaffolding protein that exists in oligomeric complexes with PAK-interacting 
exchange factor (PIX), and can interact with Rho-GTPases to control cytoskeletal regulation, 
and also controls G-protein coupled receptor (GPCR) internalisation (Hoefen and Berk, 
2006). Cytoskeletal dynamics in osteoblasts and osteoclasts contribute to cell growth, 
migration, assemble focal complexes with and adhere to the ECM (Lomri and Marie, 1996, 
Goncharenko et al., 2016). Integrin-adhesion to the ECM on MSCs is required for ECM 
proteins to initiate osteoblast differentiation (Oh et al., 2017, Hendesi et al., 2015, Zouani et 
al., 2013). Cytoskeletal reorganisation is also required for migration and adhesion of 
osteoclasts to bone surfaces, adhesion to bone surfaces, and proteolytic enzyme release 
(Lomri and Marie, 1996, Teitelbaum, 2011). GIT2 also regulates the desensitisation of 
GPCRs. Through initiating GTP hydrolysis through their ARF-GAP domains, GIT proteins are 
able to interact with and activate ADP ribosylation factors (ARF) proteins, which regulate 
membrane trafficking to and from the Golgi apparatus (Hoefen and Berk, 2006, Premont et 
al., 2000). Overexpressing GIT1 or GIT2 in vitro results in decreased sequestration and 
increased desensitisation of the β2-adrenergic receptor, (Premont et al., 1998, Premont et 
al., 2000). Therefore, it could be hypothesised that a reduced expression of GIT proteins 
would increase sequestration of GPCRs and therefore limit the effects of certain ligands and 
agonists across osteoblasts and osteoclasts. Examples of GPCRs conserved across these cells 
include: calcium-sensing receptor or P2Y receptor (Bowler et al., 1998). However, for the 
moment, there is no clear evidence that showcases GIT2’s effects on GPCR-associated bone 
metabolism. Nonetheless, regardless of the mechanism, a reduction of GIT2 in trabecular 
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bone could contribute to the reduced endochondral bone growth in kyphotic pigs (Nielsen 
et al., 2005). However, it must be stressed that GIT2-mechanisms alone cannot be 
responsible for kyphosis, as littermate piglets also showed a reduced expression of this 
biomarker and did not show any signs of kyphosis.  
The downregulation of GIT2 in pre-weaning kyphotic trabecular bone, which showed a clear 
dose-response to vitamin A in the vitamin A trial, supports that kyphotic pigs have reduced 
vitamin A activity in the bone. However, kyphotic post-weaners did not show differential 
regulation of GIT2 in trabecular bone, despite showing reduced liver REs. While GIT2 was 
confined to the pre-weaning litter, this effect was not observed with liver REs. Therefore, 
while the results in the current study agree with the hypotheses in that kyphotic pigs will 
have reduced vitamin A status, it is likely that liver REs are not directly linked to differential 
gene expression in trabecular bone. It is possible other factors such as retinoic acid 
concentrations in trabecular bone are contributing to differential gene expression. This 
could be confined to pre-weaning kyphotic and littermate piglets, explaining how GIT2 is 
confined to the litter. Retinoic acid concentrations in trabecular bone, for both trials, should 
be assessed in future studies in order to confirm the contributions. These answers will be 
required in order to understand the full scope of the link between vitamin A metabolism 
and the regulation of vitamin A-biomarkers in kyphotic vertebral trabecular bone.  
In summary, the study has identified GIT2 to be a vitamin A–regulated biomarker that is 
downregulated in pre-weaning kyphotic and littermate piglets. The exact biological 
mechanism of GIT2’s effect on bone metabolism in kyphosis, as well as the full scope of its 
association with vitamin A metabolism, will require clarification in future studies.     
5.5 Conclusions  
The current study has added an additional layer of evidence in the association between 
kyphosis and vitamin D deficiency, and adds further justification for the application of 
vitamin D in kyphosis intervention trials. The study has also highlighted that reduced vitamin 
A status is associated with growing kyphotic pigs, and demonstrates the need to investigate 
how this is occurring on UK farms.    
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The current study has also identified that vitamin A potentially contributes to kyphosis 
through regulating GIT2, which has a subsequent effect on bone metabolism. The study has 
highlighted the larger role of GIT2 in bone pathogenesis, and also offers more insight as to 
how vitamin A regulates trabecular bone development. GIT2 should be considered as a 
diagnostic biomarker in assessing pigs at risk from developing kyphosis.  
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Chapter 6: General Discussion 
6.1 Introduction 
This thesis addressed several key questions concerning bio-mineral tissue development in 
commercial growing pigs. These ranged from understanding the molecular basis of events in 
kyphotic tissues, to clarifying vitamin A’s association with the development of kyphosis and 
its role in trabecular bone metabolism. The relationship between vitamin A and vitamin D 
was also further characterised, as well as how these vitamins associate with kyphosis.    
The kyphosis trial was unique to this thesis, as it included kyphotic and control pigs from 
farms which suffer from spontaneous outbreaks. Thus, biological results obtained from this 
trial would provide the most accurate picture of the biological basis of kyphosis on UK 
farms. By pursuing molecular investigations in kyphotic bone and cartilage tissues, the thesis 
has identified genes and molecular pathways that are likely contributing to the physiological 
changes of kyphosis (Chapter 3, Chapter 5).  
The novel design of the vitamin A trial allowed for very high doses of vitamin A consumption 
over a prolonged period of time. Unanswered questions in relation to vitamin A and bone 
health include how various high doses of vitamin A affect differential gene expression 
particularly within trabecular bone, and how it influences serum 25(OH) D. The two trials 
used in this thesis allowed for characterisation of how various doses of vitamin A associate 
with serum 25(OH) D, and how the relationships between these vitamins relate back to 
skeletal diseases. Both trials also allowed for identification of vitamin A regulated 
biomarkers in trabecular bone that regulate tissue metabolism and further characterise how 
vitamin A contributes to the development of the tissue (Chapter 4, Chapter 5).  
In addition, assessing both the kyphosis and vitamin A trials in this thesis has allowed for 
identification of vitamin A-regulated genes in kyphotic trabecular bone (Chapter 5). This has 
illustrated the requirement for vitamin A’s association with kyphosis to be confirmed via an 
intervention trial.    
The current chapter will integrate findings from preceding experimental chapters in order to 
critically discuss the overall relevance of the findings. Recommendations for future work are 
also provided at the end of the chapter. 
115 
 
6.2 The Molecular Basis of Kyphosis in Pigs   
One of the objectives of this thesis was to confirm the genes and molecular pathways 
associated with kyphotic tissues. Kyphosis in pigs is not characterised by consistent 
aetiological observations, but some of these have included: a loss of a POC in thoracic and 
lumbar vertebrae (Nielsen et al., 2005, Done et al., 1999), reduced mineral content of bone 
(Done and Gresham, 1988), and collapsing of the thoraco-lumbar junction (Done and 
Pearson, 2004). Through clarifying genes and molecular pathways associated with kyphotic 
bone and cartilage tissues, the thesis aimed to establish an underlying biological basis for 
the physiological changes. This was accomplished through performing a pathway analysis of 
tissues to identify differentially expressed genes and pathways (Chapter 3), and by 
comparing which genes overlapped with genes induced by vitamin A (Chapter 5).   
The microarray and pathway analysis of kyphotic tissues in Chapter 3 led to the observation 
of the SLRP DCN upregulation in intervertebral cartilage of kyphotic pre-weaners. This 
approach also showed the SLRP ASPN to be downregulated in the trabecular bone of 
kyphotic post-weaners. The analysis also suggested that the TGF-β pathway does not 
directly contribute to kyphosis, as was suggested in the original hypotheses. DCN is 
associated with experimental models of disc degeneration (Melrose et al., 1997) as well as 
osteoarthritis, and it has been proposed that its function in osteoarthritis is to restore PG 
losses (Bock et al., 2001). Therefore, the upregulation of DCN in the cartilage of kyphotic 
pre-weaners implies the cartilage is comparable to that of osteoarthritis. This critical finding 
suggests the initial basis of the collapsing of the thoraco-lumbar junction begins at pre-
weaning, and is not just attributed to heavy musculature in older kyphotic pigs as has been 
previously suggested (Done and Pearson, 2004). Another interesting implication is that 
though ASPN regulates mineralisation of cartilage into ossified tissue, DCN can compete for 
collagen binding and inhibit the mineralisation process (Kalamajski et al., 2009). Therefore, 
an upregulation of DCN in intervertebral cartilage at pre-weaning could offer implications 
that DCN is out-competing ASPN at these stages for collagen binding, and thus contributing 
to reduced endochondral bone growth. In addition, DCN binds TGF- β (Hildebrand et al., 
1994); this interaction has been proposed to prevent TGF- β binding to its cellular receptors 
and initiate signalling (Gubbiotti et al., 2016). Conversely, DCN has also been suggested to 
facilitate binding of TGF- β to its receptors (Takeuchi et al., 1994). An overview of DCN’s 
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interaction with TGF- β is provided (Figure 6.1). TGF-β was not identified to be differentially 
expressed in kyphotic cartilage, but an upregulation of DCN could be an attempt to facilitate 
binding of TGF- β to its receptors in order to ameliorate damage in the tissue. This effect is 
more likely because if DCN was directly contributing to downregulation of TGF- β signalling, 
then genes such as SMAD4, which carries the intracellular signal from TGF- β, would have 
also likely shown differential expression. Regardless, the mRNA expression of DCN in human 
tumour tissues positively correlates with concentrations of Decorin in serum (Appunni et al., 
2017); therefore Decorin could be considered as a potential diagnostic blood marker for 
kyphosis. Pathway analysis of kyphotic trabecular bone also showed that ASPN was 
downregulated at the post-weaning stage. ASPN has been demonstrated to induce 
mineralisation of the extending collagen template and thus regulate the process of 
endochondral bone growth (Kalamajski et al., 2009), therefore this finding would indicate 
this process is halted in kyphotic pigs at 13 weeks of age. Similar to DCN, ASPN also has the 
potential to bind TGF- β, and in vitro analysis shows that ASPN may block TGF- β binding to 
its receptor; likewise, silencing of ASPN also induces expression of TGF- β (Nakajima et al., 
2007, Kou et al., 2007) (Figure 6.1). It is likely that the downregulation of ASPN could be a 
biological attempt to allow available TGF- β to bind to its receptors and repair the damage 
to the kyphotic tissue.  
Through identifying differentially expressed genes from the kyphosis trial which overlapped 
with those from the vitamin A trial, the gene GIT2 was confirmed by qPCR to be 
downregulated in kyphotic trabecular bone at the pre-weaning stage (Chapter 5).      
Knockout of GIT2 in a mouse results in decreased BMD and bone volume in trabecular 
compartments (Wang et al., 2012); this phenotype strikes similarities to kyphosis due to the 
loss of a POC in kyphotic pigs (Nielsen et al., 2005). GIT2 performs two major functions: to 
regulate ARF proteins which control trafficking of GPCRs to and from the plasma membrane, 
and to bind CDC42-PAK complexes such that high local concentrations of PAK induce auto-
phosphorylation (Hoefen and Berk, 2006) (Figure 6.2). PAK phosphorylation and its 
subsequent effects in cytoskeletal rearrangement are detrimental in regulating osteoblast 
differentiation and osteoclast resorption activity (Hoefen and Berk, 2006, Rane and Minden, 
2014, Lomri and Marie, 1996). The finding that GIT2 was downregulated in kyphotic 
trabecular bone at the pre-weaning stage is a novel finding for numerous reasons. Due to
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Figure 6.1: A. An upregulation of DCN in the intervertebral cartilage of kyphotic pre-weaners could be an attempt to either downregulate TGF-
β, or to re-upregulate the TGF-Smad signalling in order to alleviate abnormal tissue development. B. A downregulation of ASPN in the 
trabecular bone of kyphosis post-weaners could be an attempt to remove any inhibitory effects on TGF-β signalling in order to ameliorate the 
abnormal tissue development.  
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Figure 6.2: A summary of the overlap of gene expression between kyphosis (↓↑) and vitamin A supplementation (↓↑). GIT2 was differentially 
regulated in the trabecular bone of kyphotic pre-weaners, and pigs receiving vitamin A supplementation. Vitamin A upregulated GIT2 and FLNA, 
of which are associated with the Rho-GTPase CDC42. This set of molecules share a common association in that they induce cytoskeletal 
rearrangement, of which has a subsequent effect on osteoblast differentiation and osteoclast activity. Rho-GTPases were not differentially 
regulated in kyphotic trabecular bone; it is possible GIT2-associated GPCR sequestration is linked to kyphosis.     
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the vitamin A trial ascertaining GIT2 as a vitamin A regulated gene (Chapter 5), this 
demonstrates how vitamin A is biologically contributing to kyphosis. The finding also implies 
that, due to GIT2’s role in mediating osteoblast and osteoclast activity (Wang et al., 2012), 
the processes of endochondral bone growth and bone remodelling are downregulated in 
kyphotic pre-weaners. Recent reviews have also identified GIT2 as a potential contributory 
cause to osteoporosis due to its roles in bone metabolism (van Gastel et al., 2018), and the 
results of this thesis further demonstrate GIT2’s critical role in bone development. GIT2’s 
differential regulation particularly at the pre-weaning stage also illustrates that this a critical 
period of kyphotic development, and should be focussed upon in intervention, which is 
discussed in more detail below. There are no established blood markers representative of 
GIT2 activity, but if bone biopsies of pigs are to be obtained GIT2 could serve as a diagnostic 
or prognostic marker of kyphotic development.  
Due to GIT2 and DCN differential expression being associated with kyphotic pigs at the pre-
weaning stage, this suggests that outbreaks of kyphosis will initially occur on breeding 
farms. The gene expression changes at this age likely initiate the template of the kyphotic 
kink before normal growth and development through weaning. ASPN’s differential 
expression in trabecular bone at post-weaning possibly indicates an effect to initiate TGF-β, 
as discussed, but the data obtained by extrapolating the kyphosis and vitamin A trials 
suggests the dominant changes are occurring at pre-weaning. Another critical implication 
was that DCN and GIT2 were observed to associate with littermate pre-weaners as well as 
kyphotic pre-weaners. This implies that the sow, and therefore exposure of the piglet to 
factors during gestation and lactation, has had an effect on these changes. One such factor 
is vitamin A supply to the sow, which subsequently affects litter prevalence of kyphosis 
(Belsue, 2010). Since GIT2 was identified as a vitamin A regulated biomarker in kyphotic pigs 
(Chapter 5), this serves as evidence that vitamin A supply from the sow to piglet is 
contributing to kyphosis as well as the entirety of the litter. These previous studies did not 
assess, anthropometrically or biochemically, how littermate piglets have been affected by 
treatments provided to the sow. Due to the data in this thesis showing that differential gene 
expression changes are confined to the litter, this emphasises that the whole litter is 
potentially at risk from developing kyphosis. Ultimately, this suggests that the sow will 
require priority focus in intervention trials.    
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Although GIT2 was identified as a vitamin A regulated biomarker in kyphosis (Chapter 5), 
this was not the case with ASPN and DCN. The expression of these genes are possibly an 
effect of kyphosis, as discussed, but no firm conclusions can be drawn. Another approach 
that should be considered in future studies should be epigenetic analyses. The degree of 
DNA methylation on identified biomarkers could be responsible for gene expression 
changes. In vitro, methylation of CpG islands in the 5’UTR of DCN results in reduced mRNA 
expression (Qian et al., 2014). The aforementioned results were produced from a human 
cancerous cell line, which holds a different genetic make-up to a pig, but clearly 
demonstrate the requirement for investigating the role of epigenetic regulation in future 
studies. In addition to microarray analysis of kyphotic pre-weaners, it would also be 
beneficial to see which genes, or pathways, are conserved over time in kyphotic pigs, or if 
other pathways are affected. To this effect, tissues from weaning and post-weaning 
kyphotic pigs should be assessed via microarray. This would be critical in determining 
whether there are more effects, outside the influence of the sow, contributing to kyphosis. 
In cartilage, Aggregan (ACAN) is established as a major ECM protein required for healthy 
cartilage growth (Zhang et al., 2012). In line with DCN upregulation, ACAN was identified by 
the microarray to be upregulated in kyphotic intervertebral cartilage (Chapter 3) and DCN 
has been observed to directly link aggrecan and collagens, thus contributing to the 
development of the tissue (Gubbiotti et al., 2016). It is likely that the functions of these 
glycoproteins are attempting to repair and stabilise the intervertebral cartilage of kyphotic 
pigs. Chapter 3 also indicated that angiogenesis could be affected in trabecular bone if there 
is a differential regulation of BMPR1A. However, vascular endothelial growth factor (VEGF), 
which is the master regulator of angiogenesis, nor RUNX2, the master regulator of 
osteoblast differentiation, were identified to be differentially expressed by the microarray. 
The relevance of RUNX2 is discussed in more detail below, but the lack of VEGF differential 
expression ultimately shows that angiogenesis is not affected in the bone of kyphotic pigs.   
It will be desirable to have whole vertebral samples from kyphotic and control pig assessed 
for bone volume or mineral density. Due to technical issues associated with sample storage, 
this experiment was not possible for the thesis. This must be taken into consideration for 
future studies, as it will be critical to confirm if a downregulation of GIT2 is associated with 
changes in bone structure in kyphotic pigs. While major cases of kyphosis have shown 
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significantly compromised bone integrity as a result of a loss of  a POC (Nielsen et al., 2005), 
this is often not consistent among all cases (Penny and Walters, 1986, Done and Gresham, 
1988). To summarise, the thesis has identified novel genes in kyphosis that are indicative of 
reduced bone metabolism and proteoglycan losses in bone and cartilage tissues 
respectively. The thesis has therefore provided a molecular basis to the physiological 
changes that occur in kyphotic tissues. The thesis has also indicated that there is likely a 
maternal effect due to gene expression being confined within the litter. This implies that the 
pre-weaning period is a critical stage for the development of kyphosis.    
6.3 The Vitamin A – Vitamin D Relationship and Vitamin A’s role in Trabecular Bone 
Development 
Another objective this thesis was to confirm how vitamin A supplementation affects 
differential gene expression in trabecular bone and serum 25(OH) D. Through assessing 
differential gene expression by pathway analysis (Chapter 4) and by identifying vitamin A 
regulated biomarkers that overlapped with kyphotic pigs (Chapter 5), the thesis identified 
Rho-GTPase molecules FLNA, GIT2 and SPARC to be regulated by vitamin A in trabecular 
bone. In a rat model, osteoporosis is induced in response to 2 weeks of treatment with a 
diet containing 70mg/kg of vitamin A (Wu et al., 1996). This included decreased thickness of 
trabecular bone and number (Wu et al., 1996). Other observations show excess vitamin A to 
result in: decreased trabecular BMD (Lind et al., 2011), and decreased osteoblast cell 
numbers in trabecular bone (Wolke et al., 1968). Altogether, these observations implied 
that vitamin A induces bone resorption in trabecular bone, but the genes GIT2, FLNA, and 
SPARC function to regulate overall bone metabolism in relation to both osteoblasts and 
osteoclasts (Leung et al., 2010, Hong et al., 2010, Wang et al., 2012, Delany et al., 2003, 
Delany and Hankenson, 2009). Considering that the vitamin A trial was performed over a 
period of 15-22 weeks, these results demonstrate that long term exposure to high doses of 
vitamin A will favour expression of bone metabolic genes. Previous studies demonstrating 
that vitamin A compromises the structural integrity of trabecular bone (Lind et al., 2011, Wu 
et al., 1996, Wolke et al., 1968) were performed over a much shorter period than the 
vitamin A trial in the current study; therefore this demonstrates the differences acute and 
chronic exposure to vitamin A exert on trabecular bone. FLNA and SPARC, but not GIT2, 
were not differentially expressed in kyphotic pigs, whom received no specified vitamin A 
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treatments. In addition, SPARC and FLNA only showed differential expression in response to 
3000µg RP/kg BW, the same treatment which resulted in full saturation of REs in liver, 
whereas GIT2 was expressed in response to 200µg RP/kg BW, as well as in kyphosis pre-
weaners. This suggests that GIT2 is a more sensitive marker to vitamin A. Genes such as 
FLNA or GIT2 contribute to osteoblast differentiation, but it is the synthesis of non-
collagenous proteins that directly interact with and regulate bone matrix. Given that SPARC, 
an abundant non-collagenous protein in bone matrix, was only expressed in response to 
very high doses of vitamin A, this demonstrates that very high concentrations of vitamin A 
are required in order to directly exhibit effects on trabecular bone. Existing knowledge 
established that excess vitamin A affects Wnt signalling in cortical bone, and bone marrow 
(Lind et al., 2011, Lind et al., 2012); yet these studies were also performed over a much 
shorter period than the vitamin A trial. The thesis now suggests that long term exposure to 
excess vitamin A allows for interaction with Rho-GTPases to regulate bone metabolism; 
altogether these findings illustrate how excess vitamin A controls influences bone 
development.  
In relation to the vitamin A-vitamin D relationship, the thesis aimed to further characterise 
the antagonistic relationship between the two vitamins, as well as whether this relationship 
can be associated with the development of skeletal diseases. This was accomplished 
through assessing how doses of vitamin A affect serum 25(OH) D (Chapter 4), as well as how 
vitamin A and vitamin D associate with a skeletal abnormality, in this case represented by 
kyphosis (Chapter 5). In the UK, recommendations from DSM (2016) suggest supplementing 
pigs additional thousands of µgs of vitamin A over vitamin D, but it has not been clarified as 
to whether this could potentially induce antagonism of vitamin D by vitamin A. The pigs 
used in the kyphosis trial, representative of outdoor pig farms, did not show any indications 
of antagonism of vitamin D by vitamin A. In fact, the vitamin A trial showed that doses up to 
500µg RP/kg BW were required in order to observe a reduction in serum 25(OH) D. The pigs 
assigned to the 500µg RP/kg BW diet consumed, on average, 643µg/kg of BW of vitamin A 
daily (Chapter 4). If pigs consumed a diet with the highest concentrations of vitamin A 
recommended by DSM (2016) (6000µg/kg) this would result in an approximate 240µg/kg of 
BW daily intake of vitamin A, which is roughly 2.5 times below the daily intake of vitamin A 
observed to antagonise serum 25(OH)D in the vitamin A trial. Therefore, the thesis suggests 
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that the vitamin A-vitamin D antagonistic relationship does not contribute to kyphosis, nor is 
an issue that is contributing to abnormal skeletal health on UK pork farms. The thesis 
supports the recommendations from DSM in relation to vitamin A supplementation.  
The thesis has identified several biomarkers in the small intestine which could explain how 
vitamin D is absorbed in response to excess vitamin A (Chapter 4). These biomarkers will 
need to be assessed by qPCR in future analysis in order to confirm their dose-responses to 
vitamin A and discuss their roles in nutrient absorption. Analysing serum 1,25 (OH)2D should 
also be done in order to establish the end effects of 1-αhydroxylase expression in small 
intestines. Determining serum 1, 25 (OH)2 D could also shed further light on the RARG 
expression profile in trabecular bone (Chapter 5), given that this chapter suggested that 
RARG gene expression is possibly regulated by vitamin D. Chapter 4 also argued that serum 
25(OH) D and Ca levels are restored and maintained at the time of tissue sampling. Ideally, 
blood samples should have been obtained at time intervals during the experimental period 
to verify how acute and chronic exposure to vitamin A will affect maintenance of 25(OH) D 
and Ca over time. These data can then support or disprove the suggestion that these 
nutrients are initially antagonised in response to excess vitamin A, before being restored via 
intestinal mechanisms suggested in Chapter 4. Altogether, the data would provide a more 
complete picture of feedback mechanisms characterizing the relationship between vitamin 
A, and circulating vitamin D and Ca.  
CYP26A1 (Cytochrome P450 Family 26 Subfamily A Member 1) is a protein responsible for 
hydroxylating and removing ATRA present in the cell, so as to control ATRA’s effects on gene 
expression (Kedishvili, 2013). Despite being fed excess vitamin A, CYP26A1 was not observed 
to be differentially expressed in the trabecular bone of treated pigs, nor was CYP26A1 
associated with kyphotic pigs. This finding draws comparisons back to the effects of excess 
vitamin A on bone marrow, in which CYP26A1 was not significantly expressed, but was so in 
cortical bone (Lind et al., 2011). Furthermore, Abu-Abed et al. (2002) observed that, in the 
embryo, CYP26A1 was not detected in developing vertebrae. These findings could imply that 
CYP26A1 is not naturally nor highly expressed within bone tissue, and therefore detecting 
differences in expression will require the application of more sensitive technologies. A 
relatively new qPCR protocol, termed “nested real time-PCR”, has been demonstrated to 
improve assay sensitivity, and detect target transcripts at lower Ct thresholds (Tran et al., 
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2014). This method relies on two sets of primer pairs acting on the template per round of 
PCR, essentially allowing for amplification of two PCR products. This method should be 
considered in order to confirm CYP26A1 expression in vitamin A-treated, as well as kyphotic, 
pigs.  
The gene expression results obtained for the trabecular bone represent novel findings, and 
have filled a knowledge gap into how excess vitamin A affects trabecular bone development 
at the molecular level, but how the structural integrity of the trabecular bone has been 
affected by differential gene expression will require confirmation in follow-up studies. A 
limitation of the vitamin A trial was that trabecular bone samples were not obtained to be 
assessed for BMD or volume. However, cortical bone from the femur was obtained from 
control and treated pigs. Some cortical bone samples were initially assessed via MicroCt, 
and the preliminary results showed that the cortical bone from the femurs of pigs receiving 
5250µg RP/kg BW and 10000µg RP/kg BW had decreased bone volume in comparison to 
controls (Table 6.1). This finding is in agreement with previous studies showing excessive 
vitamin A induces narrowing of the cortical compartment of bone, in rat and pig studies 
(Pryor et al., 1969, Lind et al., 2011, Lind et al., 2012, Wray et al., 2011).  Nonetheless, the 
next step to take will be to verify how the trabecular bone volume is affected. The finding 
that cortical thickness was reduced in the vitamin A trial could serve as a positive control for  
 
 
Groups 
     
 
Control 
(n=2) 
500µg/kg 
(n=3) 
3000µg/kg 
(n=3) 
5250µg/kg 
(n=3) 
10000µg/kg 
(n=3) 
Treatment 
p-value 
Object Volume/ 
mm3 
4852.69 5670.50 4600.97 3807.87* 3893.33* <0.01 
SEM 619.54 5.45 413.32 274.52 136.34 
 
       
% Object Volume 19.36 22.62 17.72 15.19* 15.53* <0.01 
SEM 2.47 0.022 2.28 1.10 0.54 
 
Table 6.1: The object volume and % object volumes of cortical bone from the femur of the 
right, rear leg of control and treated pigs. One-way ANOVA found a significant effect of 
treatment on bone volume of cortical bone. *when compared to A group p<0.05.  
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the trial setup, in that the method of the trial will accurately showcase excess vitamin A’s 
effects on bone volume. The upregulation of bone metabolic genes in trabecular bone could 
suggest that these are effects in order to maintain trabecular bone mass over time. Lind et 
al. (2011) showed excess vitamin A to reduce trabecular bone density by 1 week. 
Furthermore, Wolke et al. (1968) observed decreased osteoblast cell numbers in the 
trabecular bone of pigs fed increasing levels of vitamin A over 5 weeks, which could suggest 
a loss of mineral density. On the other hand, Wray et al. (2011) showed, in comparison to 
control rats, rats fed supplementary vitamin A did not show changes in trabecular density or 
thickness from 2 to 10 months of age. Therefore, after a certain period of time, there could 
be a point in which excess vitamin A no longer reduces trabecular density, but rather 
restores bone mass. Whole vertebral samples, or defined regions of the diaphysis and 
epiphysis from the femur, should be assessed for trabecular bone volume, such as using a 
microCt approach, in future studies in order to determine excess vitamin A’s end effects on 
the tissue.  
To summarise, the thesis has determined that doses of vitamin A higher than current 
recommendations are required in order to antagonise vitamin D, and that vitamin A controls 
bone metabolism in trabecular bone through interacting with genes that control Rho-
GTPase-mediated cytoskeletal dynamics. Further work should assess trabecular bone 
volume or mineral density in order to clarify the effects of upregulated genes within the 
tissue, and identified biomarkers in small intestines should be assessed by qPCR. 
6.4 Kyphosis and its association with Vitamin A and Vitamin D    
The final objectives of this thesis were to confirm how vitamin A and vitamin D associate 
with kyphotic pigs, and to determine if vitamin A contributes to differential gene expression 
in kyphotic pigs. Kyphotic and littermate pre-weaners, raised outdoors, showed reduced 
serum 25(OH) D in comparison to controls, but older pigs did not show differences (Chapter 
5). Likewise control pigs from the vitamin A trial, representing standard grower pigs raised 
according to UK husbandry, did not show differences in serum 25(OH) D in comparison to 
the lower vitamin A dose groups (Chapter 4). These could imply that vitamin D limitation is 
an issue in relation to outdoor piglets. It has been acknowledged that differences in vitamin 
D consumption by the sow will influence vitamin D status and skeletal health in offspring 
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(Witschi et al., 2011). A study conducted in the USA showed that outdoor pigs during winter 
periods have serum 25(OH) D below reference values (Arnold et al., 2015). Given that pigs in 
the kyphosis trial were raised outdoors, whereas those in the vitamin A trial were not, the 
data in this thesis indicates that vitamin D should be supplemented to outdoor sows in 
order to assist in the eradication of kyphosis. The finding that pre-weaning kyphotic pigs 
showed reduced serum 25(OH) D is in agreement with previous trials which have shown 
vitamin D supply to the sow will affect the prevalence of kyphosis (Rortvedt and Crenshaw, 
2012). In order to avoid complications associated with vitamin D deficiency, the thesis 
suggests that additional vitamin D supplementation should be considered for outdoor sows 
on UK farms, especially during winter periods.  
Liver REs were not observed to be reduced in kyphotic pre-weaners. Yet the thesis clearly 
demonstrated an effect of vitamin A during kyphosis, given the dose-response relationship 
of GIT2 with vitamin A (Chapter 4) and GIT2’s downregulation in trabecular bone of kyphotic 
pre-weaners (Chapter 5). Given that GIT2 was confined to the pre-weaning litter, this 
implies that vitamin A supply from the sow, through either gestation or lactation, is having 
an effect on GIT2 expression in trabecular bone. Although previous studies have 
demonstrated an effect with vitamin D (Rortvedt and Crenshaw, 2012) and have suggested 
vitamin A supply from the sow is critical in relation to kyphosis (Belsue, 2010), this is the first 
study to characterise how vitamin A is biologically contributing to kyphosis. A summary of 
GIT2 signalling and how it relates to kyphosis is provided (Figure 6.2). There does remain the 
question as to which component of GIT2 mechanics, cytoskeletal rearrangement or GPCR 
sequestration, are affected in kyphosis. No Rho-GTPases, or associated molecules, were 
observed to be differentially expressed in the trabecular bone of kyphotic pigs. This could 
suggest that GIT2-associated GPCR sequestration, rather than GIT2-regulated cytoskeletal 
dynamics, could be contributing to the physiological consequences of kyphosis. If there is a 
difference in GIT2 mechanisms between the two trials, this could indicate that differences in 
vitamin A intake induce different mechanisms through GIT2 on bone metabolism. More 
work in the fields of GIT2 and GPCR-associated regulation of bone metabolism will need to 
be performed until more solid answers can be provided. Due to the clear link between GIT2 
and vitamin A metabolism, the major question remains as to whether vitamin A 
supplementation will eradicate a prevalence of kyphosis.   
127 
 
It cannot be ruled out that the pigs from the two different trials in this thesis were of 
different genotypes, were raised in separate commercial environments, and exhibited a 
large difference in age during the experimental period. However, results obtained from a 
cell line or separate model organism would not have been as comparable to kyphotic pigs as 
the pigs used in the vitamin A trial. Moreover, although liver REs were reduced in kyphotic 
post-weaners, the thesis cannot confirm what the effect of this due to the lack of 
differential gene expression in kyphotic post-weaners. It is also likely that vitamin A 
metabolism, rather than intake, has been affected in kyphotic pre-weaners, but the thesis 
has not been able to address this. Molecular analysis from small intestine, kidney and liver 
tissues could have provided more answers in relation to vitamin A and vitamin D 
metabolism. Analysis of the α-hydroxylase enzyme in the kidney could offer insight as to 
how 1, 25(OH)2D synthesis has been affected in kyphotic pigs. Also, analysis of differential 
gene expression in liver could provide more answers as to how vitamin A metabolism is 
affected in kyphotic pigs which results in GIT2 downregulation in trabecular bone. One 
hypotheses could be that the expression of retinol-binding protein (RBP), which delivers 
retinol to extrahepatic tissues (Kedishvili, 2013), is downregulated in kyphotic livers. 
However, there is no evidence to support this, and this shows the requirement to analyse 
other tissues in kyphotic pigs.  
Overall, the thesis has argued that decreased vitamin A activity in the vertebral trabecular 
bone of kyphotic pre-weaners contributes to reduced bone metabolism through GIT2. 
Kyphotic pre-weaners did not show reduced RE storage in liver (Chapter 5), but the only 
method that will conclude whether vitamin A intake will associate with kyphosis is to 
perform an intervention trial. Although Belsue (2010) showed excess vitamin A has the 
potential to induce kyphosis, they did not confirm if reduced vitamin A intake will also 
contribute to kyphosis, as suggested by the data synthesised in this thesis. Human studies 
have shown that approximately 60 times more vitamin A is transferred to offspring during 
the first 6 months of lactation in comparison to 9 months of gestation (Stoltzfus and 
Underwood, 1995). In addition DSM (2016) do not recommend additional feeding of vitamin 
A for lactating sows over gestating sows. Considering the significant demand for vitamin A 
during lactation, this raises the question as to whether lactating sows are receiving 
adequate vitamin A that satisfy nutritional demand in piglets. Therefore the proposed trial 
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should incorporate feeding reduced, adequate, or supplementary vitamin A to outdoor sows 
during gestation and lactation periods. Upon weaning, piglets should be split into two 
groups: diets with adequate or marginal concentrations of Ca and P, while containing similar 
levels of vitamin A. This setup will be crucial in determining if vitamin A supply during 
gestation and lactation will contribute to kyphosis, as suggested by the laboratory data. 
Given vitamin A’s hormonal control over skeletal development, it will be critical to observe if 
vitamin A supply during gestation and lactation will induce kyphosis in pigs fed a diet 
adequate in Ca and P. It will also be important to observe if a reduction in Ca and P will 
exaggerate kyphosis prevalence in response to vitamin A supply. Desired data that should 
be collected from the trial should include: kyphosis prevalence, and average weekly weight 
gain according to treatment. In addition, pigs should be tissue sampled at 2 weeks, 4 weeks, 
and 13 weeks of age, similar to the experimental design used in this thesis. Desired data 
from tissue should include: qPCR verification of GIT2 expression in trabecular bone, MicroCt 
analysis of individual vertebrae, liver RE concentrations, and serum Ca and P. The expression 
of GIT2 can be compared back to results obtained in this thesis in order to confirm if the 
proposed mechanisms indeed occur in response to vitamin A intake. If vitamin A is found to 
affect the prevalence of kyphotic pigs in this proposed intervention trial, a separate trial can 
be set up which can test if supplementation with vitamin A and vitamin D will eradicate 
prevalence of the disease.  
To summarise, the thesis has shown vitamin A potentially contributes to kyphosis through 
regulating GIT2 in vertebral trabecular bone, and this establishes vitamin A as a factor that 
can contribute to the disease. However vitamin A will need to be directly tested in an 
intervention trial to confirm if vitamin A intake is associated with kyphosis.    
6.5 Alternative Approaches for Future Work   
6.5.1 Zinc and Copper  
The underlying constituents of bone tissue are the minerals Ca and P (Whittemore and 
Kyriazakis, 2006). In order to progress from this research, it will be necessary to identify 
input from other nutritional factors that will be affecting Ca and P availability. A similar 
approach for how this thesis assessed the association of kyphosis with vitamin A should be 
considered in future work investigating vitamin D and kyphosis. This will allow for 
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identification of vitamin D regulated biomarkers in kyphosis that will contribute to Ca and P 
utilisation in bone. Another avenue to consider is how other minerals in the diet could be 
interfering with the activity of the enzyme phytase, which is required in pigs to digest P from 
phytate. Phytate binds ions such as Ca, or Zinc (Zn) and forms a divalent complex, digestion 
of these complexes by phytase allows for release and digestibility of these minerals (Bikker 
et al., 2013). However, supplementation of zinc to phytase-supplemented diets have 
demonstrated this lowers availability and digestibility of P (Poulsen et al., 2016, Lizardo et 
al., 2004). This could imply that, through limiting availably of P and therefore potentially 
bone mineralisation, zinc supplementation could contribute to kyphosis. To investigate this, 
zinc was preliminarily analysed in the serum of kyphotic and non-related control pre-
weaners via ICP-MS. The method allowed for analysis of copper, zinc, iron, and manganese 
in serum. While the results did not observe a difference in serum Zn, serum Cu was 
significantly reduced in kyphotic pre-weaners (Figure 6.3). However it must be noted that 
these data were not normalised according to parameters in blood such as protein content, 
nor were metal-ion free vacutainer tubes used to collect blood samples. Nonetheless, these 
initial results can direct the research in new directions.  
Low serum Cu concentrations have been associated with reduced BMD (Qu et al., 2018). In 
addition, supplementing Cu to broilers increased bone volume, trabecular thickness, as well 
as thickness of articular and epiphyseal cartilage (Muszyński et al., 2018).  There is, however, 
no clear interaction between Cu and phytase (Bikker et al., 2013). Cu could have an effect 
on cartilage, and thereafter, bone metabolism due its role in the activation of the lysyl 
oxidase enzyme, which regulates collagen cross-linking (Medeiros, 2016). It is highly 
recommended that this work be continued in future studies, and verify if serum and tissue 
concentrations of these metal ions can be associated with kyphosis across the 3 age groups 
analysed in this thesis.  To summarise, Cu and Zn should be investigated as the next dietary 
culprits in relation to the development of kyphosis. The data acquired from this analysis 
would add further insight into the role of nutrition in skeletal development.   
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Figure 6.3: The concentrations (µM) of Copper (Cu) and Zinc (Zn) in the serum of pre-
weaning (PreW) kyphotic and non-related control pigs. Data are presented as Arith means 
±SEM One way ANOVA AB p<0.05 
6.5.2 Recommended Experiments for Future Work  
One of the primary aims of this thesis was to characterise molecular associations within 
trabecular bone tissue in vertebrae. Although trabecular bone is the primary tissue type that 
composes the vertebral body, other constituents such as bone marrow persist within 
vertebrae. Due to logistical reasons, it would have been impractical to sample pure 
trabecular bone from vertebral samples in the field. Therefore, the findings in this thesis 
more accurately represent changes occurring within the vertebral body, which includes 
trabecular bone and bone marrow. The strength of this approach is that it emphasises the 
overall changes occurring within the vertebrae, but the main drawback is that it is not 
possible to pinpoint exact tissue or cellular type in which these changes are occurring. It 
would be useful to incorporate a histology approach in future efforts so as to identify 
changes in tissue architecture, as well as immunohistochemistry to visualise cellular 
localisation of translated proteins. Though the thesis has added significant knowledge in 
relation to the molecular basis of vertebral bone development, no precise biological 
mechanisms can be defined or proposed until it is possible to directly visualise and observe 
the changes occurring within the tissue.     
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One potential weakness of the approaches used in this thesis is that a microarray 
methodology was applied. This methodology can now be considered outdated in regards to 
emerging technologies which analyse differential gene expression. In recent years, RNA-
sequencing (RNA-seq) has been shown to have particular advantages over traditional 
microarrays (Wang et al., 2009). RNA-seq is not limited by detecting transcripts which 
correspond to a known genomic sequence, background noise is markedly reduced, and can 
detect a higher range of genes expressed at very low or high levels (Wang et al., 2009). An 
RNA-seq approach may therefore identify differentially expressed transcripts of which a 
microarray may not detect, but ultimately it would be beneficial to observe if transcripts 
overlap between the two technologies. Another item to take into consideration is 
interpretation from qPCR results which showed late Ct’s. A late cycle number in qPCR 
correlates with low copy numbers of the target transcript, and this can be problematic in 
relation to assay sensitivity. This is because, in the presence of low copies of the target 
transcript, primers can end up interacting with themselves to form primer-dimers, or with 
leftover RNA, resulting in the formation of non-specific PCR products. As a result, samples 
which show late Ct’s may therefore not be generating a signal truly representative of target 
transcript expression, which would lead to inaccuracy of results. Throughout this thesis, 
melting curve analysis was used to indicate the presence of non-specific PCR products, and 
therefore help identify samples producing a signal representative of the target transcript. 
This approach therefore added reliability to the obtained data from qPCR, and justifies the 
interpretation of the results in the thesis.          
The thesis has been unable to identify genes that are specifically confined to kyphotic pigs. 
However molecular investigations are not going to provide a complete picture of the biology 
of the disease. In addition, non-collagenous proteins which directly regulate bone matrix 
metabolism, such SPARC or BGLAP, were not indicated to be differentially expressed in 
kyphotic pigs. The answer, however, may not lie at the mRNA level. Post-translational 
modifications (PTMs) can occur on translated proteins to modulate or induce functional 
diversity; this field of research is termed “Proteomics” (Jensen, 2004). In the case of BGLAP, 
studies have shown the osteocalcin protein is glycated on its N-terminus, resulting in 
addition of a sugar to a free amine group (Thomas et al., 2017). The glycation of osteocalcin 
has been proposed to affect its ability to bind collagens and other non-collagenous proteins  
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during matrix mineralisation (Thomas et al., 2017). Furthermore, addition of mannose-type 
sugars to bone osteonectin have been identified that allow it to interact with various 
collagens, unlike platelet osteonectin which does not share similar PTMs (Kelm and Mann, 
1991). With TGF- β and BMP signalling, phosphorylation of TGF- β receptors, as well as 
downstream Smad molecules, is required in order to activate these molecules and thus 
regulate transmission of the pathway (Chen et al., 2012). In addition to this, PAK is 
phosphorylated upon interaction with Rho-GTPases in order to regulate cytoskeletal 
dynamics (Rane and Minden, 2014).  
However, proteomics should also be utilised to verify one critical question: the activity of 
RUNX2 in kyphotic and vitamin A treated pigs. This thesis has argued that osteoblast 
differentiation has been affected in both of these groups of pigs. Yet RUNX2 was not 
observed to be differentially expressed in either trials. However, studies in human BMSCs in 
vitro have shown that, unlike in rodent studies, the mRNA level of RUNX2 does not 
correspond to osteoblast differentiation (Shui et al., 2003). Rather, the authors observed the 
degree of phosphorylation of RUNX2 was more related to its ability to regulate osteoblast 
differentiation, despite no differences in mRNA or protein levels (Shui et al., 2003). RUNX2 
has been observed to be phosphorylated by the MAPK pathway (Xiao et al., 2000).  
The purpose of GIT2-regulated cytoskeletal dynamics are to initiate integrin-adhesion to the 
ECM, which is required to activate MAPK and ERK pathways (Hoefen and Berk, 2006, 
Hamidouche et al., 2009). In accordance with this, microarray analysis of trabecular bone 
showed MAPK12 and MAPK6 to be downregulated and upregulated in kyphotic and vitamin 
A pigs, respectively (Table 6.2). Therefore, GIT2 differential expression could be contributing 
to the degree of MAPK-dependent phosphorylation of RUNX2, which subsequently affects 
osteoblast differentiation in kyphotic and vitamin A pigs. Proteomics should be seriously 
considered as a follow-up to this thesis, in order to gain insight into how translated proteins 
and their functions have been affected in kyphotic pigs and pigs receiving vitamin A 
supplementation.  
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Pig Trial Gene Name Regulation p-value 
Kyphosis Mitogen activated 
kinase 12/MAPK12 
4.28↓ 0.007 
Vitamin A Mitogen activated 
kinase 6/MAPK6 
2↑ 0.041 
Table 6.2: Differential expression of Mitogen activated protein kinases in the trabecular 
bone of pre-weaning kyphotic pigs, and pigs receiving 10000µg RP/kg BW. The results were 
generated in Genespring, and the fold-change and p-value, determined by moderated T-Test 
in Genespring, is provided.   
Approaches beyond the laboratory also need to be considered if the causes of kyphosis are 
to be identified. While laboratory methods will help establish the biological basis of 
kyphosis, they will not confirm what factors, environmental or at the farm management 
level, cause kyphosis. To this end, an epidemiology survey must be performed in follow-up 
work. This approach will allow answers for critical questions such as: whether there is truly a 
seasonal effect in relation to kyphosis, in what age group are cases frequently observed, and 
whether particular feeding strategies on different farms can be attributed to kyphosis. This 
data, in combination with insights from laboratory analysis and intervention trials, will be 
able to provide the most detailed understanding of what causes kyphosis in pigs.      
6.6 Final Conclusions  
The research synthesised in this thesis has provided the first direct evidence of the 
underlying molecular mechanisms associated with the development of kyphosis in pigs. The 
thesis has illustrated the critical implications of DCN and GIT2 with bone development.     
Investigations have also revealed vitamin A’s association with Rho-GTPase pathways in 
trabecular bone, which has not been previously observed. The thesis has demonstrated how 
high doses of vitamin A regulates bone metabolism in trabecular bone. The thesis has also 
revealed that very high doses of vitamin A do not antagonise serum 25(OH) D, and that the 
relationship between the two vitamins is not simply antagonistic as previously assumed.   
The thesis has also ascertained vitamin A’s association with the molecular basis of kyphosis, 
particularly with GIT2 regulation in trabecular bone. The thesis adds justification to 
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determine if vitamin A supplementation will assist in the eradication of the disease. In 
addition, the thesis has illustrated that vitamin D deficiency is also associated with kyphotic 
pigs on UK farms, and supports a role for its use in intervention trials.    
Multiple approaches, beyond molecular investigations, are recommended for future 
endeavours in order to provide a complete picture of vitamin A’s roles in bone biology and 
to elucidate the cause of idiopathic lumbar kyphosis.  
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Appendix  
 
 
  
 Appendix A: Confocal microscopy images of retinyl esters (REs), stained blue, in stellate cells 
in livers from A. Controls and B. pigs receiving 3000µg RP/kg BW: blue staining, and 
therefore RE abundance, is clearly more concentrated in the treated group.   
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Appendix B: Standard operating procedure (SOP) for analysis of alkaline phosphatase in 
serum on a Roche Cobas 8000 system.  
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Appendix C: Standard operating procedure (SOP) for analysis of serum Calcium in a Roche 
Cobas 8000 system.  
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Appendix D: Standard operating procedure (SOP) for analysis of serum Phosphorus in a 
Roche Cobas 8000 system. 
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